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ABSTRACT 
Melissa A. Furlong: Prenatal Exposure to Organophosphorus Pesticides and Childhood 
Neurodevelopmental Phenotypes  
(Under the direction of Stephanie M. Engel) 
Background: Neurodevelopmental traits are often treated as independent in etiological 
studies, although neurological functions exhibit complex correlational structures. Allowing traits 
to cluster into phenotypes may produce outcomes that are more clinically and biologically 
relevant. Additionally, environmental exposures often occur in a mixture. Accounting for such a 
possibility may reduce bias that results from assuming exposures are independent. We sought 
to estimate associations between organophosphorus pesticides and neurodevelopment after 
accounting for these possibilities.    
Methods: A prospective birth cohort of 404 mother/infant pairs were followed from 
pregnancy until the children were 6 and 7-9 years of age. Factor analysis was performed on 
parent-report measures of child executive functioning and behavior, and performance-based 
measures of IQ. We estimated associations between demographic characteristics, maternal 
characteristics and environmental exposures during pregnancy and early childhood, and the 
neurodevelopmental factor scores after accounting for correlations among the factors.  
Results: We determined the existence of a seven factor solution. Smoking during 
pregnancy, canned fish consumption, maternal education, and HOME environment were 
associated with various factors. Prenatal exposure to ∑DMPs was associated with worse 
Internalizing factor scores but better Executive Functioning factor scores, while ∑DEPs were 
associated with worse Working Memory Index scores. Estimates were generally stronger for 
factor scores than for individual instrument-specific items. 
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Conclusions: Associations between prenatal exposure to OPs and worse internalizing 
behaviors and working memory scores are supported by prior findings in both human and 
animal studies. Associations with improved executive functioning are not supported by prior 
literature and may be a result of residual confounding by maternal executive functioning and 
dietary sources of OPs. 
A phenotypic outcome modeling approach may provide advantages over more traditional 
outcome modeling approaches. 
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CHAPTER I. INTRODUCTION AND SPECIFIC AIMS 
Introduction 
Prenatal exposure to organophosphorus pesticides has been associated with a wide 
range of neurodevelopmental outcomes at different stages of childhood, including deficits in 
childhood cognition (Bouchard et al., 2011a; S. M. Engel et al., 2015; S. Engel et al., 2011; V. 
Rauh et al., 2011), social responsiveness (Furlong et al. 2014), and behavior (Marks et al., 
2010). The affected domains are either hallmarks of, or are highly associated with, Attention-
Deficit Hyperactivity Disorder (ADHD) (Willoughby 2003), a syndrome characterized by 
inattention, hyperactivity, and impulsive behaviors, suggesting a plausible association between 
OPs and this overarching disorder. However, epidemiological studies that have considered 
prenatal exposures and childhood neurodevelopment or ADHD behaviors generally model 
exposures and outcomes in a 1:1 analytic framework (i.e., one chemical metabolite and one 
neurodevelopmental scale). There are several limitations to this approach. 
Using exposure mixture models can account for confounding by correlated 
contaminants. Women are actually exposed to complex mixtures of pollutants, and modeling 
exposures as though they are independent may result in biased estimates. Chemicals may be 
correlated with each other due to similar sources, such as plasticizers in products or insecticides 
for pest control (Engel and Wolff 2013). Interestingly, toxicology studies have begun to show 
that chemicals that initially act via different biological pathways may still result in similar 
downstream neuronal outcomes (such as increased neurotoxicity or altered neuronal 
differentiation) and may thus be important components in considering biological interactions or 
confounding with other chemicals.  
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Examining neurological scales and subscales singly is an overly simplistic 
representation of a complex system. Neurological development and functioning is a complex, 
interdependent system. Scientists have compartmentalized neurological functioning into bins 
(i.e., working memory, inhibitory control, perceptual reasoning, aggression), although the human 
brain evolved as an interdependent system. There are two major advantages in consolidating 
outcome data and considering phenotypes of neurodevelopment rather than using models that 
assume independence of each neurodevelopmental outcome. First, examining 
neurodevelopmental outcomes in the context of other impairments is clinically relevant. Several 
neurological functions rely on each other (for instance, the “higher-level” inhibitory control relies 
on more “basic” processing speed capability (Ridderinkhof and van der Molen 1997)), and 
deficits in one area are oftentimes compensated for by other areas. For instance, a deficit in 
working memory alone was only associated with poor social skills when accompanied by deficits 
in attention, hyperactivity, and impulsivity (Kofler et al. 2011), and working memory may only be 
associated with poorer academic achievement when accompanied by symptoms of inattention 
(Rogers et al. 2011). Second, patterns of correlations across scales may also point to different 
clinical phenotypes – when aggression problems are accompanied by high impulsivity, 
researchers note a different profile of aggressive behavior (reactive-impulsive) than when 
aggression is accompanied by higher levels of self-control (controlled-instrumental) (Vitiello and 
Stoff 1997), and these differences are associated with different patterns of behaviors and 
criminality (Nelson and Trainor 2007). Therefore, examining performance on scales within the 
context of other instruments can provide clinically relevant profiles of neurodevelopment that are 
also differentially associated with later life outcomes. 
Clustering behavioral and cognitive performance across scales can create factors that 
reflect common etiological mechanisms and allow a more biologically relevant consideration of 
the OP-neurodevelopment relationship. Behavioral and cognitive deficits that are clinically and 
statistically correlated may reflect a common etiological insult. For instance, OPs influence 
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serotonergic processing (Aldridge et al. 2005b; Aldridge et al. 2004; Slotkin et al. 2008b; Slotkin 
and Seidler 2005). Serotonin, in turn, can influence aggression, social behaviors, depression, 
and ADHD (Cadoret et al. 2003; Eley et al. 2004; Zoroğlu et al. 2002), and these symptoms may 
cluster in response to a global disruption in upstream processing like serotonergic functioning. 
Animal and human studies do support that OPs may be associated with those behavioral 
outcomes (Bouchard  et al. 2010; Eskenazi et al. 2007; Furlong  et al. 2014; Middlemore-Risher 
et al. 2010; Ricceri et al. 2003; Ricceri et al. 2006), which are perhaps mediated by serotonergic 
functioning (Slotkin and Seidler 2008; Venerosi et al. 2010). However, aggression is also 
influenced by non-serotonergic mechanisms, including disruptions to the frontal and prefrontal 
cortex, GABA, oxytocin, dopamine, and MAO-A systems (reviewed in (Nelson and Trainor 
2007)). OPs do not necessarily influence all of these systems, and patterns of behaviors that 
are influenced by serotonin are not associated with all of these systems either. However, when 
outcomes such as aggression are analyzed individually outside of the context of other 
symptoms, aggression from any neurological source is lumped, including aggression that is the 
result of non-OP-influenced mechanisms. By instead considering behavioral and cognitive 
clusters, we may characterize patterns of development (such as ADHD (Castellanos et al. 2006; 
Mattison and Mayes 2010; Semrud-Clikeman et al. 2010; Sinzig et al. 2008)) that theoretically 
represent common etiologies.  
Using data from the prospective Mount Sinai Children’s Environmental Health Center 
cohort, we take advantage of multi-pollutant exposure and multidimensional and longitudinal 
neurodevelopmental outcome data to create a model that: 1) is a more accurate depiction of 
real-life exposure mixtures, and 2) takes into consideration the interdependency of 
neurodevelopment to create behavioral and cognitive profiles. This model will account for 
confounding by co-contaminants and take advantage of clustering across scales to create 
neurodevelopmental profiles that may be more representative of biological pathways affected by 
OPs than the 1:1 analytic approach.  
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Specific Aim 1 
 To create phenotypes of neurodevelopment, using measures of cognition (Wechsler 
Preschool and Primary Scale for Infants and Toddlers [WPPSI], Wechsler Intelligence Scale for 
Children-IV [WISC-IV]), behavior (Behavioral Assessment System for Children [BASC]), and 
executive functioning (Behavioral Rating Inventory of Executive Functioning [BRIEF]), in the 
Mount Sinai Children’s Environmental Health Center Cohort.  
 Aim 1.1: To create phenotypes using a principal components analysis with orthogonal 
varimax rotation. 
 Aim 1.2: To estimate associations between prenatal and early life characteristics and 
neurodevelopmental factors created in Aim 1.1.  
 Aim 1.3: To compare estimates of associations between prenatal smoking and 
neurodevelopment using 1) factors derived from an orthogonal rotation, 2) factors derived from 
an oblique rotation, and 3) instrument-specific composite scores. 
Specific Aim 2 
 To estimate associations of OPs with phenotypes of neurodevelopment in a mixture 
model, and assess modification by potentially important characteristics.  
 Aim 2.1: Estimate associations between OPs and neurodevelopmental phenotypes in a 
mixture model that accounts for possible confounding by other classes of xenobiotic chemicals 
(phthalates, phenols, and pyrethroids) in a Bayesian framework.  
 Aim 2.2: Assess modification of the OP-neurodevelopment relationship by race, sex, and 
paraoxonase 1 (PON1) genotype, a gene integral to the metabolism of organophosphorus 
pesticides.
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CHAPTER II. BACKGROUND 
Source, Route, and Estimation of Organophosphorus Pesticide Exposure 
Organophosphorus Pesticide Use in the United States 
Organophosphorus pesticides (OPs) refer to a group of pesticides that contain an 
organic phosphorus(V)-containing compound, which in most cases is O,O-dialkyl substituted, 
where the alkyl groups are either dimethyl or diethyl (Mileson et al. 1998). Forty OPs are 
currently registered for use in the United States. In 2001, the EPA banned OPs for most 
residential uses, although stocks were allowed to run out and container-bait traps were allowed 
to remain on the market. OPs also remain in use for agricultural purposes and nonresidential 
uses such as for golf courses, greenhouses, and for mosquito and fire ant control. The EPA 
recently proposed revoking food tolerances for chlorpyrifos, one commonly used OP insecticide, 
and will issue a final ruling in December 2016 (EPA, 2016). In 2000, 88 million pounds of OPs 
were applied in the United States, and by 2007, this number had dropped to 33 million pounds 
(EPA 2011). Biomarker levels of OPs also dropped after 2001, although over 25% of the 
population still had detectable levels of OP metabolites in 2003-2004, as did over 50% in 
selected subgroups (mainly Mexican-Americans and non-Hispanic Blacks) (CDC 2009).  
Environmental Fate, Breakdown, and Metabolism of Ops 
Use of OPs grew after environmentally persistent organochlorine pesticides were 
banned in the 1970’s, in part because OPs are less persistent in the environment and break 
down fairly rapidly (within weeks to months) in the presence of sun, water, wind, and microbes. 
However, when used indoors, OPs may remain stable for months to years (Fenske et al. 2000), 
with house dust potentially acting as a long-term source of exposure. 
  6 
 Breakdown and metabolism of OPs is a complex process. Several OPs do not exhibit 
primary toxicity in the parent pesticide form, but rather confer toxicity after undergoing 
enzymatic conversion to the oxon form; an oxon is a chemical in which the phosphorus-sulfur 
bond has been replaced by a phosphorous-oxygen bond. This oxon form is toxic and 
biologically active due to the electrophilicity conferred on the phosphorous ion. The oxon is then 
hydrolyzed, and in most cases forms a general dialkyl phosphate (DAP) metabolite (usually 
either dimethyl or diethyl phosphorous derivatives, including diethylphosphate, 
diethylthiophosphates, diethyldithiophosphates, dimethylphosphate, dimethylthiophosphate, and 
dimethyldithiophosphate), along with a specific metabolite moiety (such as t-CPY for 
chlorpyrifos and methyl chlorpyrifos, or 4-nitrophenol for methyl parathion and parathion). 
Seventy five percent of OPs break down into 1 to 3 of the general metabolites (Wessels et al. 
2003). Figure 1 shows an example of these processes in the metabolism and breakdown of 
chlorpyrifos (reprinted from (Wessels  et al. 2003)). However, any given pesticide-specific 
metabolite moiety in the urine tends to have a low frequency of detection in the US population 
relative to the common metabolites (Barr et al. 2004), which derive from several different OPs 
(see Table 1).  
As a result, a common approach to the estimation of OP exposure is through summary 
urinary biomarker measures of the non-specific diethylphosphate (ΣDEPs) and 
dimethylphosphate (ΣDMPs) metabolites, despite the limitations of these biomarkers as internal 
dosimeters (Wessels  et al. 2003)). In brief, these limitations include that 1) a number of 
different OP pesticides can be metabolized into the same DEP or DMP metabolites, preventing 
investigators from making any definitive link to the parent compound of exposure, 2) the 
different parent compounds have varying levels of toxicities, so summary DAPs may not reflect 
similar toxicities across populations, and 3) metabolism of the DAPs can occur either in the 
human body or in the environment. Exposure to a preformed DAP metabolite is non-toxic, while 
exposure to the parent oxons appears to confer toxicity (Mileson  et al. 1998; Wessels  et al. 
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2003; Zhang et al. 2008). Nonetheless, use of ΣDEP and ΣDMP metabolites remain the most 
common method of exposure ascertainment in the general population, since the pesticide-
specific moieties have detection frequencies that are too low to warrant widespread 
measurement.  
Individual susceptibility to toxic effects of OPs may also vary by genotype. The 
conversion of the pesticide to the oxon is in part governed by cytochrome p450 metabolism, and 
the conversion of the oxon to the metabolites is in part governed by paraoxonase 1 (PON1) 
(Costa et al. 1999). A number of polymorphisms have been described in PON1 that affect either 
gene expression or substrate-specific catalytic efficiency. These include the coding 
polymorphisms Q192R and L55M, as well as the promoter polymorphism -108C>T. Roughly, 
Q192R determines catalytic efficiency, while L55M and -108C>T are associated with levels of 
the enzyme, although the latter two are in strong linkage disequilibrium and enzyme levels may 
only be determined by one of the two SNPs. Those with an M allele in the L55M SNP have 
lower PON1 levels on average (Brophy et al. 2001).The Q192R SNP is associated with faster 
catalytic efficiency in a substrate-specific manner. Some pesticides are more efficiently 
detoxified by the Q allele (diazoxon, sarin, soman), while others are more efficiently detoxified 
by the R allele (paraoxon) (Costa  et al. 1999). Further, OPs that break down into dimethyl 
moieties may have limited potential for detoxification by PON1 (Geldmacher‐von Mallinckrodt & 
Diepgen, 1988; Li et al., 2000).There is also significant overlap of enzymatic levels and activities 
across genotypes, and thus some researchers recommend assessing the overall “PON1 status” 
of an individual, and considering genotype and phenotype of PON1. Unfortunately, since PON1 
levels are inducible, in some cases it is unclear whether the levels or activity reflect 
responsiveness to OP exposure (and thus also higher overall OP exposure) or simply baseline 
levels (thus reflecting higher detoxifying potential and lower OP exposure).  Further complicating 
matters, PON1 is also important in protecting low density lipoproteins (LDL) from being oxidized, 
and thus may impart some protection to oxidative stress (Bhattacharyya et al. 2008; Durrington 
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et al. 2001; Li et al. 2003), although the protective alleles often vary by cohort and population (Li  
et al. 2003). 
Source of Exposure 
 In the general population, levels of DAPs are likely to predominantly arise from dietary 
exposure (Lu et al. 2006). Both parent pesticide residues and the dialkylphosphate metabolites 
are found on fruits and vegetables, with one study suggesting that a slight majority of the molar 
ratio of OP residues were preformed DAPs rather than the parent oxon or pesticide, from 
strawberries collected in 2003 (Zhang  et al. 2008). Additionally, in a study of OP exposure 
using the specific metabolites for chlorpyrifos and malathion, median metabolite levels were 
reduced to non-detectable levels after changing children’s fruit and vegetable consumption to 
completely organic sources for two weeks (Lu  et al. 2006). Thus, metabolites measured from 
dietary exposure likely reflect a combination of exposure to the preformed, non-toxic DAP 
metabolites, and to the parent pesticide. However, in populations exposed to OPs either through 
agricultural or residential use (particularly in some highly-exposed residential populations prior 
to 2001), DAP levels may mainly reflect exposure to the parent pesticide. 
Associations between Prenatal Exposure to Organophosphorus Pesticides and 
Neurodevelopmental Outcomes 
Overview 
OPs may work as developmental neurotoxins through a few different mechanisms 
(reviewed in (Eskenazi et al. 1999). OPs are primarily cited as acetylcholinesterase inhibitors, 
which results in a buildup of acetylcholine at the synaptic cleft. In acute OP poisoning, this can 
also cause overstimulation of nicotinic receptors. Symptoms include muscle weakness, fatigue, 
muscle cramps, paralysis, anxiety, headaches, and possibly coma or death. OPs also appear to 
be chronically neurotoxic at much lower doses, through the inhibition of acetylcholinesterase 
and the generation of oxidative radicals (Qiao et al. 2005), alteration of nuclear transcription 
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factors (Crumpton et al. 2000), and/or alterations in serotonergic and dopaminergic synaptic 
activity (Aldridge et al. 2005a; Aldridge  et al. 2005b).  
Low level prenatal exposure to OPs has been associated with a wide range of 
neurological outcomes in both animal and human studies. These include a cross-sectional study 
that reports associations with ADHD (Bouchard  et al. 2010), and prospective biomarker-based 
studies that report associations with decrements in attention (Barr et al. 2010; Marks  et al. 
2010; Rauh et al. 2006), IQ (Bouchard  et al. 2011; Engel  et al. 2011; Rauh  et al. 2011), social 
responsiveness (Furlong  et al. 2014), and Pervasive Developmental Disorder (Eskenazi  et al. 
2007), although Eskenazi et al. also reported no association with measures of attention at 24 
months of age. Other studies that relied on occupational histories or self-reported residential 
exposure have associated OP exposure with decrements in attention, short-term memory, and 
design copying on the Stanford Binet IQ test (Grandjean et al. 2006; Ruckart et al. 2004).  In 
animals, prenatal OP exposure has been associated with deficits in neurocognitive functioning 
(Levin et al. 2002; Timofeeva et al. 2008), impulsivity and attention problems (Cardona et al. 
2011; Chanda and Pope 1996; Middlemore-Risher  et al. 2010), animal models of depression 
(Aldridge  et al. 2005a), and other behaviors (Gupta et al. 1985). Further, many of these 
associations have been shown to be sex-specific in animals (Levin  et al. 2002; Levin et al. 
2010; Slotkin  et al. 2008b), and race- and sex-specific in humans (Engel  et al. 2011; Furlong  
et al. 2014). Many of these behaviors (inattention, impulsivity, social problems) are 
characteristic of ADHD, but no prospective epidemiological studies have evaluated this 
association with a clinically validated case group, or taken advantage of clustered outcome data 
to examine associations with ADHD-like phenotypes of behavior, cognition, and executive 
functioning. In fact, no birth cohorts have previously reported on the associations between OPs 
and executive functioning, which is a hallmark of ADHD. Thus, prenatal exposure to OPs 
appears to have a wide-ranging influence on several aspects of neurodevelopment, but may 
actually be associated with ADHD (discussed in further detail in Chapter 2: Spotlight on ADHD).  
  10 
OPs and Neurodevelopment: Birth Cohorts 
A few children’s environmental health centers were formed in the late 1990’s and early 
2000’s to address questions of associations between prenatal exposure to neurotoxicants and 
reproductive outcomes and/or childhood development. These included the CHAMACOS cohort 
in Berkeley, with participants composed predominantly of Hispanic agricultural workers; the 
Mount Sinai cohort in New York City, a multiethnic cohort with participants recruited both from 
the Bronx and the Upper East Side of Manhattan; the Columbia cohort, a cohort of Dominican 
and African American women in New York City; and the Cincinnati Health Outcomes and 
Measures of the Environment Study (HOME) cohort, with participants recruited from the 
Cincinnati metropolitan area. Mount Sinai enrolled participants from 1998 to 2001, Berkeley’s 
CHAMACOS enrolled from 1999-2000, Columbia enrolled from 1999-2006, and the Cincinnati 
cohort enrolled from 2003-2006. These cohorts thus vary by geography, socioeconomic status, 
and enrollment time period before/after the OP ban.  
Reported associations between prenatal OP exposure and child neurodevelopmental 
outcomes have not been entirely consistent across cohorts (Table 2), which in part may be due 
to the fact that sources of exposure, prevalence of different parent compounds, and the ratio of 
of preformed DAP to parent compound exposure may vary across study cohorts. As discussed 
in section 1.1, cohorts typically use ΣDEPs and ΣDMPs as a summary measure of OP exposure 
(with the exception of the Columbia cohort, which has mostly relied on a blood biomarker of 
chlorpyrifos), but since various parent pesticides may break down into the same metabolites 
(Table 1), and not all of these parent pesticides have similar toxicities, the toxicity of ΣDEPs and 
ΣDMPs may not be highly comparable across populations with different exposure sources. 
Participants in the Mount Sinai cohort were primarily exposed to pesticides used for urban pest 
control measures or through pesticide residues from their diet, while in CHAMACOS, 
participants were primarily exposed to pesticides in an agricultural setting. CHAMACOS 
participants had much higher levels of ΣDMPs than any other cohort. In the Cincinnati HOME 
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study, the cohort is primarily semi-urban or suburban, and participants were generally exposed 
to pesticide residues in their diet, since the cohort began enrollment two years after the ban on 
most residential uses of chlorpyrifos and diazinon. HOME is the only cohort to have reported a 
positive association between OP pesticide metabolites and neurodevelopment, which is likely 
confounded by consumption of fruits and vegetables, the primary vector for OP metabolites in 
this population. Additionally, fruit and vegetable consumption may result in a high consumption 
of preformed metabolites, which are non-toxic and reduce the accuracy of the ΣDAP 
metabolites as a measure of exposure to the toxic OP oxon. Findings from this cohort on 
associations between prenatal OP exposure and later neurodevelopmental outcomes have not 
yet been published at the time of the present study, thus, it is unknown whether these positive 
associations are maintained throughout childhood. Differences in source, type, and dose may 
explain why some studies report different associations with different metabolites (see Table 2 
for summary of associations). Indeed, a recent pooled study that incorporated DAPs across the 
four cohorts reported substantial heterogeneity by cohort, with DMPs from CHAMACOS 
resulting in the strongest adverse associations with the Bayley’s MDI at age 2 (S. M. Engel et 
al., 2015).  
PON1 and Other Modifying Factors 
PON1 
 Associations of the PON1 polymorphisms (PON1 Q192R, L55M and -108C>T) and 
PON1 enzyme levels have been assessed as potential modifiers (and as main effects) in the 
associations between prenatal exposure to OPs and childhood neurodevelopment. However, 
results have not been consistent with regards to the important polymorphism or the oxons that 
appear to be modified. For instance, Engel et al (2011) report that Q192R modifies the 
association between ΣDEPs and ΣDMPs and the BSID-II 12-month Bayley MDI in the Mount 
Sinai Cohort with stronger adverse associations among those with the QR/RR genotype. 
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However, this effect is absent in the 24-month MDI and in the 6-to-7-year WISC IQs. In 
CHAMACOS, Eskenazi et al (2010) reported that the -108T allele itself resulted in lower MDI 
scores, although there was no interaction between genes and OPs on Bayley MDIs or PDIs 
among 2-year-olds. They also measured maternal arylesterase and paraoxonase activity levels, 
and reported that children of mothers with higher activity levels were slightly less likely to display 
PDD (pervasive developmental disorders). Regardless of inconsistent evidence, PON1 
genotype and phenotype may play important roles in modifying the associations between OPs 
and neurodevelopment in the Mount Sinai cohort. 
OPs not only impart toxicity through the mechanisms discussed earlier, but they also 
generate oxidative radicals (Qiao  et al. 2005). Thus, while much of the research on PON1 as a 
modifier of organophosphorus pesticides has been driven by its potential to detoxify 
organophosphorus pesticides, PON1 may also be important in reducing oxidative stress 
responses to these pesticides.  
Race and Sex 
In animal models, OPs and other prenatal exposures appear to have sex specific effects 
(Aldridge  et al. 2004; Levin  et al. 2010; Slotkin et al. 2008a), and this has been partially borne 
out in the epidemiological literature on OPs (Furlong  et al. 2014). Additionally, a small-scale 
fMRI study of children who were highly exposed to chlorpyrifos reported suggestive neurological 
differences by sex (Rauh et al. 2012). In general, the developing male brain may be more 
susceptible to environmental insults (Barrett 2009), although behavioral issues may be under-
diagnosed in females (Begeer et al. 2013; Bruchmüller et al. 2012), possibly leading to 
substantial outcome misclassification which may obscure associations. 
Race may be an important modifier due to differences in culture, genotype frequency, or 
insofar as it reflects imperfectly measured socioeconomic vulnerabilities. The strength of these 
differences vary by cohort; in CHAMACOS, almost all mothers were Hispanic; in Columbia, 
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cohort members were restricted to blacks and Hispanics (predominantly Dominicans); in 
Cincinnati, mothers were predominantly upper-middle-class whites; while in Mount Sinai, 
participants were a mix of both whites from Manhattan and blacks and Hispanics from the Bronx 
and East Harlem. Notably, Mount Sinai is the only cohort to have reported any modifications by 
race, probably because this is the only cohort which has sufficient racial/ethnic variability, and 
also because the racial differences reflect drastic differences in socioeconomic status. In Mount 
Sinai, studies generally report stronger adverse associations between OPs and 
neurodevelopment among blacks, and little or no effect of OPs among whites. Cincinnati is the 
only cohort to have reported positive associations between OPs and any childhood outcome. 
These differences by race may be due to differences in exposure source, or access to 
resources. For instance, higher SES mothers may be more likely than lower SES mothers to 
access early intervention services for their children, which might obscure possible effects of 
pesticide exposure in these children. Race in this cohort will thus be assessed as a modifier.  
Other Xenobiotics and Neurodevelopmental Outcomes 
 Other chemicals with different mechanisms of action also have been associated with 
various aspects of neurodevelopment. Phthalates have been consistently associated with 
alterations in behavior, executive functioning, and possibly sex development in prospective 
cohort studies (Engel et al. 2010; Kobrosly et al. 2014; Miodovnik et al. 2011; Swan et al. 2010; 
Whyatt et al. 2012; Yolton et al. 2011). Associations with IQ have been reported in cross-
sectional studies (Cho et al. 2010), but results from the prospective cohort studies that report 
prenatal phthalate associations with IQ in children over 1 year are mixed (Factor-Litvak et al. 
2014; Polanska et al. 2014; Téllez-Rojo et al. 2013; Werder 2012). Phthalates may act as 
endocrine and thyroid disruptors (Colborn 2004), and some studies do report sex-specific 
effects (Cho  et al. 2010; Engel et al. 2009; Kim et al. 2009; Téllez-Rojo  et al. 2013). Phthalates 
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may be associated with outcomes that are also associated with OP exposures, although 
potentially through different biological mechanisms.  
Phenols (BPA in particular) have been associated with measures of behavior, typically in 
a sex-selective manner (Braun et al. 2009; Evans et al. 2014; Harley et al. 2013; Perera et al. 
2012). Spot urine of BPA measures, however, may be an unreliable measurement of BPA 
throughout pregnancy, since intra-class correlation coefficients are typically <0.20 (Braun et al. 
2010; Mahalingaiah et al. 2008). 
The literature on prenatal pyrethroid insecticides and neurodevelopment is small, 
perhaps due to the relatively recent rise in pyrethroid use. Nevertheless, two recent studies 
have reported associations between prenatal exposure to pyrethroids and adverse 
neurodevelopment (Qi et al., 2011; Watkins et al., 2016), while another reports associations 
between exposure during childhood and adverse verbal and working memory scores (Viel et al., 
2015). Another study found no association between prenatal permethrin exposure and 
neurodevelopment, but did report an association between piperonyl butoxide, a permethrin 
synergist, and adverse scores on the BSID-II (Bayley II) Mental Development Index in 3-year-
olds (Horton et al. 2011). Finally, another study examined associations between a permethrin 
metabolite, PBA, and birth outcomes and head circumference, and reported no association 
(Berkowitz et al. 2004). In animal models, prenatal exposure to pyrethroids have been 
associated with altered cholinergic functioning and decreases in learning and memory 
performance (Sinha et al. 2006), and studies commonly report changes in motor activity and 
acetylcholinergic receptor density (reviewed in (Shafer et al. 2005)).  
Phthalates, phenols, and pyrethroid pesticides are all relatively common environmental 
exposures with a wide range of suspected impacts on neurodevelopment. These exposures 
may confound the OP – neurodevelopment associations through correlated sources of 
exposure. 
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Confounding and the Mixture Problem 
Toxicology 
Few epidemiologic studies have taken mixtures into account in the modeling process. As 
described above, prenatal exposure to several ubiquitous chemicals have been implicated in 
neurodevelopmental outcomes during childhood. These chemicals may impact 
neurodevelopment either by disrupting the endocrine system (Colborn 2004), through 
interference with neurotransmitters (Kwong 2002; Picciotto et al. 1998; Slotkin and Seidler 
2008), or by interfering with DNA repair and inducing general neurotoxicity (Jamal et al. 2002). 
Since exposure is ubiquitous (Castorina et al. 2005; Neta et al. 2010), people are generally 
exposed to these and other chemicals as a mixture. However, previous studies have modeled 
associations as if chemical exposures occur independently. This is despite the fact that several 
of these chemicals have similar mechanisms of action (phthalates and some phenols are 
endocrine disrupting chemicals), while others have correlated reasons for use (pesticides). 
Additionally, exposures may be correlated due to demographic features. For example, chemical 
exposure overall is higher in individuals of lower socioeconomic status (Evans and Kantrowitz 
2002), although this might not be true for all chemical classes. In a select few epidemiologic 
studies, researchers have found that accounting for mixtures produces different results from 
analyzing them individually (Rull et al. 2006; Wickerham et al. 2012). 
In sum, accounting for mixtures may yield different results than considering compounds 
as if they were independent.  
Statistical Approaches 
 In the face of substantial collinearity between predictors, standard estimates may have 
extremely wide variances. Additionally, power to detect an effect will be constrained as the 
number of covariates increases, and the model may become unwieldy and less informative as 
more covariates are added. Some statisticians have recommended using penalized maximum 
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likelihood, which maximizes the log-likelihood but also implements a penalty favoring 
coefficients close to zero, in order to address these problems of high dimensionality and 
collinearity (Genkin et al. 2007; Tibshirani 1996).  
 Lasso and ridge regression are two methods that rely on penalized maximum likelihood. 
Lasso penalizes the sum of the absolute values of the regression coefficients, while ridge 
regression penalizes the sum of the squared coefficients (Genkin  et al. 2007; Tibshirani 1996). 
Both methods stabilize the estimation and result in lower mean squared error than standard 
maximum likelihood estimation (MLE) by shrinking coefficient estimates toward zero. These 
methods work well compared to standard MLE when sample size is relatively small and the 
number of parameters to estimate is relatively large.  
 In Bayesian models, a prior distribution is assigned and estimates are shrunk towards 
the prior to an extent determined by the likelihood of the observed data. Estimates from the 
lasso produce estimates that are equivalent to the posterior estimates in a Bayesian regression 
that implements a double-exponential prior distribution on the coefficients (Park and Casella 
2008; Tibshirani 1996). Use of independent normal priors on coefficients in a Bayesian model 
results in posterior estimates that are equivalent to those from a ridge regression (Griffin and 
Brown 2010). Ridge and lasso, however, do not account for uncertainty in the “priors” or 
penalties, and may result in over-shrinkage of important exposures. In Bayesian modeling, we 
are free to adopt alternate priors which may avoid this problem and account for uncertainty in 
prior assignment (Dunson et al. 2008; Herring 2010).  
Clustering Outcomes Data 
 Prospective epidemiological cohort studies that examine the associations between 
environmental contaminants and childhood behavior/neurodevelopment have collected a range 
of neurodevelopmental instruments at various ages, motivated by a desire to obtain a broad 
view of that child’s neurodevelopmental functioning. To date, most studies have assessed 
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associations within one instrument at a time, possibly presenting the results of multiple 
instruments in a single manuscript, but rarely considering results across instruments with 
phenotypic groupings. For instance, for the Wechsler Intelligence Scale for Children- IV (WISC-
IV), researchers may report associations with scores on individual scales such as memory, 
processing speed, verbal comprehension, perceptual reasoning, and also on Full Scale IQ 
scores, which reflects performance on several scales. Or, if studying behavior and considering 
the Behavioral Assessment System for Children (BASC), researchers may report individual 
associations with aggression, hyperactivity, anxiety, depression, somatization, and attention. If a 
researcher finds associations between OPs and both behavioral measures and IQ subscales, 
researchers may interpret that OPs have separate impacts on both behavior and cognition. This 
interpretation might be faulty for several reasons reviewed below. 
Advantages of Clustering Outcomes Data: Clinically Relevant Outcomes  
 Phenotyping of individuals using data from multiple instruments is not a unique 
approach. Indeed, qualitatively, this is the approach clinicians use when evaluating children for 
a neurodevelopmental disability. Since neurological functioning evolved as an interdependent 
system, functions that govern behavior are highly reliant on each other and may compensate for 
each other in the event of weaknesses or deficits in specific areas. For instance, “higher-level” 
inhibitory control relies on more “basic” processing speed capability (Ridderinkhof and van der 
Molen 1997). Accurate working-memory for conjunctions (or relations), which is typically 
considered a function of the prefrontal cortex, relies on proper functioning of the hippocampus 
(Olson et al. 2006). And, higher-level executive functions (EFs) are dependent on less complex 
EF processes, including attention, memory, perception, and categorization (Eslinger 1996). 
Deficits may also be compensated for by strengths in other regions; working memory alone is 
only associated with poor social skills when accompanied by deficits in attention, hyperactivity, 
and impulsivity (Kofler  et al. 2011), and problems with working memory may only be associated 
  18 
with poorer academic achievement when accompanied by symptoms of inattention (Rogers  et 
al. 2011).  
 Patterns of correlations across scales may also point to different clinical phenotypes – 
when aggression problems are accompanied by high impulsivity, researchers see a different 
profile of aggressive behavior (reactive-impulsive) than when aggression is accompanied by 
higher levels of self-control (controlled-instrumental) (Vitiello and Stoff 1997), and these 
differences are associated with different patterns of behaviors and criminality (Nelson and 
Trainor 2007). Similarly, children with ADHD who display both inattention and hyperactivity, but 
not hyperactivity alone, have significantly lower cognitive scores than their non-ADHD 
counterparts (Ramos et al. 2013). Different subtypes of ADHD may have different executive 
function profiles, although this is a debated topic  [reviewed in (Geurts et al. 2005), and 
discussed in further detail in section 1.5.3]. Therefore, examining performance on subscales 
within the context of other instruments may provide clinically relevant profiles of 
neurodevelopment that are also differentially associated with later life outcomes.     
Advantages of Clustering Outcomes Data: Relevance to Biological Interpretations of OP 
Mechanisms  
 Clustering outcome data may help reveal mechanisms of OP toxicity. Behavioral and 
cognitive deficits that are clinically and statistically correlated may reflect a common etiological 
insult. For instance, OPs influence serotoninergic processing (Aldridge  et al. 2005b; Aldridge  et 
al. 2004; Slotkin  et al. 2008b; Slotkin and Seidler 2005). Serotonin, in turn, can influence 
aggression, social behaviors, depression, and ADHD (Cadoret  et al. 2003; Eley  et al. 2004; 
Zoroğlu  et al. 2002), and these symptoms may cluster in response to a global disruption in 
upstream processing like serotonergic functioning. Animal and human studies do support that 
OPs may be associated with those behavioral outcomes (Bouchard  et al. 2010; Eskenazi  et al. 
2007; Furlong  et al. 2014; Middlemore-Risher  et al. 2010; Ricceri  et al. 2003; Ricceri  et al. 
2006), which are perhaps mediated by serotonergic functioning (Slotkin and Seidler 2008; 
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Venerosi  et al. 2010). However, aggression is also influenced by non-serotonergic 
mechanisms, including disruptions to the frontal and prefrontal cortex, GABA, oxytocin, 
dopamine, and MAO-A systems (reviewed in (Nelson and Trainor 2007)). OPs do not 
necessarily influence all of these systems, and patterns of behaviors that are influenced by 
serotonin are not associated with all of these systems either. When outcomes such as 
aggression, are analyzed individually outside of the context of other symptoms, all aggression is 
lumped, including aggression that is the result of non-OP-influenced mechanisms. By instead 
considering behavioral and cognitive clusters, we can characterize patterns of development 
(such as ADHD (Castellanos  et al. 2006; Mattison and Mayes 2010; Semrud-Clikeman  et al. 
2010; Sinzig  et al. 2008)) that theoretically represent common etiologies.  
While correlated deficits may reflect a common etiological insult, behavioral deficits in one 
area may also interfere with appropriate development of other behaviors or cognitive functions. 
For instance, aggression may interfere with the development of intellectual functioning 
(Huesmann et al. 1987), and the development of successful social skills and emotional self-
regulation are potentially reliant on some levels of inhibitory control at earlier ages (Carlson and 
Wang 2007). Inattention and impulsivity are correlated with lower IQs later (Ramos  et al. 2013). 
The correlation in these deficits may be in part because proper functioning in one area relies on 
appropriate development of earlier behaviors. Thus treating outcomes that are clinically and 
statistically correlated as independent may obscure the underlying mechanism of OP toxicity. 
Advantages of Clustering Outcomes Data: Spotlight on ADHD 
Attention Deficit Hyperactivity Disorder (ADHD) is a complex, heterogeneous disorder 
characterized by inattention, impulsivity, and hyperactivity. ADHD is one of the most common 
childhood neurobehavioral disorders, and in 2011, approximately 11% of children between 4 
and 17 had ever received a clinical diagnosis of ADHD, an increase of 43% from 2003 (Visser et 
al. 2014). The disorder appears to be more prevalent in males than females by a factor of 2-3 to 
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1, which may reflect diagnostic bias, with notable under-ascertainment among females 
(Bruchmüller  et al. 2012). Risk factors for ADHD include having a relative with the disorder 
(Biederman et al. 1992), alcohol use or smoking during pregnancy  (Milberger et al. 1996) 
(although there is controversy on whether the smoking/ADHD relationship is confounded by 
genetics), preterm birth, and possibly prenatal exposure to high levels of PCBs, lead, and 
pesticides (Polańska  et al. 2013; Sioen et al. 2013).  
A gold-standard ADHD diagnosis is based on observations from a clinical exam, home, 
and school reports. The DSM-V criteria states that children must meet at least six of the criteria 
established for hyperactivity and impulsivity, or six of the criteria established for inattention 
(criteria included in Appendix 1). Symptoms must be present in at least two different settings, 
and behavioral or clinical assessments are often given to provide further evidence of behavioral 
abnormalities.  
However, this categorical construct of ADHD has been recently challenged in the 
literature, with psychologists proposing that a dimensional view of ADHD is a more relevant 
model than the categorical view (Coghill and Sonuga‐Barke 2012). Children with high levels of 
ADHD symptomatology may not qualify for an ADHD diagnosis, but these children still often 
experience similar difficulties in social adjustment and academic achievement (Loe and 
Feldman 2007). Further, deficits that are typically considered specific to ADHD, such as deficits 
in basic information processing and inhibitory-based executive functioning, are linearly 
associated with ADHD symptoms across categories of children with no ADHD behaviors, 
subclinical-ADHD, and ADHD (Salum et al. 2014). In fact, most childhood behavioral disorders 
exist on a spectrum in the population. Oppositional defiant disorder (ODD), autism spectrum 
disorder (ASD), and obsessive compulsive disorder (OCD) display varying levels of trait severity 
among children with the disorder, and symptoms are also present at subclinical levels in the 
population (Coghill and Sonuga‐Barke 2012; Constantino and Todd 2003; Fergusson and 
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Horwood 1995). From an etiological perspective, using continuous measures of behaviors 
associated with ADHD may be more appropriate for assessing degree of symptomatology. 
Increasing symptomatology likely reflects increasing deficits in neurological functioning, which 
may itself have a dose-response relationship with an environmental factor, such as OPs. Using 
continuous measures of trait severity will also lend increased power in statistical analyses. 
Recently, psychologists have shifted away from the hypothesis that attention deficits are 
the primary construct underlying ADHD and have moved towards the theory that ADHD may be 
a disorder characterized by deficits in EF, with a primary deficit in inhibitory control (Barkley 
1997). This general theory has undergone much refinement in the last 15 years. Executive 
functioning refers to the ability to plan and execute actions with a future goal in mind. Five 
domains are typically considered in EF: response inhibition, planning, cognitive flexibility/set 
shifting, working memory, and verbal fluency. However, while deficits in EF are certainly 
implicated in ADHD (Marije Boonstra et al. 2005; Woods et al. 2002), these deficits also occur in 
people with Oppositional Defiant Disorder(ODD) and Conduct Disorder (CD), though there is 
substantial comorbidity among the three disorders (Biederman et al. 1991; Maughan et al. 
2004). People with ADHD display deficits in non-EF cognitive areas as well (Marije Boonstra  et 
al. 2005; Woods  et al. 2002). While the specificity of EF deficits as a diagnostic tool for ADHD 
has been debated because of these issues (Willcutt et al. 2005), recent research in psychology 
has focused on examining how patterns across different domains of executive functioning are 
associated with ADHD, rather than EF as a whole.  
Although deficits in executive functioning may be the primary underlying neurological 
dysfunction in ADHD, EFs are still only one non-specific characteristic behavioral domain of 
ADHD, and may differ among different ADHD subtypes. ADHD is also associated with a number 
of other behaviors and cognitive characteristics, and considering all of these alongside EF may 
enhance specificity of clusters or factors. For instance, higher-level EF functions are dependent 
on less complex processes, including attention, memory, perception, and categorization 
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(Eslinger 1996), and ADHD is associated with other behavioral problems, such as internalizing 
and externalizing behaviors, aggression, and other behaviors that are assessed by the 
Behavioral Assessment System for Children (BASC). Social problems have also consistently 
been associated with ADHD. Deficits in all of these areas are likely not independent in ADHD, 
however, and considering them together may present a more comprehensive picture of the 
clinical phenotype. This approach may also help distinguish associations between OPs and 
specific behavioral patterns, if OPs act on one overarching pathway that affects all of these 
domains. 
 Finally, performing dimension reduction results in a small number of discrete phenotypes 
that can be used as outcomes. This provides an advantage in reducing type I error rates – 
traditional models warrant the testing of associations between an exposure and each composite 
scale and subscale. This can lead to a high number of tests and results may be subject to 
multiple testing bias. However, the use of factors as outcomes limits the number of tests with a 
single exposure to the number of factors – typically this is under 10 tests, compared with the 
potential for over 50 or even 100 tests if we used the individual instrument-specific scales. 
Dimension reduction not only improves statistical performance by reducing type I error, but also 
increases the digestibility of results by only requiring the interpretation of a few results by the 
reader.  
Innovation 
Previous epidemiologic research on prenatal exposures to xenobiotics and childhood 
neurodevelopment has typically used the 1:1 exposure-outcome approach to describe 
associations. While some researchers may control for one or two other xenobiotics, such as 
PCBs and/or lead, most cohorts have limited power to address issues of possible interaction 
and confounding by more than one or two other co-exposures with the use of traditional 
statistical methods. Additionally, most previous research on this topic has reported associations 
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with individual neurological outcomes, although many of the outcomes are correlated and 
interpreting associations with single subscales may be less clinically relevant and biologically 
meaningful. This dissertation is innovative because it a) addresses the issue of potential 
uncontrolled confounding between OPs and other co-exposures using methods that can 
account for small sample size, b) considers neurodevelopmental outcomes in a clinically 
meaningful manner that addresses problems of correlated outcomes and c) creates a potential 
model for other cohorts to use in assessing associations with neurodevelopment.    
Bayesian hierarchical models allow the incorporation of prior knowledge into regression 
analyses, which may result in more precise “confidence intervals” (actually termed posterior or 
credible intervals) with less data. These models also provide flexibility in model building when 
there is little prior knowledge, and allows shrinkage towards chemical class means. This 
shrinkage process is responsible for the increase in precision and provides some advantages 
when using a small cohort (<400 mother-child pairs). Thus, this dissertation is innovative in that 
it addresses problems of small sample size and uncontrolled mixture effects of co-exposures by 
using novel analytical methods. 
Factor analysis tackles problems associated with correlated outcomes and multiple 
testing. This technique groups variables that are highly correlated and is one method of 
dimension reduction. Aside from the Faroese birth cohort that examined associations between 
prenatal mercury exposure and neurodevelopment (Budtz-Jørgensen et al. 2002), such 
techniques have been relatively under-used in neurodevelopmental epidemiology, despite their 
potential for collapsing neurobehavioral scores into more meaningful clinical outcomes. Current 
common practice is to report associations between chemical exposures and each subscale on 
single instruments, although associations with single subscales have little interpretability and 
offer no support to hypotheses about biological mechanisms of action. Using factor analysis can 
theoretically reveal common factors that a) may represent an underlying, meaningful biological 
mechanism, b) correlate with clinically meaningful neurobehaviors across instruments, and c) 
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reduce the number of statistical tests performed. This approach to modeling the outcomes may 
provide a model for other birth cohort studies to follow, so that epidemiological research into 
psychological outcomes can take advantage of methods developed by psychologists and 
psychometricians that are designed to deal with these particular aspects of measuring 
neurodevelopment.  
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1
Chemicals enclosed in boxes are excreted in the urine. 
Figure 1 Chlorpyrifos Breakdown and Resulting Metabolites1 
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Table 1 Common Metabolites of Selected Organophosphorus Pesticides 
 OP Dialkylphosphate 
Dimethylphosphate    
 Dichlorvos DMP   
 Dicrotophos DMP   
 Mevinphos DMP   
 Naled DMP   
 Tetrachlorvinphos DMP   
 Trichlorfon DMP   
 Acephate DMP DMTP  
 Chlorpyrifos methyl DMP DMTP  
 Fenitrothion DMP DMTP  
 Fenthion DMP DMTP  
 Methamidophos DMP DMTP  
 Methyl Parathion DMP DMTP  
 Oxydemeton methyl DMP DMTP  
 Primiphos methyl DMP DMTP  
 Temephos DMP DMTP  
 Azinphos methyl DMP DMTP DMDTP 
 Dimethoate DMP DMTP DMDTP 
 Malathion DMP DMTP DMDTP 
 Methidathion DMP DMTP DMDTP 
 Phosmet DMP DMTP DMDTP 
Diethylphosphate    
 Chlorethoxyfos DEP DETP  
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 Chlorpyrifos DEP DETP  
 Coumaphos DEP DETP  
 Diazinon DEP DETP  
 Ethyl parathion DEP DETP  
 Sulfotepp DEP DETP  
 Disulfoton DEP DETP DEDTP 
 Ethion DEP DETP DEDTP 
 Phorate DEP DETP DEDTP 
 Phosalone DEP DETP DEDTP 
 Terbufos DEP DETP DEDTP 
 Reprinted from Duggan et al 2003
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Table 2 Summary of Prenatal Exposure to OPs and Associations with Neurodevelopment 
in Children's Environmental Health Center Cohorts 
  Birth Characteristics and Measures of 
Behavior 
Measures of Cognition 
OP  Age 
at 
Test 
Mount 
Sinai 
Colu
mbia 
CHAMAC
OS 
Cincinna
ti 
Mount 
Sinai 
Colu
mbia 
CHAMAC
OS 
Cincinn
ati 
DEPs  ≤1 
yr 
Abnormal 
primitive 
reflexes, 
head 
circumfer
ence
1
, 
birth 
weight
1
 
Birth 
length, 
birth 
weight, 
Abnormal 
primitive 
reflexes 
Birth 
weight
2
, 
Improved 
attn 
 
Null 
MDI, 
null 
PDI 
Null PDI, 
MDI 
  
DMPs  ≤ 1 
yr 
Abnormal 
primitive 
reflexes
1
, 
birth 
length
1
 
Gestati
onal 
age 
Abnormal 
primitive 
reflexes, 
gestational 
age 
Gestational 
age and 
birth 
weight
2
 
MDI
1,2 
 Null PDI, 
MDI,  
 
DEPs 2 yr   Null PDD  Null 
PDI, 
MDI 
Null 
MDI, 
PDI 
Null PDI, 
MDI 
 
DMPs 2 yr    PDD  Null 
PDI, 
MDI 
 Adverse 
MDI
1
, no 
PDI 
 
DEPs  3 yr  Attn/A
DHD 
PDD 
Null 
attn/ADHD 
  MDI, 
PDI  
  
DMPs 3 yr   Null 
attn/ADHD 
     
DEPs >3 – 
6 yr 
  Attn & 
ADHD 
indicators 
     
DMPs >3 – 
6 yr 
  Attn & 
ADHD 
indicators 
     
DEPs >6 
yr 
SRS, 7-9 
years
2 
   Null IQ Workin
g 
Memor
y, 
FSIQ 
Processing 
Speed 
 
DMPs >6 
yr 
Null 
SRS, 7-9 
years 
   Percept
ual 
Reasoni
ng
1
 
 Working 
Memory, 
Verbal 
Comprehen
sion, FSIQ 
 
PDI – Psychomotor Development Index of the BSID-II; MDI- Mental Development Index of the BSID-II; 
PDD – Pervasive Developmental Disorder as measured by the Child Behavior Checklist (CBCL); SRS - 
Social Responsiveness Scale; FSIQ – Full Scale IQ from WISC-IV 
1
Modification by PON1 genotype or PON1 levels 
2
Modification by race and/or sex 
*Many of the “null” associations reported here show a trend, but confidence intervals include the null. The 
Columbia cohort only reports results for chlorpyrifos, so associations with DMPs are not reported in that 
cohort. 
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CHAPTER III. METHODS 
Study Design/Research Strategy Overview 
 We used Bayesian hierarchical mixture models to assess the associations between 
organophosphorus pesticides (OPs) on neurodevelopment in a multiethnic cohort in New York 
City (n=404 mother/infant pairs at birth, see Table 3 for demographic characteristics). 
Specifically, we shrunk estimates for individual xenobiotic biomarkers towards a common class 
mean, and also estimated these associations by assigning a more commonly used prior with a 
mean of 0 and variance of 1 to the individual biomarkers. The model included the OPs and 
controlled for phthalates, pyrethroids, and phenols. Other important modifiers, including race, 
sex, and PON1 genotype, were assessed for interaction with OPs in individual models. 
Covariates of interest are described below and were included in a DAG to determine inclusion in 
final models. Outcomes are continuous factor scores derived from scales of instruments 
collected at 6 and 7-9 years of age (instruments described in further detail in Chapter 3 Section: 
Outcomes, and factor analysis described in further detail in Chapter 3 Section: Factor Analysis).  
Study Population 
The Mount Sinai Children’s Environmental Health Study is a prospective multiethnic 
cohort of primiparous women with singleton pregnancies who delivered at the Mount Sinai 
Hospital between May 1998 and July 2001 (Berkowitz et al. 2003; Berkowitz  et al. 2004). 
Women were recruited at either the Mount Sinai Diagnostic and Treatment Center, which serves 
a predominantly minority East Harlem population, or at one of two private practices on the 
Upper East Side of Manhattan. 404 mother-infant pairs were successfully recruited during 
pregnancy and met inclusion criteria (i.e., free of medical complications, gestation ≥ 32 weeks of 
pregnancy, infant free of genetic abnormalities, continued residence in New York City). At 
  30 
enrollment, mothers were predominantly young (67.9% < 25 years), non-white (68.7%), 
unmarried (71.0%), with high school educations or less (71.8%). An additional group of women 
did not have prenatal data available but did have neurodevelopmental assessments performed 
for their children (n= 48). These women were not included in any analyses that required 
prenatal data but were included in the factor analysis. 
Although the population is highly mobile due to their socioeconomic status and the 
cohort experienced a relatively high degree of drop out over follow up (188 out of 404 pairs were 
ultimately re-contacted in follow-up at either the 6 or 7-9 year visit), the missingness of the data 
has not substantially altered findings and women at follow-up were only slightly different than 
the cohort at enrollment. Women who returned for follow-up were more likely to be single at 
enrollment (Table 3).   
Exposure, Outcome, and Covariate Assessment 
Exposures, outcomes, and covariates were measured with a variety of instruments, 
including biomarkers, parent/caregiver surveys, and validated child assessments. 
Chemical Exposures  
Exposure to chemicals was assessed with biomarkers in urine or blood. Maternal blood 
and urine was collected at a mean gestational age of 31.2 (sd 3.7) weeks. Maternal urine 
samples were analyzed by the Centers for Disease Control and Prevention (Atlanta, Georgia) 
using gold standard techniques for measuring metabolites of organophosphorus pesticides 
(Engel et al. 2007), phthalates and phenols (Wolff et al. 2008), and pyrethroids (Barr et al., 
2010). In the actual data analysis, values below the LOD were handled with a truncated normal 
distribution, and concentrations of log values above the LOD were modeled with a normal 
distribution.  
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Outcomes 
Participants were followed up when children were 4.5-5 years, 6-6.5 years, and 7-9 
years of age. At follow-up, children were assessed for IQ, behavior, and executive function 
using validated and age-appropriate scales described below and in further detail in Table 4.  
Wechsler Preschool and Primary Scale of Intelligence, 3rd edition (WPPSI-III), and 
Wechsler Intelligence Scale for Children, 4th edition (WISC-IV) (n=210 children had scores from 
either the WPPSI or the WISC at 6-9 years; correlations between the WISC-IV and the WPPSI-
III historically are 0.89) (Engel  et al. 2011). Administered to children under the age of 7, the 
WPPSI-III provides measures of Verbal, Performance, Processing Speed, and Full-Scale IQ. 
The WISC-IV provides measures of Composite Verbal, Perceptual Reasoning, Working 
Memory, Processing Speed, and Full-Scale IQ. These composite scales are also composed of 
subscales (see Table 4 for full lists).  
Behavior Rating Inventory of Executive Functioning (BRIEF) (n=210 with a measurement 
at any time point). The BRIEF is an 86-item parent report questionnaire designed to assess 
executive cognitive function in children 5-18 years of age. Executive functions are used to 
achieve goals that require planning and holding in memory a multi-step sequence of thoughts or 
actions, to monitor and control attention and emotion, to inhibit inappropriate behaviors, and to 
formulate mental models based on life experiences. The BRIEF is composed of 8 clinical 
scales, including  
1) Inhibit- ability to control impulses, 
2) Shift- ability to transition between situations,  
3) Emotional control- ability to modulate emotional responses,  
4) Initiate- the ability to begin a task,  
5) Working memory – the ability to retain information for task completion,  
6) Plan/organize – the ability to anticipate future events, set goals, and develop a 
systematic plan of action,  
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7) Organization of materials – the ability to keep workspace orderly, and  
8) Monitor – the ability to assess personal performance and to register the effect of one’s 
own behavior on others.  
These eight scales generate two broad indices: the Behavioral Regulation Index (BRI) 
and the Metacognition Index (MI). An overall score, the Global Executive Composite (GEC), is 
obtained from the raw scores for the MI and BRI.   
Behavioral Assessment Scale for Children (BASC) (n=210 with a measurement at any 
point). The BASC is designed to evaluate problematic behaviors in children and adolescents 2.5 
to 18 years of age. The BASC includes nine clinical scales to assess a child’s adaptive and 
problem behaviors in home and community settings. Parents respond to 130 items on a 4 point 
scale that ranges from never to almost always. Externalizing problems is a composite scale 
derived from the hyperactivity (including both hyperactivity and impulsivity items), aggression, 
and conduct problems scale items. Internalizing problems is a composite of the anxiety, 
depression, and somatization scale items. Three additional scales are attention problems, 
atypicality, and withdrawal. The adaptive behavior skills composite combines information from 
the adaptability, social skills, and leadership scale items. The Behavioral Symptoms Index (BSI) 
is the apical summary score that assesses the overall level of behavioral functioning. 
Taken together, these instruments provide details on several aspects of 
neurodevelopment, including IQ, behavior, and executive functioning. Table 4 describes the 
instruments used and when they were administered. All outcomes were analyzed as continuous 
variables. 
Covariates 
Covariates of interest for the OP-neurodevelopment relationships included maternal 
education, maternal race/ethnicity, maternal marital status, alcohol use during pregnancy, drug 
use during pregnancy, maternal age, child sex, maternal IQ, HOME environment scores, and 
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maternal smoking during pregnancy. All prenatal covariates were obtained through a 
questionnaire administered at the time of biomarker collection (mean gestational age 31.2 
weeks). Child sex and other features of the delivery were determined through the perinatal 
database at the hospitals where they were delivered.  
Data Analysis 
 The proposed aims seek to 1) comprehensively account for correlations among the 
outcomes and to reduce the dimensionality of these outcomes in a factor analysis, 2) to 
estimate associations between prenatal and early life characteristics and the 
neurodevelopmental factors and to 3) consider OPs as part of a mixture, and to account for 
possible correlations and confounding by other xenobiotics in Bayesian hierarchical models.   
Outcomes: Factor Analysis  
 Factor analysis (FA) allows items that are highly correlated with each other to cluster. 
The degree to which any given variable contributes to that overall factor is known as a factor 
loading. Squared factor loadings represent the amount of variance explained by any given 
variable for that factor. In deciding what factor loading values indicate an important variable, 
generally analysts use a rule of thumb of loadings > 0.3 to indicate important variables (Field, 
Miles, & Field, 2012). Loadings are also related to the eigenvalues, which indicate the 
substantive importance of a factor. Relatively high eigenvalues indicate that a factor should be 
retained, while relatively low eigenvalues indicate that a factor should be discarded. A general 
rule of thumb that is commonly used dictates that eigenvalues above 1 should be retained, 
although more sophisticated methods are also available for choosing number of factors. A scree 
plot plots each eigenvalue against the factor with which it is associated, and generally is 
characterized by a steep decline followed by a leveling off. In parallel analysis, a random 
dataset with the same number of observations and variables is drawn, eigenvalues are 
estimated, and the scree plots are compared. When the eigenvalues from the observed dataset 
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dip below those from the randomly drawn data, this indicates that the later factors are mostly 
noise. We considered both the eigenvalue cutoff method and the factor solution that is one 
above and below the number indicated by parallel analysis.   
 Factor rotation methods impose either a correlated or uncorrelated structure on the 
factors. In etiological analyses, we primarily adopted an orthogonal varimax rotation, in order to 
assess associations with factors that are linearly independent of other neurodevelopmental 
domains. However, in Aim 1 we compared models using orthogonal rotation, oblique rotation, 
and instrument-specific composite scores, to evaluate the utility of adopting the varimax 
rotation.  
 Factor scores are assigned to each participant to measure how highly they rate on any 
given factor. For instance, if a participant scores highly on a factor that measures problems with 
attention, then that participant likely displays more problems with attention than the rest of the 
cohort. Similarly, if a participant has a low score on that factor, then she has fewer attention 
problems than the rest of the participants in that cohort. These scores can be extracted and 
used as outcomes in the Bayesian methods described in Chapter 3. To determine factor scores, 
we used the standardized factor score regression coefficients.  
In sum, we used analysis with orthogonal varimax rotation, eigenvalue cutoffs, and 
parallel analysis to decide on the correct number of factors, factor loadings above 0.30 to 
determine variable retention, and standardized factor score regression coefficients to determine 
factor scores. Scores from the neurodevelopmental instruments were scaled using z-scores for 
comparability in the factor analysis. Due to sample size restrictions, we used the averages of 
the subscale scores across visits, and included behavioral subscale scores and IQ composite 
scores into a FA. Since the WPPSI and the WISC do not have exactly overlapping composite 
scores and subtest scores, we used the composite scores that overlap (Full Scale IQ, Verbal IQ, 
and Processing Speed), and the overlapping subtest scores for the finer-level dimension 
reduction (See Table 4 for included scales).  
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Association Models  
 For Aim 1, we used a series of multivariable linear regressions to estimate associations 
between prenatal exposure to smoking and other early life characteristics and 
neurodevelopmental factors. Aim 2, however, involves correlated exposures with a potentially 
high number of variables relative to sample size. Linear regressions of models with such 
characteristics can produce effect estimates that are notoriously unstable and inflated. 
Therefore, in Aim 2 we used a hierarchical Bayesian mixture model (BMM) to account for both 
correlated variables and to stabilize models with high numbers of parameters relative to the 
sample size (de Vocht et al. 2012; Herring 2010; Wakefield et al. 2010). Bayesian statistics 
allows for the incorporation of prior knowledge into analyses, typically with the result of shrinking 
effect estimates towards the specified prior and creating more precise posterior 95% intervals. 
In this dissertation, we shrunk estimates towards a mean of 0 with a variance of 1, and 
performed sensitivity analyses where estimates were shrunk towards chemical class means. 
Exposure values below the LOD were modeled as truncated normal, with values above the 
LOD modeled using log normal distributions (Herring 2010). Missing covariate values were 
imputed using full information maximum likelihood methods under the missing-at-random 
assumption (MAR). Modeled outcomes were factor scores derived from structural equation 
models/factor analysis described further in Chapter 3.  
Comparative Analyses 
For comparison purposes, we also presented results from a traditional linear regression 
that considers associations between OPs and the composite scores of the instruments, along 
with the other instrument-specific items that comprise the factors. These models used 
covariates in a minimally sufficient set derived from a DAG.   
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Table 3 Characteristics of Study Population at Enrollment and Follow Up, Mount Sinai 
Children's Environmental Health Cohort 
 Enrolled at 
Birth 
N=404 
Followed-up 
ages 6-9 
years 
N=162
1 
Not Followed-
Up ages 6-9 
years 
N=242 
Maternal Age at delivery (years)    
 <20 142 (35.2) 50 (30.9) 92 (38.0) 
 20-24 132 (32.7) 55 (34.0) 77 (31.8) 
 ≥25 130 (32.2) 57 (35.2) 73 (30.2) 
     
Maternal Race/ethnicity    
 White 86 (21.3) 30 (18.5) 56 (23.1) 
 Black/other 118 (29.2) 50 (31.9) 68 (28.1) 
 Hispanic 200 (49.5) 82 (50.6) 118 (48.8) 
     
Maternal Education during pregnancy    
 High School or Less 288 (71.8) 118 (73.3) 170 (70.8) 
 Some College or higher 113 (28.2) 43 (26.7) 70 (29.2) 
     
Marital Status during pregnancy
2 
   
 Married 117 (29.0) 37 (22.8) 80 (33.1) 
 Living with Partner 98 (24.3) 37 (22.8) 61 (25.2) 
 Single/Divorced/Widowed 189 (46.8) 88 (54.3) 101 (41.7) 
     
Alcohol use during pregnancy     
 None 337 (85.1) 132 (83.0) 205 (86.5) 
 Any 59 (14.9) 27 (17.0) 32 (13.5) 
    
Smoking during pregnancy     
 No smoking during pregnancy 337 (83.4) 134 (82.7) 203 (83.9) 
 Any smoking during pregnancy 67 (16.6) 28 (17.3) 39(16.1) 
  Smoking only during 1
st
 
trimester 
46 (11.4) 17 (10.5) 29 (12.0) 
  Any smoking during 2
nd
 or 3
rd
 
trimester 
21 (5.2) 11 (6.8) 10 (4.1) 
1
 Population included in the multivariate adjusted regression models of associations between early life 
characteristics and the factor scores.  
2
Marital status at baseline of mothers from the original birth cohort (n=404) who returned for follow up 
differed from mothers who did not return (p= 0.03). No other characteristics were significantly different at 
the alpha=0.05 level for these two groups.  
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Table 4 Instruments Included in Factor Analysis of Behavior, Executive Functioning, and 
IQ 
Instrument  Scales Age 
Assessed,  
N children 
Wechsler Preschool and 
Primary Scales of 
Intelligence (WPPSI-III) 
Verbal IQ (subtest: Vocabulary), 
Performance IQ (subtests: Block Design, Matrix 
Reasoning, Picture Concepts) 
Processing Speed Index (subtests: Symbol 
Search, Coding) 
Full Scale IQ 
6 years  
(n=162) 
Wechsler Intelligence Scale 
for Children (WISC-IV) 
Verbal IQ (subtests: Vocabulary), 
Perceptual Reasoning (subtests: Block Design, 
Matrix Reasoning, Picture Concepts) 
Processing Speed Index (subtests: Symbol 
Search, Coding) 
Full Scale IQ 
7-9 years 
(n=161) 
Behavior Rating Inventory of 
Executive Functioning 
(BRIEF) 
Behavioral Regulation Index (subtests: Inhibit, 
Shift, Emotional Control) 
Metacognition Index (Initiate, Working Memory, 
Plan/Organize, Organization of Materials, 
Monitor)  
Global Executive Composite 
4-9 years 
(N=242)  
Behavioral Assessment 
Scale for Children (BASC) 
Externalizing Problems (Aggression, 
Hyperactivity, Conduct Problems) 
Internalizing Problems (Anxiety, Depression, 
Somatization,) 
Adaptive Skills composite (Adaptability, 
Leadership, Social Skills) 
Other Problems (Atypicality, Withdrawal) 
Behavioral Symptoms Index (Aggression, 
Hyperactivity, Anxiety, Depression, Attention, 
Conduct Problems, Atypicality) 
4-9 years 
(N=238) 
210 participants had the BASC, the BRIEF, and either the WPPSI-III or the WISC-IV 
BRIEF items and descriptions: 
The Behavioral Regulation Index includes these clinical scales:  
 Inhibit (the ability to control impulses),  
 Shift (the ability to switch between activities and tolerate change), 
  Emotional Control (the ability to regulate emotional responses appropriately).  
The Metacognition Index includes these clinical scales:  
 Initiate (the ability to begin activities and generate problem-solving strategies),  
 Working Memory (the ability to hold information when completing a task),  
 Plan/Organize (the ability to set goals, develop steps, and anticipate events),  
 Organization of Materials (the ability to put work, play, and storage spaces in order), and  
 Monitor (the ability to check one’s own work and performance). 
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CHAPTER IV. EARLY LIFE CHARACTERISTICS AND NEURODEVELOPMENTAL 
PHENOTYPES IN THE MOUNT SINAI CHILDREN’S ENVIRONMENTAL HEALTH CENTER 
Introduction 
Neurodevelopment is a complex interdependent system, and yet epidemiological studies 
of neurodevelopment generally consider performance across dimensions of neurodevelopment 
in isolation. For example, studies may report on the relationship between a sociodemographic 
variable and childhood intelligence, executive functioning, or behavior, but not on all three 
dimensions simultaneously. Modern approaches have emphasized the need for “deep 
phenotyping” (Robinson, 2012). This approach uses statistical models that reflect the known 
complexity and interrelatedness of neurodevelopmental processes, and considers sources of 
variability within and across developmental or psychopathological domains (Baynam et al., 
2015; Calkins et al., 2015; Robinson, 2012).  
One statistical approach to deep phenotyping involves dimension reduction techniques, 
which take advantage of information in patterns of covariance across instruments. There are 
major conceptual advantages in jointly modeling domains of neurodevelopment. Accounting for 
interrelatedness between developmental domains may be more clinically relevant, since 
behavioral traits rarely present in isolation. This may be particularly true for children with a 
pathological diagnosis. For instance, the hallmarks of an ADHD diagnosis include problems with 
attention, hyperactivity, executive functioning, and impulsivity (Barkley, 1997). Patients with 
ADHD often also present with anxiety, conduct disorder, depression, and difficulties in forming 
social relationships (Jensen, Martin, & Cantwell, 1997). Even in a general population sample, 
traits such as anxiety and depression are often highly comorbid (Sartorius, Ustun, Lecrubier, & 
Wittchen, 1996), implying potentially common neurological underpinnings for these traits. 
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Despite these co-occurring patterns, there is a trend in etiological studies to either focus on a 
holistic outcome such as ADHD, or to adopt a trait-driven approach and to assume 
characteristics that such as anxiety or depression are independent. However, in a general 
population sample, a more nuanced approach that accounts for correlational patterns across 
traits may be more neurologically and clinically relevant.  
 Many perinatal, social, behavioral, environmental, and demographic characteristics 
have been associated with individual dimensions of neurodevelopment (Bradley, Caldwell, 
Rock, & Ramey, 1989; Gale et al., 2008; Indredavik, Brubakk, Romundstad, & Vik, 2007; Piper 
& Corbett, 2012; Willford, Leech, & Day, 2006). However, few etiological studies have attempted 
to jointly model domains of neurodevelopment while accounting for their interrelationships. As 
neurological capabilities scaffold into phenotypes during childhood, examining the associations 
between prenatal and early life characteristics and neurodevelopmental phenotypes may 
provide more insights into underlying etiological pathways. Our goal was to estimate 
associations between perinatal, social, demographic and behavioral characteristics and 
neurodevelopmental phenotypes while accounting for outcome interdependencies using a 
phenotyping approach. 
Methods 
Study Population 
The Mount Sinai Children’s Environmental Health Study is a prospective cohort study of 
primiparous women with singleton pregnancies who delivered at the Mount Sinai Hospital in 
New York City between May 1998 and July 2001 (Berkowitz et al., 2003, 2004). Mother/infant 
pairs were followed from pregnancy until the child was 7-9 years of age. Women were recruited 
during prenatal visits at either the Mount Sinai Diagnostic and Treatment Center, which serves a 
predominantly East Harlem population, or at one of two private practices on the Upper East 
Side of Manhattan. Exclusions have been detailed elsewhere (S. M. Engel et al., 2007). After 
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exclusions, there were 404 women with available birth data. Additionally, a small number of 
women who enrolled after birth and participated in follow-up visits are included in the 
neurodevelopmental factor analysis (n = 48). Participants were invited to return for 
neurodevelopmental follow-up visits with their child at ages 1, 2, 4, 6, and 7-9 years (Figure 1).   
Child Behavior and Executive Functioning 
We measured children’s executive functioning with the Behavior Rating Inventory of 
Executive Functioning (BRIEF). The BRIEF is a parent-report assessment of the child’s 
executive functioning (Gioia, Isquith, Guy, & Kenworthy, 2000), which consists of 86 items that 
are rated on a 3-level scale from “never” to “almost always”. Validity studies report good 
reliability with high test-retest reliability (mean rs=0.81 for parents across scales) and internal 
consistency (Cronbach’s alphas range from 0.80-0.98 across scales)(Gioia et al., 2000). 
Individual items are summarized into eight clinical scales and their age-normed T-scores. 
Clinical scales are then collapsed into two indices, which also include age-normed T-scores. 
The Behavioral Regulation Index includes the following three clinical scales: Inhibit (the ability to 
control impulses), Shift (the ability to switch between activities and tolerate change), and 
Emotional Control (the ability to regulate emotional responses appropriately). The Metacognition 
Index includes five clinical scales: Initiate (the ability to begin activities and generate problem-
solving strategies), Working Memory (the ability to hold information when completing a task), 
Plan/Organize (the ability to set goals, develop steps, and anticipate events), Organization of 
Materials (the ability to put work, play, and storage spaces in order), and Monitor (the ability to 
check one’s own work and performance). The Behavioral Regulation and Metacognition indices 
are then combined into one overarching Global Executive Composite score. Mothers completed 
the BRIEF at the 4, 6, and 7-9 year follow-up visits. We used the average T-scores across visits. 
We assessed children’s problem and adaptive behaviors in the home and community 
setting with the parent report version of the Behavioral Assessment System for Children (BASC) 
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(Reynolds & Kamphaus, 1998; Sandoval & Echandia, 1994). Internal consistency reliability of 
this instrument is good (Cronbach’s alphas average 0.80 across scales and ages), and test-
retest reliabilities are also high (mean rs = 0.85 for preschool, mean rs = 0.87 for children ages 
6-11)(Sandoval & Echandia, 1994). Parents completed a survey consisting of over 200 items 
that describe the frequency of a specific behavior on a four point scale from “Never” to “Almost 
Always”. Items are then collapsed into clinical and adaptive scales, which are normed to the 
general population by child age to produce T-scores. Clinical and adaptive scales are then 
consolidated into composites, which are also age normed. These composites included 
Externalizing Problems (Aggression, Hyperactivity, Conduct Problems), Internalizing Problems 
(Anxiety, Depression, Somatization), Adaptive Skills (Adaptability, Leadership, Social Skills), 
and the Behavioral Symptoms Index (Aggression, Hyperactivity, Anxiety, Depression, Attention 
Problems, Atypicality). Withdrawal is the only scale that is not included in a composite. The 
BASC was completed at the 4, 6, and 7-9 year visits, and we used the average T-scores across 
visits.  
Psychometric Intelligence Testing 
Children were administered the Wechsler Preschool and Primary Scales of Intelligence-
III (WPPSI-III) at age 6 (mean age = 6.2, SD = 0.2), and the Wechsler Intelligence Scales-IV 
(WISC-IV) between the ages of 7-9 years (mean age = 7.8, SD= 0.8). The WPPSI-III subtests 
included in this analysis were Block Design, Matrix Reasoning, and Picture Concepts (for the 
Performance IQ), Symbol Search and Coding (for Processing Speed), and Vocabulary (for the 
Verbal IQ). A Full Scale IQ (FSIQ) is generated from the age-normed composites. The 
assessed WISC-IV subtests were Block Design, Matrix Reasoning, and Picture Concepts (for 
Perceptual Reasoning), Vocabulary (for Verbal Comprehension), and Coding and Symbol 
Search (for Processing Speed). Because the FSIQ from the WPPSI-III and WISC-IV are highly 
correlated (rs =0.84 in our population), if a child returned for both visits, we preferentially used 
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the WISC-IV scores for all subtests. In our analyses, we were only able to include subscales 
that were administered in both the WPPSI-III and the WISC-IV. Thus, from the WPPSI-III, we 
excluded Word Reasoning and Information. From the WISC-IV we excluded Digit-Span, Letter-
Number Sequencing, the Working Memory Index, Similarities, and Comprehension (see Table 5 
for full list of included scales).  
Covariates 
During their third trimester and at follow-up visits, mothers completed questionnaires that 
assessed a variety of sociodemographic, occupational, environmental, medical history and 
behavioral characteristics. We classified maternal characteristics as follows: maternal education 
at follow-up (high school or less vs some college or higher), maternal age (<20, 20-25, >25), 
maternal race/ethnicity (white/non-white), smoking during pregnancy (we examined both a 
binary form of this variable that included any smoking during pregnancy vs no smoking, and a 
three-level categorical variable that included no smoking, smoking in first trimester only, and 
smoking in either second or third trimesters), alcohol use during pregnancy (ever/never), and 
canned fish consumption during pregnancy (≥1 time per week or < 1 time a week). 
A perinatal database at the Mount Sinai Department of Obstetrics, Gynecology, and 
Reproductive Science was used to abstract delivery characteristics and birth outcomes, 
including head circumference, birth weight, birth length, and gestational age. We categorized 
gestational age into preterm (<37 weeks) or term (37 weeks or more) and used a continuous 
measure of head circumference (centimeters). Birth weight and length were dichotomized at the 
median (<51 cm vs ≥51 cm for birth length; < 3270 vs ≥3270 grams for birth weight). 
An in-office interview version of the Home Observation for Measurement of the 
Environment (HOME scale) (Caldwell & Bradley, 1984) was administered at 12 and 24 months. 
The HOME subscales include 1) Involvement, which measures how an adult interacts physically 
with the child (sample items include: parent keeps child within visual range, talks to child while 
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doing work); 2) Learning Materials, which measures whether a child has appropriate play 
materials at home and elsewhere (sample items include: child has one or more large muscle 
activity toys); 3) Organization, which measures how a child’s time is organized outside the 
house and what the child’s personal space looks like (sample items include: safe play 
environment, regular caregivers); 4) Acceptance, which measures how the adult disciplines the 
child (sample items include: parent does not shout at child during the visit, parent not overly 
restrictive of the child’s movements), 5) Responsivity, which measures the emotional and verbal 
sensitivity and responsivity of parent to the child (sample items include: mother caresses or 
kisses child at least once during visit), and 6) Variety, which measures opportunities for variety 
in daily stimulation (sample items include: father provides some caregiving every day, family 
visits or receives visits from relatives approximately once a month).  
We used mean overall HOME scores and HOME subscale scores across the 1-2 year 
visits. The HOME overall score exhibited a wide range with sufficient variability across scores 
and was included as a continuous variable. However, the HOME subscale scores exhibited a 
limited range with most observations clustered at the higher, more positive end of the 
distributions. We thus categorized the HOME subscale scores into tertiles and included them as 
ordinal categorical variables. The HOME subscale scores met assumptions for linearity when 
categorized in this fashion.  
Maternal intelligence was assessed during pregnancy using the Peabody Picture 
Vocabulary Test-III (Dunn & Dunn, 1997) and the covariate was defined as a continuous 
variable. 
  
  44 
Statistical Methods  
 Characteristics by Follow-Up Status 
We examined demographic characteristics of mothers by follow-up and covariate status. 
We used chi-square goodness-of-fit tests with an alpha cutoff of 0.05 to assess if mothers from 
the original birth cohort (n=404) who returned for follow-up and completed the BASC, the 
BRIEF, the WPPSI-III/WISC-IV differed from mothers who did not return for a complete follow-
up visit. Maternal education and marital status at baseline were used to assess differences by 
follow-up status, since maternal education and marital status at follow-up are unavailable for 
those who did not return for a follow-up visit.  
Factor Analysis 
We performed dimension reduction on the BASC, BRIEF, WPPSI-III, and WISC-IV by 
using a principal components analysis with an orthogonal varimax rotation and present loadings 
above the cutoff of 0.3. We included standardized versions of both the composite scores and 
the subscales of the instruments. The neurodevelopmental scales included in this analysis are 
listed in Table 1. We examined criteria for factorability, including Kaiser’s measure of sampling 
adequacy and Bartlett’s test of sphericity, both of which assess the suitability of the data for 
factor analysis based on correlations among the variables (Dziuban & Shirkey, 1974). We also 
examined communalities to assess suitability of items, and average communality size to assess 
adequacy of sample size (MacCallum, Widaman, Zhang, & Hong, 1999). To determine the 
number of factors, we examined factors with eigenvalues greater than one, and also considered 
parallel analysis to optimize the number of factors selected (Hayton, Allen, & Scarpello, 2004). 
Parallel analysis computes eigenvalues from a correlation matrix that is derived from a random 
dataset with the same numbers of observations and variables as the original data, and 
compares them against the eigenvalues from the observed data. We then examined the factor 
solution that was one higher and one lower than that which was indicated by parallel analysis. In 
order to aid interpretation, we scaled factors so that positive/negative attributes go in the same 
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direction across all factors in the regression analyses. Thus, positive scores on all of the factors 
indicate better outcomes and negative scores indicate more adverse outcomes in all regression 
analyses. For regression analyses, we standardized all factors to have a mean of 0 and a 
standard deviation of 1. Thus, a beta coefficient of one can then be interpreted as an increase of 
one standard deviation of the factor. In sensitivity analyses, we assessed whether the factor 
structure differed for whites and non-whites and also assessed the factor structure with a 
promax rotation. 
Association Analyses of Early Life Characteristics with Neurodevelopmental Factors 
We estimated associations between characteristics hypothesized to be associated with 
neurodevelopment, and orthogonal varimax-rotated factors, in mutually adjusted analyses. We 
considered covariates that have previously been hypothesized to be associated with 
neurodevelopment. These covariates include maternal age at enrollment, maternal education at 
follow-up, maternal marital status at follow-up, maternal IQ, maternal race, smoking during 
pregnancy, alcohol consumption during pregnancy, canned fish consumption during pregnancy, 
birth head circumference, preterm birth, birth weight, birth length, child sex, and HOME 
environment scores. To address potential issues with collinearity, we eliminated some 
covariates that were highly correlated (variance inflation factor >2). When covariates were 
strongly correlated, we retained the variable that was the strongest predictor in bivariate tests. 
The birth characteristics of birth length, birth weight, and preterm birth were correlated; of this 
set, preterm birth was retained. Maternal age, maternal marital status, and maternal IQ were 
dropped due to their high correlation with maternal race in this dataset, which was the strongest 
predictor for a number of factors. We did, however, perform sensitivity analyses including these 
three dropped covariates (maternal age, maternal marital status, and maternal IQ). The final 
covariate set for the primary analyses included maternal education, maternal race, smoking 
during pregnancy, alcohol consumption during pregnancy, canned fish consumption during 
pregnancy, birth head circumference, preterm birth, child sex, and the HOME subscale scores 
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of Organization, Learning Materials, Involvement, and Variety. We multiplied imputed missing 
covariate data and estimated associations between early life characteristics and factor scores in 
multivariable linear regression models (PROC GLM with PROC MI and MIANALYZE in SAS, 10 
imputations). No adjustment for multiple comparisons was performed. In sensitivity analyses, we 
evaluated whether associations were different by white race. 
In order to evaluate whether using the phenotypes resulted in different effect estimates 
compared to a more traditional approach of using instrument-specific composite scores, we 
performed a case study of a single exposure with well-characterized associations with 
neurodevelopment, smoking. We estimated associations between smoking and 
neurodevelopment as measured by the phenotypes, and also estimated associations between 
smoking and neurodevelopment as measured by the highest loading composite item from each 
factor (i.e., the BASC’s Externalizing Composite, the BRIEF’s Metacognition Index, the BASC’S 
Internalizing Composite, the WISC-IV/WPPSI-III’s Perceptual Reasoning IQ score, the BASC’s 
Adaptive Skills Index, the WISC-IV/WPPSI-III’s Processing Speed IQ score, and the WISC-
IV/WPPSI-III’s Verbal IQ score). In these analyses, we did not adjust for birth characteristics as 
they may be intermediate on the causal pathway between smoking and neurodevelopment. The 
final adjustment set was otherwise the same as in the primary analyses.  
All analyses were performed in SAS V9.4. 
Results 
Study Population Characteristics and Follow-up 
 Of the 404 eligible women who enrolled during pregnancy, 162 returned for at least one 
visit between 6-9 years and completed the BASC, the BRIEF, and the WPPSI-III/WISC-IV. An 
additional 48 women who enrolled after birth had at least one complete visit between 6-9 years, 
although these women had no prenatal data available (Figure 2 and Table 6). 210 participants 
in total returned for at least one complete visit between ages 6-9 years, and these participants 
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were all included in the factor analysis. The majority of the 162 participants with prenatal data 
were young (64.9% under 25 at delivery) and non-white (82.5%). Most participants reported not 
drinking alcohol (83.0%), not smoking during pregnancy (82.7%), and most had an education of 
high school or less at enrollment (73.3%; Table 6). The distributions of education at enrollment, 
maternal age at delivery, race, alcohol consumption during pregnancy, and smoking during 
pregnancy were generally similar among those who did and did not return for follow-up, 
although mothers who were single, divorced, or widowed were more likely to return for follow-up 
than mothers who were married (p=0.03). 
Principal Components Analysis  
We examined several criteria for factorability of the neurodevelopmental outcome data. 
Kaiser’s measure of sampling adequacy was 0.71, above the standard of 0.60 (Field et al., 
2012), and Bartlett’s test of sphericity was significant (χ2 (666) =13,875, p < 0.01). Parallel 
analysis indicated six factors had eigenvalues greater than those generated from random data, 
while seven factors had eigenvalues greater than one. After examining the two solutions, we 
determined that the seven factor solution was almost equivalent to the six factor solution, with 
the seven factor solution including a separate factor for verbal intelligence. In the six factor 
solution, the items for verbal intelligence loaded with perceptual reasoning items. We selected 
the seven factor solution because perceptual reasoning and verbal intelligence capture different 
aspects of intelligence (W. Johnson & Bouchard, 2005), and it had both good statistical fit based 
on the eigenvalues and was in line with previous literature on neurodevelopment. All 
neurodevelopmental scales loaded on at least one factor at >0.30, and all had sufficiently high 
communalities (all scales had communalities > 0.50, and the average communality was 0.79), 
thus all scales were retained. Factor structures were similar for varimax and promax rotation. In 
order, the seven unrotated factors explained 37.92%, 13.71%, 7.86%, 6.33%, 5.10%, 4.25%, 
and 3.05% of the variance in the data, for a total of 78.22%.  
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In order of variance explained, these seven factors are herein described as: 1) 
Impulsivity/Externalizing, 2) Executive Functioning, 3) Internalizing, 4) Perceptual Reasoning, 5) 
Adaptability, 6) Processing Speed, and 7) Verbal Intelligence (Table 7). The 
Impulsivity/Externalizing factor was composed primarily of the BASC’s Externalizing Problems 
composite and associated subscales, and the BRIEF’s Behavioral Regulation Index (BRI) and 
BRI subscales. The Executive Functioning factor was primarily characterized by the 
Metacognition items from the BRIEF, although items from the BASC Behavioral Symptoms 
Index (BSI) also loaded weakly on to this factor. Items with high loadings for the third factor, 
Internalizing, included the BASC’s Internalizing Problems composite and the associated 
subscales of Anxiety, Somatization, and Depression. Withdrawal also loaded highly on this 
factor, although it is not part of the BASC’s Internalizing Problems composite. Items that loaded 
at lower levels on this factor include the BRIEF’s BRI and the BRI subscales of Shift and 
Emotional Control, and the BASC’s BSI and Atypicality scale. The Perceptual Reasoning factor 
was composed entirely of items from the IQ instruments, including the Perceptual/Performance 
IQ composite score along with the associated subscales of Matrix Reasoning, Block Design, 
and Picture Concepts. The Adaptability factor was characterized by items from the BASC’s 
Adaptive Skills composite, including Social Skills and Adaptability, and also by improved 
Attention scores from the BASC. The Processing Speed factor was characterized by the 
Processing Speed IQ Composite score and associated subscales of the WISC-IV/WPPSI-III, 
and the Verbal Intelligence factor was characterized by the Verbal IQ Composite score and the 
Verbal IQ Composite subscale of Vocabulary. In addition, Organization problems from the 
BRIEF also loaded onto the Verbal Intelligence factor; this seventh factor of Verbal Intelligence 
then is characterized not just by verbal intelligence but also by somewhat increased problems 
with organizational skills, although the loading for this item was low. 
In sensitivity analyses we examined consistency of the factor structure by race (data not 
shown). The factor analysis was similar when conducted separately for whites and non-whites, 
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with the exception of the seventh factor for verbal intelligence. This is likely because this factor 
only includes two items to characterize verbal intelligence – verbal IQ and vocabulary -- and 
thus has less capacity to explain variance. When we included items from the WISC-IV Verbal IQ 
composite that had been previously excluded (i.e., comprehension and similarities from the 
WISC-IV), then the seven factor solution in whites contained the same factors in both whites 
and non-whites, even though the total sample size dropped substantially because these 
analyses were limited to only white children who were administered the WISC-IV (n=21). Finally, 
the factor structure was similar when using an oblique promax rotation (Appendix 2). 
Associations between smoking and neurodevelopment were similar when using promax rotated 
scores and the instrument-specific composite scores, but slightly different when using the 
varimax rotated scores (Appendix 3). This suggests the difference in results between the 
varimax rotated scores and the composite scores is due to the orthogonal rotation of the factors 
rather than the use of factor scores themselves. 
Early Life and Neurodevelopment Factors 
After accounting for the interrelationships among neurodevelopmental outcomes there 
were several notable associations (Table 6). The strongest associations for modifiable 
characteristics were for canned fish consumption, education, and preterm birth. Mothers who 
consumed canned fish at least once a week had children who scored half a standard deviation 
higher on the Perceptual Reasoning factor (
^
 0.50, 95% CI 0.03, 0.97). In contrast, children of 
mothers with a high school education or less had Verbal Intelligence factor scores 
approximately half a standard deviation lower than children of mothers with a higher education 
level (
^
 -0.47, 95% CI -0.78, -0.17). Preterm birth was also associated with more adverse 
Processing Speed (
^
 -0.72, 95% CI -1.31, -0.13), and Internalizing (
^
 -0.62, 95% CI -1.23, -0.02) 
factor scores. Of the HOME scores, only Organization displayed any associations with 
neurodevelopment, with a one tertile increase (corresponding approximately to slightly more 
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than a one-point increase in the Organization score) resulting in a quarter of a standard 
deviation improvement in Executive Functioning (
^
 0.26, 95% CI 0.04, 0.49), and a small tenth 
of a standard deviation improvement in Adaptability factor scores (
^
 0.10, 95% CI 0.00, 0.19). 
Of the non-modifiable characteristics, white race was associated with stronger 
Perceptual Reasoning and Verbal Intelligence scores (Perceptual Reasoning 
^
 0.68, 95% CI 
0.25, 1.10; Verbal Intelligence 
^
 0.81, 95% CI 0.42, 1.20), but was not associated with any other 
neurodevelopmental outcome. Girls averaged much higher Adaptability scores (
^
 0.54, 95% CI 
0.24, 0.84) and higher Processing Speed scores (
^
 0.31, 95% CI 0.00, 0.62). Finally, larger 
head circumference at birth was associated with worse Executive Functioning factor scores (
^
 -
0.12, 95% CI -0.22, -0.01), but better Perceptual Reasoning (
^
 0.10, 95% CI 0.00, 0.19). 
These associations were generally similar in the crude analyses, although some 
additional characteristics were found to have significant bivariate associations that were 
attenuated in multivariable adjusted models (Appendix 4). These multivariate regression 
associations also generally held in strata-specific analyses for whites and for non-whites, and 
were similar when additionally adjusting for maternal IQ, maternal marital status, and maternal 
age (data not shown).  
As a case study, to compare associations across analysis methods, we examined the 
relationship of maternal prenatal smoking with neurodevelopment as measured by factor scores 
and the instrument-specific composite scores (Table 7). Of the 162 participants included in the 
analyses, 28 mothers reported any smoking during pregnancy, 17 of whom reported quitting 
before the second trimester.  
Any smoking during pregnancy was associated with worse Impulsivity & Externalizing 
factor scores in both methods assessed (Impulsivity & Externalizing factor 
^
  -0.51, 95% CI -
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0.92, -0.10; Externalizing composite (
^
 -0.60, 95% CI -1.00, -0.21). However, while smoking 
during pregnancy was not associated with worse Executive Functioning factor scores, it was 
associated with approximately ½ a standard deviation worse Metacognition Index scores 
(Executive Functioning factor 
^
 -0.32, 95% CI -0.72, 0.10; Metacognition Index 
^
 -0.47, 95% CI -
0.86, -0.09). This trend was more pronounced when examining associations between smoking 
in later pregnancy and associations with executive functioning (EF Factor 
^
  -0.32, 95% CI -0.94, 
0.30; Metacognition Index 
^
  -0.55, 95% CI -1.12, 0.03). The smoking-neurodevelopment 
associations were generally stronger for participants who smoked during late pregnancy. While 
smoking in later pregnancy was negatively associated with the Adaptive Skills composite 
(Adaptive Skills composite 
^
  -0.66, 95% CI -1.23, -0.10), the association was closer to the null 
for the corresponding factor (Adaptability factor 
^
  -0.27, 95% CI -0.83, 0.31). Smoking was not 
associated with the Internalizing composite or Internalizing factor scores, or with any of the IQ 
composites or factor scores. Overall, accounting for the correlations among outcome measures 
by rotating factors to be linearly independent of one another resulted in attenuation of estimates 
for all but the Impulsivity and Externalizing factor, though all estimates were on the same side of 
the null. 
Discussion  
Summary   
We identified seven factors that together captured 78% of the variation in a principal 
components analysis of the BASC, BRIEF, and WPPSI-III/WISC-IV in children between 6 and 9 
years old. These factors were: 1) Impulsivity/Externalizing, 2) Executive Functioning, 3) 
Internalizing, 4) Perceptual Reasoning, 5) Adaptability, 6) Processing Speed, and 7) Verbal 
Intelligence. Although these factors roughly align with the composite indices of the included 
instruments, items from both the BASC and the BRIEF loaded onto all of the first three factors. 
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This implies the existence of a meaningful correlational structure that is perhaps as strong 
across the BASC and the BRIEF as it is within-instrument: the Behavioral Regulation Index of 
the BRIEF and the Externalizing Index of the BASC appear to measure a similar underlying 
domain and load together, while the Metacognition Index of the BRIEF and the attention 
subscale from the BASC appear to measure another unique domain and load together.  
Additionally, etiological interpretations were different for factor scores and composite 
scores. Although smoking in later pregnancy was associated with externalizing, executive 
functioning, and adaptive skills when using the composite scores, it was associated with only 
the Impulsivity & Externalizing factor when using the orthogonal varimax rotated factor scores, 
which rotates factors to be linearly independent of one another. This implies that at least part of 
the association between smoking during pregnancy and the Metacognition Index and the 
Adaptive Skills Composite may be due to the correlation between those constructs and the 
Externalizing Composite. Accounting for such correlations by using factor scores may portray 
associations that are more accurate than using instrument-specific composites alone.  Finally, 
the modifiable characteristics of education, canned fish consumption during pregnancy, preterm 
birth, and HOME Organization were associated with different neurodevelopmental factors.   
Factor Structure 
The factors to some extent aligned with measurement method. Specifically, scales from 
the BASC and the BRIEF loaded together without IQ items on four of the seven factors, while IQ 
items in the Processing Speed and Perceptual Reasoning factors loaded independently of the 
BASC and the BRIEF. The only exception was that organizational deficits from the BRIEF 
loaded positively on the Verbal Intelligence factor. Importantly, these clustering patterns also 
aligned with the measurement constructs of the instruments: the BRIEF and the BASC are both 
based on parent-report, while the WPPSI-III/WISC-IV are performance-based and assessed by 
research personnel. A limitation of the analysis is that we were unable to include multi-method 
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measurements of the same neurodevelopmental outcome; for instance, our analysis included 
parent-report measures of executive functioning but lacked performance-based assessments of 
executive functioning. Previous factor analyses on performance-based and parent-report 
measures of executive functioning have shown that measurement method may explain more 
variance than the underlying domain (Bodnar, Prahme, Cutting, Denckla, & Mahone, 2007; 
McAuley, Chen, Goos, Schachar, & Crosbie, 2010). In those studies, parent-reported executive 
functioning and performance-based executive functioning loaded on separate factors, and the 
correlation between them was low, suggesting they measured different underlying features of 
executive functioning (Bodnar et al., 2007; McAuley et al., 2010). It is possible that this 
difference in measurement method drove the differential loadings of performance-based 
intelligence and parent-reported behavior and executive functioning in this analysis. Since factor 
structures of neurodevelopment vary according to the included instruments, specific phenotypes 
may vary across studies as different studies adopt different measurement tools. However, 
generalizable phenotypes may emerge from factor analyses of various instruments, such as the 
Impulsivity and Externalizing phenotype, which may help in interpreting etiologic associations 
across different studies. 
Early Life Characteristics and Neurodevelopmental Factors 
Several maternal and behavioral characteristics, as well as features of the home 
environment, were associated with factor scores after accounting for their interdependence. 
These associations were generally consistent with prior literature. Of the modifiable 
characteristics, there were particularly strong associations for consuming canned fish at least 
once a week during pregnancy and Perceptual Reasoning factor scores in childhood, higher 
maternal education and Verbal Intelligence factor scores, and preterm birth and Internalizing 
and Processing Speed factor scores, all of which are consistent with prior literature (Bhutta, 
Cleves, Casey, Cradock, & Anand, 2002; Daniels, Longnecker, Rowland, Golding, & ALSPAC, 
  54 
2004; S. Johnson & Marlow, 2011; Oken et al., 2005; Sameroff, Seifer, Barocas, Zax, & 
Greenspan, 1987). Although canned fish is often a source of other contaminants which have 
been associated with adverse neurodevelopment, such as PCBs and mercury (Gilbert & Grant-
Webster, 1995), fish is also a source of other beneficial nutrients such as polyunsaturated fatty 
acids. Several studies of prenatal fish consumption support our findings that the benefits of fish 
consumption may outweigh the negative effects of environmental contamination (Cohen et al., 
2005; Daniels et al., 2004; Hibbeln et al., 2007; Oken et al., 2005).   
The only association that appeared inconsistent with prior findings was the relationship 
between head circumference at birth and Executive Functioning. Interestingly, while larger birth 
head circumference was associated with more deficits in Executive Functioning factor scores, it 
was also associated with better Perceptual Reasoning factor scores, in both unadjusted and 
adjusted analyses. While children with autism have larger head circumferences during 
childhood than average (Courchesne, Carper, & Akshoomoff, 2003; Woodhouse et al., 1996), 
and have more problems with executive functioning (Christ, Holt, White, & Green, 2007; Geurts, 
Verté, Oosterlaan, Roeyers, & Sergeant, 2004), these children also have normal or smaller 
head circumferences at birth (Courchesne et al., 2001, 2003; Lainhart et al., 1997). In the 
animal literature, larger brain size across species has been associated with higher levels of 
inhibitory control (MacLean et al., 2014), although this ecological data does not necessarily 
apply within-species or at birth. This area of research is therefore relatively unexplored, and 
further research is necessary before drawing more definitive conclusions.   
Maternal Prenatal Smoking and Neurodevelopment 
Consistent with the prior literature, children of participants who reported smoking during 
later pregnancy had worse behavioral scores for the BASC’s Externalizing composite, the 
BRIEF’s Metacognition Index, and the BASC’s Adaptive Skills composite, after adjustment for 
maternal education and race. However, after applying a rotational method to the factors that 
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implemented statistical independence of the factors, only the association between smoking and 
the Impulsivity & Externalizing factor remained in our study. The relationship between prenatal 
exposure to cigarettes and externalizing behaviors, ADHD, and executive functioning deficits in 
childhood has been frequently reported (Daseking, Petermann, Tischler, & Waldmann, 2015; 
Langley, Rice, van den Bree, & Thapar, 2005; Linnet et al., 2003; Piper & Corbett, 2012). 
However, observed relationships between prenatal cigarette smoking and deficits in executive 
functioning may partially reflect associations between smoking and impulsivity and externalizing 
behaviors, due to the high correlation between these two constructs (rs for the Externalizing 
composite and Metacognition Index in our population = 0.62). While alternative methods may 
also be available to account for high correlation among outcomes (e.g., controlling for the 
correlated outcomes), applying orthogonal rotation techniques requires fewer degrees of 
freedom and is easily implemented while performing a factor analysis.  
It should be noted that the reported association between smoking and Impulsivity and 
Externalizing may also be confounded by postnatal exposure to smoking and unmeasured 
maternal traits that increase both the propensity for smoking and risk of externalizing or 
executive functioning disorders (e.g., parental ADHD), which we were unable to control for 
(Thakur, Sengupta, Grizenko, Choudhry, & Joober, 2012; Thapar et al., 2009). Although we 
report the strongest associations for maternal smoking in the second and third trimesters with 
Impulsivity and Externalizing factor scores, there are a number of potential caveats for these 
findings. Women who fail to quit smoking during pregnancy may smoke more per day and over 
a longer period. Children of women who smoked in later pregnancy may thus have a higher 
cumulative dose as well as a longer duration of exposure.  Although the estimates for maternal 
first trimester smoking are not significant, they are in the same direction as the later pregnancy 
estimates. However, women who quit smoking before the second trimester may also have fewer 
problems with impulse control and addictive behaviors. Such characteristics may be either 
genetically or environmentally related to their children’s propensity for such behaviors, and 
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could confound associations between maternal smoking and childhood behavior. Additionally, 
the numbers of participants in each smoking category was relatively small; only 11 women 
reported any smoking in later pregnancy. However, the patterns of associations were similar 
when including all 28 women who reported any smoking during pregnancy, so the small 
numbers might not pose a significant threat.   
Strengths and Weaknesses 
A major strength of this analysis is the ability to examine multiple important 
characteristics and multiple neurodevelopmental outcomes while accounting for 
interdependencies among the covariates and the outcomes. The longitudinal, prospective 
nature of the original study allowed us to examine whether characteristics from the prenatal 
stage were associated with outcomes in later childhood. Dimension reduction enabled the 
simultaneous examination of a wide range of behaviors and cognitive outcomes, while taking 
advantage of correlational structures underlying different instruments. Accounting for the 
correlational structure among the factors may help clarify associations of specific characteristics 
with specific neurodevelopmental phenotypes, as we demonstrated in the case study of 
maternal smoking. Another advantage is the reduction in number of tests performed; examining 
associations with each subscale of each instrument would pose a larger threat from multiple 
testing. Finally, the principal components approach we employed presents conceptual 
advantages: factors that consolidate information across scales may provide a richer source of 
information than any single scale or composite. In etiological analyses, such factors may more 
closely mirror biological pathways that may be affected by prenatal and early life characteristics.  
 The most notable weakness is loss to follow-up; approximately 60% of the sample 
recruited at birth did not return for any follow-up assessment between the ages of 4-9 years. 
However, the distribution of the characteristics was mostly equivalent across these groups, so 
loss to follow-up was not influenced by any known covariates, with the possible exception of 
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marital status. The loss to follow up did result in a reduced sample size, which may influence the 
quality of the factor analysis. Earlier recommendations for the necessary sample size for factor 
analysis range from at least 100 to at least 300, although later studies have suggested that the 
sample size is less important as long as communalities are high and there are enough items 
with strong loadings on each factor (MacCallum et al., 1999). Our factor analysis had strong 
communalities and several items loaded highly on each factor, so the sample size of 210 for 
deriving the factor structure is likely adequate.  
Another weakness is that although we were able to include important covariates in all 
models, only the models for smoking were built etiologically to examine associations with 
neurodevelopment. Depending on the “exposure” of interest, the associations in the general 
predictive models may include mediators or adjust for colliders, which may result in biased 
associations (Greenland, 2003; Kaufman, Maclehose, & Kaufman, 2004).  
A feature of the study that is both a strength and a limitation is that the study population 
was quite diverse and included both wealthy, mostly white mothers from the Upper East Side of 
Manhattan, and low-income, mostly minority mothers from East Harlem. Although these 
neighborhoods are adjacent, their socioeconomic features are widely divergent. In our analysis, 
these groups display little overlap with regards to socioeconomic characteristics. Regardless, 
the multivariate regression analyses remained similar for whites and non-whites, and the factor 
structure was similar for both whites and non-whites, suggesting such racial stratification may 
not be a significant threat. 
In summary, we identified several maternal, birth, and home environment characteristics 
that were associated with neurodevelopmental phenotypes in linear regression analyses in a 
racially and socioeconomically diverse, urban cohort of mother-child pairs enrolled during 
pregnancy. We demonstrated that associations between smoking and correlated outcome 
domains may be substantially attenuated after accounting for their correlational structure. This 
“deep phenotyping” approach, that takes advantage of orthogonal rotation techniques, may 
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more accurately represent associations with correlated neurodevelopmental domains than more 
traditional approaches that use instrument-specific composite scores. Phenotyping approaches 
may thus be useful in future etiological analyses of neurodevelopment in rich datasets with 
sufficient participants and measurements of multiple neurodevelopmental outcomes.  
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Figure 2 Origination and Follow-up of Participants Included in Factor Analysis and 
Regression Analyses
Enrolled during 
pregnancy n=404 
Enrolled after 
delivery (n=56)  
  
Factor Analysis 
(n=210)
Association Models 
(n=162) 
Returned for 6-9 year follow-up 
and completed BASC, BRIEF, 
and WPPSI/WISC (n=162)
Provided complete 
covariate data (n=0) 
  
Provided covariate data 
(n=162)
 
Returned for 6-9 year follow-up 
and completed BASC, BRIEF, and 
WPPSI/WISC (n=48) 
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Table 5 Varimax Rotated Factor Pattern Structure and Item Loadings of Childhood 
Neurodevelopmental Scales (n=210) 
Factor 1 
 Impulsivity & 
Externalizing 
Factor 2 
 Executive Functioning 
Factor 3  
Internalizing 
Factor 4 
 Perceptual Reasoning 
Scale 
Loadin
g Scale 
Loadi
ng Scale 
Loadi
ng Scale 
Loadin
g 
Externalizing 
Problems
1
 0.90 
Metacognition 
Index
2
 0.89 Internalizing
1
 0.88 
Perceptual 
Reasoning IQ
3
 0.97 
Aggression
1
 0.78 Planning
2
 0.83 Anxiety
1
 0.77 
Matrix 
Reasoning
3
 0.76 
Conduct
1
 0.76 
Global Exec 
Composite
2
 0.79 Somatization
1
 0.67 Block Design
3
 0.72 
Hyperactivity
1
 0.74 
Working 
Memory
2
 0.78 Withdrawal
1
 0.67 
Picture 
Concepts
3
 0.71 
Behavioral Reg 
Index
2
 0.69 Monitor
2
 0.77 Depression
1
 0.64 Full Scale IQ
3
 0.70 
Behavioral 
Symp Index
1
 0.68 Initiate
2
 0.77 Atypicality
1
 0.58 Verbal IQ
3
 0.39 
Inhibit
2
 0.66 Organization
2
 0.62 
Behavioral 
Symp Index
1
 0.53 Vocabulary
3
 0.31 
Emotional 
Control
2
 0.63 Attention
1
 0.57 Shift
2
 0.50 
  
Adaptability
1
 -0.59 Inhibit
2
 0.56 
Emotional 
Control
2
 0.44 
  
Shift
2
 0.51 
Behavioral 
Reg Index
2
 0.50 
Behavioral 
Reg Index
2
 0.38 
  Global Exec 
Composite
2
 0.49 
Behavioral 
Symp Index
1
 0.42 
Global Exec 
Composite
2
 0.31 
  Depression
1
 0.46 Shift
2
 0.42 
    Attention
1
 0.45 Hyperactivity
1
 0.37 
    
Monitor
2
 0.41 
Emotional 
Control
2
 0.35 
    Organization
2
 0.35 Atypicality
1
 0.30 
    Adaptive Skills
1
  -0.33 
      Atypicality
1
 0.30 
      Internalizing
1
 0.30 
      Working 
Memory 0.3       
        
Factor 
Structure        
% Variance 
accounted for  37.92  13.71  7.86  6.33 
Eigenvalue 14.03  5.07  2.91  2.34 
1BASC scales, 2BRIEF scales, 3WISC-IV or the WPPSI-III scales. Only items with loadings with absolute 
values >0.30 are shown here. Loadings are from a PCA with orthogonal varimax rotation (factors are 
uncorrelated). Positive loadings for items from the BRIEF and BASC all indicate more problems with 
those items, except for the BASC’s Adaptive Skills, Social Skills, Leadership, and Adaptability.  
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Table 5 (continued) Varimax Rotated Factor Pattern Structure and Item Loadings of 
Childhood Neurodevelopmental Scales (n=210) 
Factor 5  
Adaptability  
Factor 6  
Processing Speed 
Factor 7  
Verbal Intelligence 
Scale 
Loadin
g Scale Loading Scale Loading 
Adaptive 
Skills Index
1
 0.89 
Processing 
Speed Index
3
 0.96 Vocabulary
3
 0.85 
Social Skills
1
 0.85 Coding
3
 0.88 Verbal IQ
3
 0.83 
Leadership
1
 0.85 
Symbol 
Search
3
 0.71 Full Scale IQ
3
 0.57 
Adaptability
1
 0.56 Full Scale IQ
3
 0.36 Organization
2
 0.38 
Attention
1
 -0.36 
  
Symbol Search
3
 0.31 
Initiate
1
 -0.30 
    
      
      
      
      
      
      
      
      
      
                  
      
      
 5.10  4.25  3.05 
 1.89  1.57  1.13 
1
BASC scales, 
2
BRIEF scales, 
3
WISC-IV or the WPPSI-III scales. Only items with loadings with absolute 
values >0.30 are shown here. Loadings are from a PCA with orthogonal varimax rotation (factors are 
uncorrelated). Positive loadings for items from the BRIEF and BASC all indicate more problems with 
those items, except for the BASC’s Adaptive Skills, Social Skills, Leadership, and Adaptability. 
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Table 6 Covariate-Adjusted Linear Regression Associations Between Prenatal and Early 
Life Characteristics and Neurodevelopmental Factors In The Mount Sinai Children’s 
Environmental Health Cohort (n=162) 
 
 
Factor 1 
 Impulsivity 
& 
Externalizi
ng 
β (95% CI) 
Factor 2  
Executive 
Functioni
ng  
β (95% 
CI) 
Factor 3  
Internali
zing 
β (95% 
CI) 
Factor 4 
Perceptual 
Reasoning 
β (95% CI) 
Factor 5 
Adaptabili
ty 
β (95% 
CI) 
Factor 6  
Processin
g Speed 
β (95% 
CI) 
Factor 7  
Verbal 
Intelligen
ce 
β (95% 
CI) 
Maternal Characteristics       
 
High School 
or less 
-0.11  
(-0.46, 
0.24) 
0.24  
(-0.12, 
0.60) 
-0.13  
(-0.49, 
0.22) 
0.00  
(-0.33, 
0.34) 
-0.15  
(-0.50, 
0.19) 
0.25  
(-0.10, 
0.60) 
-0.47  
(-0.78, -
0.17) 
 Any college 
or higher referent referent referent referent referent referent referent 
 Non-
Hispanic 
White 
-0.11  
(-0.55, 
0.34) 
-0.16  
(-0.62, 
0.30) 
-0.11  
(-0.57, 
0.35) 
0.68  
(0.25, 
1.10) 
0.11  
(-0.33, 
0.55) 
-0.09  
(-0.54, 
0.36) 
0.81  
(0.42, 
1.20) 
 Hispanic, 
Black, Other referent referent referent referent referent referent referent 
 
Any alcohol 
pregnancy 
0.02  
(-0.41, 
0.45) 
0.16  
(-0.28, 
0.60) 
0.16 
(-0.29, 
0.60) 
0.29  
(-0.12, 
0.71) 
0.00  
(-0.43, 
0.43) 
0.13  
(-0.31, 
0.57) 
0.34  
(-0.03, 
0.71) 
 No alcohol 
pregnancy referent referent referent referent referent referent referent 
 
Canned fish  
≥ 1x/week 
 
0.04  
(-0.45, 
0.53) 
-0.18  
(-0.69, 
0.33) 
0.11  
(-0.39, 
0.61) 
0.50  
(0.03, 
0.97) 
0.28  
(-0.20, 
0.77) 
-0.17  
(-0.66, 
0.33) 
-0.09  
(-0.51, 
0.34) 
 Canned fish 
< 1x/week referent referent referent referent referent referent referent 
Child and Birth 
Characteristics       
 
Female 
0.23  
(-0.08, 
0.53) 
-0.15  
(-0.46, 
0.17) 
-0.14  
(-0.46, 
0.17) 
-0.04  
(-0.34, 
0.25) 
0.54  
(0.24, 
0.84) 
0.31  
(0.00, 
0.62) 
-0.13  
(-0.39, 
0.14) 
 Male referent referent referent referent referent referent referent 
 
Preterm 
birth 
0.41  
(-0.18, 
1.00) 
-0.22  
(-0.82, 
0.39) 
-0.62  
(-1.23, -
0.02) 
0.24  
(-0.32, 
0.80) 
0.32  
(-0.26, 
0.90) 
-0.72  
(-1.31, -
0.13) 
0.32  
(-0.19, 
0.83) 
 Term birth referent referent referent referent referent referent referent 
 Birth Head 
Circumferen
ce (cm) 
-0.03  
(-0.13, 
0.08) 
-0.12  
(-0.22, -
0.01) 
0.01  
(-0.10, 
0.11) 
0.10 
(0.00, 
0.19) 
0.03  
(-0.07, 
0.14) 
0.06  
(-0.05, 
0.16) 
-0.01  
(-0.10, 
0.08) 
HOME scores       
 
Organizatio
n 
-0.11  
(-0.32, 
0.11) 
0.26  
(0.04, 
0.49) 
0.20  
(-0.02, 
0.43) 
-0.05  
(-0.26, 
0.15) 
0.10  
(0.00, 
0.19) 
-0.13  
(-0.35, 
0.09) 
-0.01  
(-0.20, 
0.17) 
 
Learning 
Materials 
0.02  
(-0.21, 
0.25) 
0.02  
(-0.21, 
0.26) 
0.01  
(-0.22, 
0.25) 
0.06  
(-0.16, 
0.27) 
-0.05  
(-0.26, 
0.15) 
0.16  
(-0.07, 
0.40) 
0.12 
 (-0.08, 
0.32) 
 
Involvement 
0.06  
(-0.16, 
0.27) 
-0.17  
(-0.40, 
0.06) 
-0.07  
(-0.29, 
0.15) 
0.09  
(-0.12, 
0.29) 
0.06  
(-0.16, 
0.27) 
0.09  
(-0.13, 
0.31) 
-0.03  
(-0.22, 
0.16) 
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Factor 1 
 Impulsivity 
& 
Externalizi
ng 
β (95% CI) 
Factor 2  
Executive 
Functioni
ng  
β (95% 
CI) 
Factor 3  
Internali
zing 
β (95% 
CI) 
Factor 4 
Perceptual 
Reasoning 
β (95% CI) 
Factor 5 
Adaptabili
ty 
β (95% 
CI) 
Factor 6  
Processin
g Speed 
β (95% 
CI) 
Factor 7  
Verbal 
Intelligen
ce 
β (95% 
CI) 
 
Variety 
-0.02  
(-0.25, 
0.21) 
0.13  
(-0.11, 
0.38) 
0.11  
(-0.13, 
0.34) 
0.01  
(-0.22, 
0.23) 
0.09  
(-0.12, 
0.29) 
0.05  
(-0.19, 
0.29) 
-0.07  
(-0.28, 
0.13) 
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Table 7 Comparison of Prenatal Smoking and Neurodevelopment Associations by 
Analysis Method (n=162) 
 
Any smoking during 
pregnancy 
Smoking in First 
Trimester Only 
Smoking in 
Second or Third 
Trimesters 
 N=28 N=17 N=11 
Impulsivity & Externalizing 
factor1 -0.51 (-0.92, -0.10) -0.29 (-0.80, 0.22) -0.82 (-1.42, -0.23) 
Externalizing Composite2 -0.60 (-1.00, -0.21) -0.36 (-0.84, 0.13) -0.97 (-1.55, -0.39) 
    
Executive Functioning 
factor1 -0.32 (-0.75, 0.10) -0.32 (-0.85, 0.21) -0.32 (-0.94, 0.30) 
Metacognition Index2 -0.47 (-0.86, -0.09) -0.23 (-0.71, 0.25) -0.55 (-1.12, 0.03) 
    
Internalizing factor1 0.26 (-0.16, 0.68) 0.32 (-0.21, 0.84) 0.18 (-0.43, 0.80) 
Internalizing Composite2 0.07 (-0.33, 0.47) 0.18 (-0.32, 0.68) -0.09 (-0.68, 0.50) 
    
Perceptual Reasoning 
factor1 0.06 (-0.33, 0.45) 0.28 (-0.21, 0.77) -0.26 (-0.83, 0.31) 
Perceptual Reasoning IQ2 0.14 (-0.25, 0.53) 0.37 (-0.11, 0.85) -0.19 (-0.76, 0.38) 
    
Adaptability factor1 -0.08 (-0.48, 0.33) 0.06 (-0.45, 0.56) -0.27 (-0.85, 0.32) 
Adaptive Skills Composite2 -0.33 (-0.71, 0.06) -0.10 (-0.58, 0.37) -0.66 (-1.23, -0.10) 
    
Processing Speed factor1 -0.16 (-0.57, 0.26) -0.09 (-0.61, 0.43) -0.26 (-0.87, 0.36) 
Processing Speed IQ2 -0.22 (-0.66, 0.23) -0.11 (-0.69, 0.48) -0.46 (-1.07, 0.15) 
    
Verbal Intelligence1 0.04 (-0.31, 0.40) -0.12 (-0.56, 0.32) 0.28 (-0.23, 0.79) 
Verbal IQ2 0.15 (-0.16, 0.46) 0.10 (-0.29, 0.49) 0.22 (-0.24, 0.68) 
All models adjusted for maternal race, maternal education at follow-up, fish consumption, child sex, 
alcohol consumption during pregnancy, and HOME scores. Referent category for all three models is no 
reported smoking during pregnancy.  
1 
Factors are rotated using Varimax (orthogonal) rotation (factors are statistically uncorrelated with each 
other).  
2 
The composite/index items are the highest loading composite item for each factor.     
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CHAPTER V. ASSOCIATIONS BETWEEN PRENATAL EXPOSURE TO 
ORGANOPHOSPHORUS PESTICIDES AND CHILDHOOD NEURODEVELOPMENTAL 
PHENOTYPES 
Introduction 
 Prenatal exposure to organophosphorus pesticides (OPs), phthalates, and phenols have 
been associated with several aspects of risk to neurodevelopment in different populations 
(reviewed in (Bellinger, 2013)). However, epidemiological studies of OPs and 
neurodevelopment have typically considered only a single component of neurodevelopment at a 
time—for example, IQ or behavior. There are major conceptual advantages in jointly modeling 
domains of neurobehavioral development (Robinson, 2012). Accounting for interrelatedness 
between developmental domains is more clinically relevant, in part because several 
neurological functions rely on each other. For example, higher-level inhibitory control – typically 
considered to be a component of executive functioning -- relies on more basic processing speed 
capability, which is typically measured in intelligence tests (Ridderinkhof & Van Der Molen, 
1997). Additionally, deficits in one aspect of neural functioning may be compensated for by 
performance in other areas – for instance, declarative memory can compensate for multiple 
impairments across a range of disorders (Ullman & Pullman, 2015). Finally, considering multiple 
aspects of neurodevelopment simultaneously allows the investigator to employ dimension 
reduction techniques, such as factor analysis, which enables the user to rotate factors to be 
linearly independent. This may account for any remaining interrelatedness among unique 
aspects of neurodevelopment in etiological studies. 
By jointly considering behavior, cognition, and executive functioning, we may also better 
characterize patterns of deficits in neurodevelopment (Castellanos, Sonuga-Barke, Milham, & 
Tannock, 2006; Mattison & Mayes, 2012; Semrud-Clikeman, Walkowiak, Wilkinson, & Butcher, 
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2010; Sinzig, Morsch, Bruning, Schmidt, & Lehmkuhl, 2008) that may provide insights into 
common etiological pathways. For instance, OPs can negatively influence serotoninergic 
processing (Aldridge, Meyer, Seidler, & Slotkin, 2005; Aldridge, Seidler, & Slotkin, 2004; Slotkin 
& Seidler, 2005, 2008). Serotonin, in turn, can influence aggression, other problematic social 
behaviors, depression, and ADHD (Cadoret et al., 2003; Eley et al., 2004; Zoroğlu et al., 2002), 
the latter of which is characterized by impairments in executive functioning (Barkley, 1997). 
Animal and human studies do support that OPs may be associated with these outcomes 
(Bouchard, Bellinger, Wright, & Weisskopf, 2010; Children et al., 2007; Furlong, Engel, Barr, & 
Wolff, 2014; Middlemore-Risher, Buccafusco, & Terry, 2010; Ricceri et al., 2003, 2006).  
In addition, previous approaches to modeling associations between OPs and 
neurodevelopment have generally assumed that exposure to OPs and other chemicals is 
independent, and that such chemicals do not confound or alter the OP-neurodevelopment 
relationship. However, this modeling approach may bias estimates due to confounding by 
correlated xenobiotics. Chemicals may be correlated with each other due to similar sources, 
such as plasticizers in consumer products, insecticides for pest control, or multiple compounds 
found in food due to production or delivery practices or common dietary patterns (S. M. Engel & 
Wolff, 2013). Epidemiological investigations of exposure mixtures are still in their infancy, and 
have typically focused on confounding by co-exposures within a class of compounds (e.g. within 
phthalates), rather than across classes of compounds. Bayesian hierarchical mixture models 
allow the stable estimation of effects in the presence of collinearity and a high number of 
covariates relative to sample size, through the use of prior assignment (Dunson, Herring, & 
Engel, 2008; Herring, 2010)  
 In this study, we evaluate associations between OPs and behavior, executive 
functioning, and IQ after accounting for possible mixture effects with other co-exposures 
(specifically, phthalates, phenols, and pyrethroid pesticides), and implement a phenotypic 
approach to modeling neurodevelopment with a factor analysis. We also consider possible 
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sources of heterogeneity in associations due to race, sex and genetic variants in PON1, a gene 
which is involved in the detoxification of OPs. 
Methods 
Study Recruitment and Population 
The Mount Sinai Children’s Environmental Health Center is a prospective cohort study of 
404 mother infant-pairs from New York City. We recruited women during prenatal visits at either 
the Mount Sinai Diagnostic and Treatment Center, which serves a predominantly East Harlem 
population, or one of two private practices on the Upper East Side of Manhattan. Eligible 
mothers were primiparous with singleton pregnancies, and delivered at the Mount Sinai Hospital 
between May 1998 and July 2001 (Berkowitz et al., 2003, 2004). Exclusions have been detailed 
elsewhere (Berkowitz et al., 2003; S. M. Engel et al., 2007). Mothers completed questionnaires 
during their third trimester that assessed a variety of sociodemographic, behavioral, and medical 
history characteristics. We also obtained maternal spot urine samples between 25 and 40 
weeks of gestation (mean= 31.2 weeks).  
We invited participants to return for follow-up visits with their child at ages 1, 2, 4, 6, and 
7-9 years. At follow-up visits, mothers completed questionnaires describing sociodemographic 
features and developmental milestones. The Home Observation for Measurement of the 
Environment (HOME scale) (Bradley et al., 1989) was administered in home visits at the 1 and 2 
year follow-up visits. The HOME subscales include Involvement, Learning Materials, 
Organization, Acceptance, Responsivity, and Variety (descriptions provided in Chapter 4). 
Exposure Biomarker Measurements 
The Centers for Disease Control (CDC) analyzed all maternal urine samples. Six 
dialkylphosphate metabolites, including three dimethylphosphate (DMP) and three 
diethylphosphate (DEP) metabolites, were analyzed in two batches between 2002-2003. Quality 
control and laboratory methods have been published previously (Barr et al., 2005; Bravo et al., 
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2004). We excluded participants with very dilute urines (creatinine <10 mg/dL) due to the 
potential for inaccurate biomarker measurements (Wolff et al., 2008). After exclusion, 375 
participants had at least one non-missing metabolite and 158 of these participants returned for a 
complete neurodevelopmental follow-up visit, had factor scores, and are included in this 
analysis. 
Samples were also analyzed for 9 phthalate, 3 pyrethroid, and 5 phenol metabolites, 
using laboratory and quality control methods that have been described previously (Barr et al., 
2010; Kato, Silva, Needham, & Calafat, 2005; Ye, Kuklenyik, Needham, & Calafat, 2005). 
Briefly, phthalates in urine were measured using automated sample preparation and an on-line 
solid-phase extraction method in conjunction with isotope dilution high-performance liquid 
chromatography/tandem mass spectrometry (SPE-HPLC-MS) (Kato et al., 2005). Urinary 
phenols were also measured using SPE-HPLC-MS (Ye et al., 2005). For the pyrethroids, an 
internal standard mixture of isotopically labeled 3PBA and trans-DCCA was used to spike 2 ml 
of urine, which was then incubated with Beta-glucuronidase/sulfarase to liberate the conjugated 
metabolites. Hydrolysates were extracted with OASIS HLB mixed-mode solid-phase extraction 
cartridges, which were then washed with 5% methanol in a 0.1% acetic acid solution. 
Metabolites were eluted with methanol. HPLC/MS was used to analyze the extracts. Isotope 
dilution calibration was used to quantify 3PBA and trans-DCCA, while cis-DCCA was quantified 
using labeled trans-DCCA as an internal standard (Barr et al., 2010).  
Child Behavior, Executive Functioning, Psychometric Intelligence Testing 
We measured children’s executive functioning and behavior at the 4, 6, and 7-9 year 
visits using parent report measures, and IQ at the 6 and 7-9 year visits using performance-
based measures. 
The Behavior Rating Inventory of Executive Functioning (BRIEF) is a parent-report 
assessment of children’s problems with executive functioning over the past 6 months (Bodnar et 
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al., 2007). Parents reported whether each behavior had been a problem on a 3 point scale, 
ranging from never, sometimes, or often. Validity studies report good reliability with high test-
retest reliability (mean rs=0.81 for parents across scales) and internal consistency (Cronbach’s 
alphas range from 0.80-0.98 across scales)(Gioia et al., 2000). Indices include the Behavioral 
Regulation Index and the Metacognition Index, both of which are age normed and combined to 
form the overall Global Executive Composite. Detailed descriptions of the indices and subscales 
are included in Table 4.  
The Behavior Assessment System for Children (BASC) is a parent-report assessment of 
children’s problem and adaptive behaviors in the home and community setting (Sandoval & 
Echandia, 1994). Internal consistency reliability of this instrument is good (Cronbach’s alphas 
average 0.80 across scales and ages), and test-retest reliabilities are also high (mean rs = 0.85 
for preschool, mean rs = 0.87 for children ages 6-11) (Sandoval & Echandia, 1994). Composite 
indices include Externalizing Behaviors, Internalizing Behaviors, Adaptive Skills, and the 
Behavioral Symptoms Index. Parents score individual items as happening or relevant Never, 
Sometimes, Often, Almost always, which are converted into scores of 0, 1, 2, or 3, and reflect 
increasing frequency. Scores are age-normed and reported as T-scores. Detailed descriptions 
of the composites and subscales are included in Table 4. The BASC and BRIEF were both 
completed at the 4, 6, and 7-9 year visits. We used the mean T-scores across all visits.  
 We administered the Wechsler Preschool and Primary Scales of Intelligence-III (WPPSI-
III) at age 6 (mean age = 6.2, SD=0.2), and the Wechsler Intelligence Scales-IV (WISC-IV) 
between the ages of 7-9 years (mean age =7.8, SD=0.8). WISC-IV composite scores include 
the Verbal Comprehension score, the Perceptual Reasoning score, the Working Memory Index, 
and Processing Speed. Similarly, the WPPSI-III composites are corollaries of the WISC-IV 
composites and include Verbal Intelligence, Performance IQ (similar to Perceptual Reasoning), 
and Processing Speed, but not Working Memory. The WISC-IV and WPPSI-III are highly 
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correlated (rs= 0.84 in our population); thus, if a child returned for both visits we used the WISC-
IV scores for all subtests.  
Statistical Methods 
We examined demographic characteristics of participants at enrollment by follow-up 
status. We used frequentist chi-square goodness-of-fit tests and alpha of 0.05 to assess if 
participants from the original birth cohort with OP biomarker data who did not return for follow-
up differed from participants who had OP biomarker data and returned for a complete 
neurodevelopmental evaluation. Although we used follow-up characteristics in our association 
models, only characteristics at enrollment were available for participants who did not return for 
follow-up. Thus, we used characteristics at enrollment for these comparisons. 
Neurodevelopmental Factor Analysis and Outcomes 
We assessed neurodevelopmental factors by performing dimension reduction on the 
BRIEF, BASC, and WPPSI-III/WISC-IV instruments with a principal components analysis. 
Details have been described elsewhere (Furlong et al., n.d.). Briefly, we included composites 
and subscales in the factor analysis if they were available at both the 6 and 7-9 year visits. By 
using average scores across visits we were able to include participants who returned for 
different visits in a single factor analysis. For this analysis, we used a varimax rotation to ensure 
neurodevelopmental outcome factors were linearly independent. We standardized all factor 
scores to have a mean of 0 and a standard deviation of 1. A beta coefficient of one can then be 
interpreted as an increase in one standard deviation of the factor score. Additionally, we scaled 
factors so that positive/adverse characteristics go in the same direction across factors in 
regression analyses, with positive scores indicating better outcomes and negative scores 
indicating more adverse outcomes. Additionally, since the WISC-IV Working Memory Index 
provides unique information on a performance-based metric of executive functioning, and could 
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not be included in the factor analysis because it is only a component of the WISC-IV, we also 
included this index as an outcome in models. 
In order to assess the utility of the factor analysis approach over a more traditional 
approach, we also conducted analyses of associations between the OPs and the individual 
items from the factors that displayed associations with the OPs.  
Coexposures 
Coexposures included phthalates, phenols, and pyrethroid pesticides. Four phthalate 
metabolites are metabolites of the same parent compound, Di(2-ethylhexyl) phthalate (DEHP) 
and were thus included as a micromolar sum of those metabolites (MEHP, MEHHP, MEOHP, 
and MECPP). MBzP, MCPP, MiBP and MBP were individually included. The pyrethroid 
metabolites 3PBA, c-DCCA, and t-DCCA displayed a low frequency of detection and were 
dichotomized to indicate concentrations above or below the LOD. The DCCA isomers and 3PBA 
were highly collinear; only five participants with detectable levels of c-DCCA or t-DCCA did not 
have detectable levels of 3PBA, so the DCCA metabolites were excluded from the analysis. 
Phenols included metabolites for BPA, BP3, triclosan, and 2,5 -DCP, and these individual 
metabolites were included as co-exposures. We excluded the phenol 2,4-DCP because it is a 
marker of the same parent compound as 2,5-DCP, but had a lower detection frequency. We 
standardized the natural log form of all continuous co-exposures to a mean of 0 and a standard 
deviation of 1. 
Bayesian Exposure Mixture Analyses 
In order to address potential issues of collinearity among metabolites and to stabilize 
models with large numbers of co-exposures and interactions, we used a Bayesian exposure 
mixture modeling framework. We employed hierarchical shrinkage techniques and specified 
priors for means and variances of beta coefficients for all variables. We assigned independent 
normal prior distributions with a mean of zero and a variance of 1/τ2 (MacLehose, Dunson, 
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Herring, & Hoppin, 2007), where τ equals 1 for all exposures and covariates (priors with mean of 
0 and standard deviation of 1). In sensitivity analyses, prior distributions on beta coefficients for 
the OPs and co-exposures were specified such that individual metabolites within classes were 
shrunk towards a class mean; e.g., phthalate metabolites were shrunk towards a phthalate 
mean and each OP sum was shrunk towards the OP mean. The τ for all metabolites within a 
class thus originated from the same class-specific distribution; in this analysis we used a 
uniform distribution from 0.001 to 5 for τ (Gelman et al., 2013). The outcomes were specified 
with means originating from a normal distribution with a mean of 0, and variances originating 
from a uniform distribution from 0 to 2. 10,000 burn-in samples were discarded and we used 
50,000 iterations to arrive at the posterior estimates. 
We imputed values below the limit of detection (<LOD) at each iteration of the Markov 
chain Monte Carlo algorithm from a truncated normal distribution with parameters defined as the 
mean and standard deviation of the underlying distribution, a lower bound of 0, and an upper 
bound equal to the LOD (WinBUGS package djl.trunc.norm). If an OP metabolite was missing 
due to analytic interference, the missing value within a class was imputed based on the other 
non-missing values within that class, as has been described previously (S. M. Engel et al., 
2007). Diethyl- and dimethyl-phosphate metabolites were then summed on a molar basis at 
each iteration of the MCMC algorithm to obtain total diethylphosphate (DEPs) and total 
dimethylphosphate (DMPs) biomarker concentrations.  
Phthalate and phenol metabolite concentrations that were below the LOD were imputed 
as described above. The pyrethroid metabolite was dichotomized at the LOD in all models due 
to the low detection frequency in our population. All continuous co-exposures and outcomes 
were standardized to have a mean of 0 and a standard deviation of 1. All continuous covariates 
were standardized to a mean of 0 and a standard deviation of 1 in order to facilitate the 
assignment of priors and comparisons of estimated effect sizes with dichotomous covariates, 
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and to improve MCMC convergence (Gelman et al., 2013). Missing covariate data were imputed 
at each iteration of the MCMC algorithm under the assumption that covariates were missing at 
random. We assigned covariate estimates priors with a mean of 0 and standard deviation of 1. 
Covariates with missing data included HOME scores, alcohol consumption during pregnancy, 
and maternal IQ. The HOME subscale scores were modeled as normally distributed random 
variables conditional on race, education, child sex, maternal IQ, smoking during pregnancy, 
canned fish consumption during pregnancy, the factor scores, marital status, and maternal age 
at enrollment. We modeled alcohol consumption during pregnancy using a logistic model 
conditional on race, education, canned fish consumption, smoking, the factor scores, marital 
status, maternal age at enrollment, maternal IQ, and HOME scores. Maternal IQ was modeled 
as a normally distributed random variable conditional on race, education, smoking during 
pregnancy, canned fish consumption, marital status, age at enrollment, HOME scores, and the 
factor scores. Models were run using WinBUGS14.  
Covariate Selection 
 We constructed directed acyclic graphs (DAGs) for each factor, and considered the 
following variables for inclusion in the DAGs: maternal education at follow-up (high school or 
less, some college, or bachelor’s degree), race/ethnicity (non-Hispanic white, Hispanic, black), 
maternal marital status at follow-up (single, living with a partner, married), maternal age, HOME 
environment (overall scores included as continuous, subscales included as ordinal categorical 
tertile variables due to their limited range), smoking during pregnancy (ever/never), alcohol use 
during pregnancy (none, light drinking <3 drinks on average per week during any trimester, 
moderate to heavy drinking of ≥ 3 drinks on average per week during any trimester, child sex, 
canned fish consumption during pregnancy (<1 time per week vs ≥ 1 time per week during 
pregnancy), Spanish language spoken in home, OP analysis batch, and an indicator variable for 
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examiner for the WISC-IV/WPPSI-III. We used the DAGs to identify and adjust for the minimally 
sufficient set for each factor. We adjusted for creatinine and OP analysis batch in all models 
Interaction Analyses 
We also assessed modification by race/ethnicity, sex, and maternal PON1 genotype 
status (PON1 Q192R and PON1 -108 C>T polymorphisms). The PON1 polymorphisms of -108 
C>T and Q192R were dichotomized (-108: CC vs CT or TT; Q192R: QQ vs QR or RR). We 
considered interactions to be present if the 95% credible interval for the interaction term did not 
cross the null. Interactions between OPs and possible modifiers were assessed one at a time; 
i.e., we assessed interactions between ∑DMPs and race separately from interactions between 
∑DEPs and race.  
Sensitivity Analyses 
 In sensitivity analyses we employed a frequentist linear regression approach to assess 
overall associations between DEPs and DMPs and neurodevelopmental factors, with and 
without adjustment for co-exposures to phthalates, phenols and pyrethroids. If individual 
metabolite concentrations were below the limit of detection (LOD), a single random value <LOD 
was imputed from a log-normal distribution truncated at the LOD. Metabolites missing due to 
analytic interference were handled as above. Due to collinearity, inclusion of co-exposures was 
treated slightly differently in frequentist models. The phthalate metabolites of MiBP, MBP, and 
MEP are all members of a class of low molecular weight phthalates and thus were included as a 
molar sum, alongside DEHP and the individual metabolites MCPP and MBZP. The log forms of 
the variables were standardized to a mean of 0 and a standard deviation of 1 for comparability 
in frequentist models. We used multiple imputation to fill in missing covariate data (PROC GLM 
with PROC MI and PROC MIANALYZE) (10 imputations), and examined studentized residuals 
and leverages to identify potential outliers. We used SASV9.4 for frequentist analyses. All 
relevant code is included in Appendix 6. 
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Results 
Of the 404 mother/child pairs that participated in the original birth cohort, 162 returned 
for at least one complete neurodevelopmental follow-up visit when their child was between 6-9 
years old. 158 of these women had prenatal OP biomarker data. Of the 158 women with 
complete neurodevelopmental data and OP biomarker data, 141 had complete co-exposure 
data and were included in the analysis. Participants included in this analysis were generally 
young (64% under 25 at enrollment) and non-white (82%). Most participants reported no alcohol 
consumption (83%) and no smoking during pregnancy (84%), and most had an educational 
attainment of high school or less at enrollment (73%) (Table 8). Single marital status at 
enrollment was the only predictor of returning for follow-up (p=0.03), and the distributions of 
education at enrollment, maternal age at delivery, race, alcohol, and smoking were generally 
similar for those included in this analysis compared to those who were not.  
Individual OP metabolites varied in their frequency of detection, with 
dimethylthiophosphate (DMTP) displaying the highest frequency at 93.6% detects and 
diethyldithiophosphate (DEDP) displaying the lowest frequency at 16.7% detects (Table 9). 
Results were similar when including all 158 participants with OP biomarker data. Of the 158 
participants with OP biomarker data, all had phthalate biomarkers, 153 had phenols, and 148 
had pyrethroid data. 141 participants had a complete panel of biomarker data. Detection 
frequencies for the phthalates were high, ranging from 97.5% to 99.4% for the individual 
metabolites. Among the phenols, BP3 and 2,5-DCP were detected in every sample, while BPA 
was detected in 86.3% of samples and triclosan was detected in 79.7% of samples. The 
pyrethroid metabolite PBA had a much lower detection frequency and was only detected in 
24.3% of samples.  
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Bayesian Exposure Mixture Modeling of Neurodevelopmental Factors 
After examining eigenvalues and parallel analysis results, we determined there was an 
optimal seven factor solution (Furlong et al., n.d.). The factors are 1) Impulsivity and 
Externalizing, 2) Executive Functioning, 3) Internalizing, 4) Perceptual Reasoning, 5) 
Adaptability, 6) Processing Speed, and 7) Verbal Intelligence (Table 5).  
We examined studentized residuals and leverages and identified and excluded one 
outlier from both frequentist and Bayesian models with the highest residuals in several factor 
models. This participant had extremely low behavioral factor scores and exclusion of this 
observation changed effect estimates by more than 20%.  
Convergence diagnostics of the Bayesian models were excellent. 
After adjustment for covariates and co-exposures, ∑DMPs were unexpectedly 
associated with better scores on the Executive Functioning factor (
^
 0.18, 95% CI 0.04, 0.31), 
which was also supported by nonsignificant results for the Working Memory Index (
^
 0.12, 95% 
CI -0.02, 0.25) (Table 10). ∑DMPs were at the same time associated with more adverse 
Internalizing factor scores (
^
  -0.13, 95% CI -0.25, 0.00). In contrast, ∑DEPs were associated 
with more adverse scores on the WISC-IV’s Working Memory Index (
^
  -0.17, 95% CI -0.33, -
0.03), with no other notable associations among the individual factor scores. The magnitude of 
each of these associations is fairly small, representing less than a quarter of a standard-
deviation change in the outcome per one standard deviation increase in exposure. 
Associations of ∑DMPs with individual item scores within the Executive Functioning 
factor were generally similar, although there were no item-specific associations for the BRIEF’s 
Organization, Shift, Behavioral Regulation Index, or Emotional Control scales, nor the BASC 
Behavioral Symptom Index, Hyperactivity or Atypicality scales. In contrast, the association 
between ∑DMPs and items within the Internalizing factor was mostly restricted to the BASC’S 
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Anxiety scale (
^
 -0.14, 95% CI -0.28, 0.00), with no other associations among items in that 
factor (Table 11).  
Heterogeneity in Associations by Race  
There were no interactions between sex, race, or PON1 and the ∑DMPs or ∑DEPs, for 
any factor. However, there was an interaction between race and ∑DMPs for the WISCIV’s 
Working Memory Index. The positive association between ∑DMPs and the Working Memory 
Index was only present for blacks (
^
  0.34, 95% CI 0.15, 0.53), but not for Hispanics (
^
  -0.09, 
95% CI -0.27, 0.08) nor whites (
^
  0.16, 95% CI -0.16, 0.49), 95% credible interval did not cross 
the null). 
Sensitivity Analyses 
 In sensitivity analyses we shrunk exposure estimates toward class means. Estimates 
were generally similar although all estimates were slightly closer to the null, as expected. We 
also examined associations using a frequentist, single exposure linear regression framework 
and overall found little difference in associations as compared to the Bayesian method, however 
effects were slightly more inflated and tended to be less precise, as expected. Directionality in 
associations, however, was generally conserved (Appendix 5).  
Discussion 
Using a Bayesian hierarchical approach, we report associations between ∑DMPs and 
worse Internalizing factor scores. Among the items that comprise the Internalizing Factor, the 
inverse associations with ∑DMPs appeared to be largely restricted to anxiety. Supporting 
associations between DMP parent pesticides and depression and anxiety, have been previously 
reported in murine models and one human study. Malathion induces anxiety and/or depressive 
behaviors in adult rats when administered in adulthood or in utero (Assini et al., 2005; Brocardo 
et al., 2007; Hashjin, Dizaj, Attaran, & Koohi, 2013; N’Go et al., 2013). In humans, occupational 
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exposure to malathion has also been associated with depression in adult farmers (Beard et al., 
2014). Although there are no previously published findings of exposure to OPs in utero and 
internalizing, anxiety, or depressive symptoms in childhood, one study has reported an 
association between prenatal exposure to ∑DMPs and Pervasive Developmental Disorder 
(PDD) at 24 months as measured by the Child Behavior Checklist (CBCL) (Children et al., 
2007). The PDD designation in the CBCL includes some behaviors that are indicative of general 
internalizing psychopathology, such as avoiding eye contact and being unresponsive to 
affection, which is consistent with our findings. 
We also found a relationship between ∑DEPs and the Working Memory Index, which is 
consistent with other analyses within this cohort (S. Engel et al., 2011). however, our analytic 
approach enabled estimation with more precision. Several previous studies report associations 
between OPs and deficits in different domains of IQ, including the Working Memory Index, 
(Bouchard et al., 2011b; S. Engel et al., 2011; V. A. Rauh et al., 2006; V. Rauh et al., 2011), 
although we found inverse associations only for ∑DEPs and the Working Memory Index.  
Finally, we report an unexpected positive association between ∑DMPs and the 
Executive Functioning factor, and supported by an elevated, but non-significant, association 
with the Working Memory Index. However, the association between ∑DMPs and the Working 
Memory Index differed by race, with a positive association among blacks and no associations 
among whites or Hispanics. 
In contrast to our findings, several previous studies have reported adverse associations 
between OPs and various measures of executive functioning, including attention, ADHD, and 
working memory (Bouchard et al., 2011a, 2010; Eskenazi et al., 2014; Marks et al., 2010; V. A. 
Rauh et al., 2006; V. Rauh et al., 2011; Yu et al., 2016), although studies examining prenatal 
exposure originate from only two other cohorts (Bouchard et al., 2011a; Marks et al., 2010; V. A. 
Rauh et al., 2006; V. Rauh et al., 2011). In the CHAMACOS cohort, Marks et al (Marks et al., 
2010) reported associations between ∑DMPs and ∑DEPs and parent-report measures of 
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attention problems at 3.5 but not 5 years, and also associations with a performance-based 
measure of attention, the Kiddie Connors Performance Test (K-CPT). ∑DEPs, but not ∑DMPs, 
were additionally associated with a psychometrician rating of ADHD symptoms in the same 
cohort of 5 year olds (Marks et al., 2010). Also in CHAMACOS, Bouchard et al (Bouchard et al., 
2011b) reported strong associations between increasing prenatal levels of DMPs (but not DEPs) 
and worse performance on the Working Memory Index at seven years of age, along with other 
dimensions of IQ (Bouchard et al., 2011a). In the Columbia Center for Children’s Environmental 
Health, Rauh et al report associations between prenatal chlorpyrifos exposure, which devolves 
into DEPs, and parent-report measures of ADHD problems and attention problems, at 3 years 
(V. A. Rauh et al., 2006). In the same cohort, Rauh et al reported associations between prenatal 
exposure to chlorpyrifos and more adverse performance on the Working Memory Index (V. 
Rauh et al., 2011). Therefore, the existing literature is limited and somewhat mixed. Our findings 
of an adverse association between prenatal DEP exposure and the Working Memory Index is 
supported by the studies from the Columbia Center for Children’s Environmental Health, which 
are based on a population of women residing in New York City that were enrolled at the same 
time as our cohort. However, we also found a positive association between ∑DMPs and the 
Executive Functioning factor, which seemingly contradicts the associations reported in the 
CHAMACOS cohort. These inconsistencies may be attributed in part to the limitations of the 
DAP (dialkylphosphate; includes DMPs and DEPs) biomarkers as estimates of exposure to 
organophosphorus pesticides.  
DAP biomarkers are non-specific, as the same metabolite is produced by multiple parent 
compounds, which may vary in their toxicities. The CHAMACOS cohort was recruited in an 
agricultural region of CA and over 80% of households had a farmworker that lived in the 
household during pregnancy. The participants in this cohort were likely exposed to a different 
constellation of pesticides than the urban Mount Sinai or Columbia populations. In a recent 
pooled analysis of these cohorts, significant heterogeneity was found in associations between 
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∑DMPs and the Bayley Mental Development Index (MDI) by cohort. Associations between 
∑DMPs and the MDI in CHAMACOS were substantially more deleterious than the three other 
included cohorts, and the authors argued that a specific agricultural pesticide used in the 
Salinas Valley that devolves into DMPs and was not experienced by the other urban cohorts, 
may partly explain this pattern (S. M. Engel et al., 2015). The exposure profile of our cohort is 
likely much more similar to the Columbia cohort, and thus their findings of an adverse 
association between chlorpyrifos and Working Memory are highly relevant. We are unable to 
compare our findings of improved executive functioning with increasing DMP exposure with the 
other cohorts, as the Columbia cohort measured only a chlorpyrifos-specific biomarker. 
We did not find inverse associations between ∑DEPs and the Executive Functioning 
factor, which was somewhat surprising since working memory is a component of executive 
functioning. Interestingly, the parent-report measure of the BRIEF (from which the majority of 
the Executive Functioning factor is derived) displays almost no correlation with the performance-
based measures of executive functioning (the Working Memory Index) in our data (rs = 0.09). 
This lack of correlation is consistently reported in the executive functioning measurement 
literature (reviewed in (Toplak, West, & Stanovich, 2013)). In previous studies, parent-report and 
performance-based measures of executive functioning load on different factors, suggesting they 
measure different underlying features of executive functioning (Bodnar et al., 2007; McAuley et 
al., 2010). Our Executive Functioning factor, which is comprised entirely of parent-report 
features, may reflect a broad capacity to self-regulate and execute goal-directed behaviors in a 
home or community environment while coping with typical environmental distractions. In 
contrast, the Working Memory Index is measured by an external examiner whose goal it is to 
direct and keep a child on task in an environment that is relatively controlled and free of external 
distractions, and thus may reflect a child’s working memory capacity only in this very specific 
context (Toplak et al., 2013). While the inconsistency between the two measures may caution 
interpretation of the factor’s validity, in this same cohort, we previously reported an association 
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between prenatal smoking and worse Executive Functioning factor scores in the expected 
direction (Furlong et al., n.d.). Since the smoking-executive functioning association is consistent 
with the literature, (Fried, Watkinson, & Gray, 2003; Julvez et al., 2007; Piper & Corbett, 2012) 
this serves as one positive control for the overall validity of this factor.  
The heterogeneity in associations of DMPs with Working Memory by race suggests the 
presence of race-specific residual confounding in the association of DMPs. For instance, OP 
biomarkers (DAPs) measure metabolites of the toxic parent compounds, rather than exposure 
to the parent compounds themselves. The use of a urinary DAP biomarker when diet is a 
primary source of exposure has some limitations (Lu, Barr, Pearson, & Waller, 2008; Wessels, 
Barr, & Mendola, 2003). Participants may be exposed either to preformed metabolites on fruits 
and vegetables, or to the parent insecticide, which they subsequently metabolize. Preformed 
metabolites do not inhibit cholinesterase and are less toxic than parent compounds in this case 
(Duggan et al., 2003). In one study of OP exposure from fruits and vegetables, over half of 
samples obtained from fruits and vegetables were composed of more preformed metabolites 
than parent oxons or pesticides (Zhang, Driver, Li, Ross, & Krieger, 2008). Thus, measured 
urinary DAP biomarker levels may not always accurately reflect extent of exposure to the parent 
compound. If fruit and vegetable consumption is either directly associated with improved 
executive functioning or is a marker of generally healthier behaviors, exposure source could be 
an important confounder. Little has been published on direct associations between prenatal fruit 
and vegetable consumption and cognitive development, although one recent study showed 
improved cognitive outcomes at 1 year for children of mothers who consumed high amounts of 
fruit and fruit juice during pregnancy (Bolduc et al., 2016), despite also being a likely vector for 
pesticide exposure.  
Additionally, executive functioning is highly heritable (Friedman et al., 2008). Mothers 
with robust executive functioning may be more successful at planning and consuming a well-
balanced diet that is rich in fruits and vegetables, and the use of the DAP biomarkers may be 
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less accurate at measuring toxicity in these women. Women with higher executive functioning 
may also be more likely to return for follow-up. Thus, for these women, DAP biomarkers might 
be a surrogate for higher executive functioning. Although we did have maternal IQ, the 
correlation between Full Scale IQ and executive functioning as measured by the BRIEF in our 
data and in the literature is close to zero; thus this residual confounder was truly unmeasured. 
Finally, women with high biomarker levels of OPs in New York City may live in close proximity to 
outdoor areas such as parks, which may be sprayed for mosquito control. Their children may 
experience more aerobic exercise and engage in more play experiences with other children, 
which have been associated with improvements in executive functioning (reviewed in (Diamond 
& Lee, 2011)). In these instances, OP biomarkers would be confounded by early life 
experiences that enhance executive functioning.   
The literature on OP-PON1 interactions is sparse. While some studies have also 
reported no interactions with PON1 and OPs on mental development at 24 months (Eskenazi et 
al., 2010), recently a pooled study of four different birth cohorts showed stronger associations 
between ∑DEPs and worse mental development at 24 months among carriers of the PON1 Q 
allele (S. M. Engel et al., 2015). A previous study in our population reported adverse 
associations between ∑DMPs and perceptual reasoning among those with the PON192 QQ 
genotype (S. Engel et al., 2011). While the strata-specific estimates for PON1 interactions in this 
current study were all highly imprecise and all interaction p-values were greater than 0.05, the 
estimate for ∑DMPs and the Perceptual Reasoning factor remained negative among those with 
the QQ genotype. Although PON1 is an important component in the detoxification pathway for 
OP and other pesticides, this enzyme may have limited capacity to hydrolyze OP pesticides with 
dimethyl parent oxons (Geldmacher‐von Mallinckrodt & Diepgen, 1988; Li et al., 2000; Wolff et 
al., 2007), which may in part explain the general lack of interactions between DMPs and PON1 
genotype.  
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Strengths and Limitations of Study 
Primary strengths of this study include the incorporation of mixture modeling techniques 
for the exposures, and the use of dimension reduction across multiple scales and subscales of 
behavior, executive functioning, and intelligence. The use of factor scores resulted in reduced 
dimensionality of the outcomes and enabled comparison of risk estimates across a wide range 
of outcomes in an easily interpretable format. Factor scores may capture information over and 
above individual item scores. Although some items in different factors were correlated with each 
other (e.g., the Metacognition Index from the Executive Functioning factor and the Internalizing 
Composite score from the Internalizing factor are correlated at ~0.5), the rotated factor scores 
are forced to be orthogonal. Thus, associations with the factor scores are independent of any 
relationship between OPs and the other outcomes. The same is not true when interpreting 
associations with the individual items that make up these factors. An attempt to assess 
associations with all scales and subscales of several instruments in the absence of dimension 
reduction would present challenges to interpretation, and raise concerns about multiple testing 
bias.  
 Primary limitations include loss to follow-up and the lack of corroborating data on parent 
pesticide exposure. Approximately 60% of the original cohort did not return for follow-up. 
However, the only characteristic that differed between those who did and did not return was 
marital status, which was included as a covariate in several models. Still, if other unknown 
covariates predicted follow-up, these could bias associations. For instance, if more health 
conscious mothers consume more fresh fruits and vegetables and are more likely to return for a 
follow-up visit, they would be expected to have higher urinary OP metabolite levels and might 
also have children with better behavior and intelligence scores. We lacked data on such 
attitudes among study participants. Finally, urinary metabolites are an imperfect surrogate of 
insecticide exposure. Individuals who consume high levels of fresh fruits and vegetables may 
show higher urinary levels of ingested preformed OP metabolites, but experience less adverse 
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effects, than individuals whose primary exposure is to the more toxic parent compound, which 
they subsequently metabolize.  
Conclusions 
 In this prospective study of in utero exposure to organophosphorus pesticides, we report 
adverse associations between ∑DMPs and Internalizing Factor scores, which was somewhat 
restricted to an item-specific association with anxiety, and between ∑DEPs and the Working 
Memory Index. We also report an unexpected positive association between ∑DMPs and the 
Executive Functioning factor. Dimension reduction across multiple scales of neurodevelopment 
reflects broad phenotypes of development, eases presentation of associations, and incorporates 
information across multiple scales to enhance precision of estimates. 
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Table 8 Characteristics of Mount Sinai Children's Environmental Health Center Study 
Population by Follow Up Status, For Those with Complete Panel of Biomarkers 
  Original 
Birth cohort 
N=404 
Did not 
return for 
Follow-up 
n=263  
Follow-up 
Population N (%) 
N = 141 
Maternal Marital Status at 
Enrollment 
   
 Married  117 (29) 83 (32) 34 (24) 
 Living with partner 98 (24) 68 (26) 30 (21) 
 Single/Divorced/ Widowed 189 (47) 112 (43) 77 (55) 
Maternal Education at Enrollment    
 High school or less 288 (72) 186 (71) 102 (73) 
 Some college or higher 113 (28) 75 (29) 38 (27) 
Maternal Age at enrollment    
 <20 142 (35) 101 (38) 41 (29) 
 20-25 132 (33) 83 (32) 49 (35) 
 >25 130 (32) 79 (30) 51 (36) 
Maternal Race    
 Black or other race 118 (29) 76 (29) 42 (30) 
 White 86 (21) 60 (23) 26 (18) 
 Hispanic 200 (50) 127 (48) 73 (52) 
Any smoking during pregnancy    
 None 337 (83) 218 (83) 119 (84) 
 Any 67 (17) 45 (17) 22 (16) 
Alcohol use during pregnancy    
 None 337 (85) 222 (86) 115 (83) 
 Light 49 (12) 30 (12) 19 (14) 
 Moderate 10 (3) 6 (2) 4 (3) 
Canned fish consumption during 
pregnancy 
   
 < 1 times per week 341 (84) 218 (83) 123 (87) 
 1 or more times per week 63 (16) 45 (17) 18 (13) 
Child Sex    
 Male 220 (54) 148 (56) 72 (51) 
 Female 184 (46) 115 (44) 69 (49) 
†Maternal marital status at enrollment differed for those with biomarker data who returned for follow-up vs 
those who didn't (p = 0.03). No other enrollment characteristics differed by follow-up status. 
Follow-up population includes those with complete biomarker data and a complete neurodevelopmental 
follow-up visit. Comparison population includes those without biomarker data or those who did not return 
for a complete follow-up visit 
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Table 9 Distributions of Organophosphorus Pesticide Metabolites and Co-exposures, 
Among Participants with Complete Follow-Up Measurements 
  N  Values 
>LOD  
(% of 
total) 
Geometric 
Median 
(GSD) 
Geometric 
25, 75 
percentile 
Min, Max 
Organophosphorus Pesticides (nm/L)    
ƩDEP 
Diethylthiophosphate (DETP) 156 
127 
(81.4) 10.0 (3.5) 4.9, 17.0 0.8, 122.3 
Diethyldithiophosphate 
(DEDP) 
156 
26 
(16.7) 0.1 (4.5) 0.1, 0.1 0.0. 59.9 
Diethylphosphate (DEP) 156 
72 
(46.2) 0.2 (15.1) 0.2, 31.5 0.2, 371.8 
∑DEP 156 
138 
(88.5)
¥
 
17.5 (3.2) 
7.3, 47.1 2.7, 422.3 
ƩDMP Dimethylthiophosphate 
(DMTP) 
158 
146 
(93.6) 23.8 (6.2) 8.1, 71.9 0.2, 4754.3 
Dimethyldithiophosphate 
(DMDP) 
158 
47 
(30.1) 0.3 (6.2) 0.3, 5.1 0.3. 275.1 
Dimethylphosphate (DMP) 158 
102 
(64.6) 13.6 (8.7) 0.6, 45.0 0.6, 1173.1 
∑DMP 158 149 
(94.3)
¥
 
41.2 (5.2) 12.2, 
148.5 0.2, 4903.2 
Phthalates (ng/mL)    
 
ƩDEHP (µm/L)
 ¥
 158 
158 
(100.0)
¥
 0.3 (3.6) 0.1, 0.5 0.0, 19.9 
 
Low- MWP*(µm/L)
 ¥
 158 
158 
(100.0)
¥
 2.5 (4.4) 1.0, 6.5 0.0, 313.8 
 
Monoethyl phthalate (MEP)  158 
157 
(99.4) 
217.0 
(4.2) 
84.9, 
532.5 6.5, 29528.4 
 Mono-n-butyl phthalate 
(MBP) 
158 
154 
(97.5) 34.0 (3.6) 14.3, 83.3 0.8, 4042.5 
 Monoisobutyl phthalate 
(MIBP) 
158 
155 
(98.1) 6.5 (2.9) 3.1, 15.1 0.4, 65.1 
 Mono(3-carboxypropyl) 
phthalate (MCPP) 
158 
154 
(97.5) 3.1 (2.8) 1.7, 6.4 0.3, 129.3 
 Monobenzyl phthalate 
(MBZP) 
158 157 
(99.4) 
15.8 (3.9) 6.3, 34.1 0.6, 481.3 
Phenols (ng/mL)     
 Biphenyl-A (BPA) 153 132 
(86.3) 1.5 (2.4) 0.9, 2.5 0.4, 35.2 
 Benzophenone-3 (BP3) 153 153 
(100.0) 6.5 (7.4) 2.7, 23.7 0.2, 9290.0 
 2,5-Dichlorphenol (2,5-DCP) 153 153 
(100.0) 56.3 (5.5) 
22.4, 
174.0 2.8. 8510.0 
 Triclosan 153 122 
(79.7) 20.0 (5.2) 7.2, 82.8 2.3, 1790.0 
Pyrethroids (binary for above or below the LOD)    
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 3-PBA 148 36 
(24.3) 
   
¥
Values > LOD for sum values indicate number of observations where at least one metabolite in the sum 
is above the LOD 
Low molecular weight phthalates include MEP, MBP, MIBP 
Values presented are after imputing values below the LOD from a normal distribution truncated at the 
LOD 
141 participants had a complete panel of biomarker data
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Table 10 Overall Associations between OPs and Neurodevelopmental Factor Scores 
(n=141) 
 ∑DMPs  β̂ (95% 
CI) ¥ 
∑DEPs  β̂ (95% CI) 
¥ 
Impulsivity & Externalizing Factor -0.02 (-0.16, 0.11) 0.08 (-0.06, 0.22) 
Executive Functioning Factor 0.18 (0.04, 0.31) -0.05 (-0.21, 0.11) 
Internalizing Factor -0.13 (-0.25, 0.00) -0.01 (-0.15, 0.12) 
Perceptual Reasoning Factor 0.00 (-0.14, 0.13) -0.02 (-0.17, 0.14) 
Adaptability Factor -0.02 (-0.14, 0.12) -0.08 (-0.23, 0.07) 
Processing Speed Factor -0.01 (-0.14, 0.13) 0.03 (-0.12, 0.19) 
Verbal Intelligence Factor 0.07 (-0.04, 0.19) -0.03 (-0.17, 0.09) 
Working Memory Index 0.12 (-0.02, 0.25) -0.17 (-0.33, -0.03) 
¥
These Bayesian beta coefficients and 95% credible intervals are from models that include both ∑DAP 
measures (∑DEPs and ∑DMPs), the molar sum of DEHP and the individual phthalate congeners of MEP, 
MIBP, MBP, MCPP, MBZP, as well as the individual phenol metabolites BPA, BP3, DCP25, and triclosan, 
and the pyrethroid metabolite 3PBA  
In Tables 10 and 11, scores have been scaled so that positive scores indicate more positive outcomes 
and negative scores indicate more adverse outcomes 
HOME scores, maternal IQ, maternal education at follow-up, maternal marital status at follow-up, 
maternal age, maternal race/ethnicity, maternal smoking during pregnancy, maternal alcohol consumption 
during pregnancy, maternal canned fish consumption during pregnancy, and alcohol were included in a 
DAG used to derive minimally sufficient sets for each factor 
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Table 11 Associations between DMPs and Individual Factor Items from Executive 
Functioning and Internalizing Factors (n=141) 
Rank of 
Item 
Loading 
Items from Executive 
Functioning Factor 
Associations with 
∑DMPs β̂  (95% 
CI) 
Items from 
Internalizing factor 
Associations with 
∑DMPs β̂  (95% CI) 
1 BRIEF Metacognition 
Index 0.13 (-0.01, 0.28) 
BASC Internalizing 
Composite -0.08 (-0.21, 0.05) 
2 BRIEF Planning 0.16 (0.02, 0.30) BASC Anxiety -0.14 (-0.28, 0.00) 
3 BRIEF Global Executive 
Composite 0.10 (-0.04, 0.24) 
BASC Somatization 
0.00 (-0.12, 0.13) 
4 BRIEF Working Memory 0.14 (-0.01, 0.28) BASC Withdrawal -0.10 (-0.25, 0.05) 
5 BRIEF Monitor 0.14 (0.00, 0.28) BASC Depression -0.04 (-0.18, 0.10) 
6 BRIEF Initiate 0.10 (-0.05, 0.25) BASC Atypicality 0.06 (-0.06, 0.18) 
7 BRIEF Organization 
0.00 (-0.13, 0.14) 
BASC Behavioral 
Symptoms Index -0.01 (-0.14, 0.13) 
8 BASC Attention 0.13 (-0.01, 0.26) BRIEF Shift 0.00 (-0.13, 0.13) 
9 BRIEF Inhibit 
0.13 (-0.01, 0.28) 
BRIEF Emotional 
Control -0.04 (-0.19, 0.11) 
10 BRIEF Behavioral 
Regulation Index 0.04 (-0.10, 0.18) 
BRIEF Behavioral 
Regulation Index 0.04 (-0.10, 0.18) 
11 BASC Behavioral 
Symptom Index 
-0.01 (-0.14, 0.13) 
BRIEF Global 
Executive 
Composite 0.10 (-0.04, 0.24) 
12 BRIEF Shift 0.00 (-0.13, 0.13)   
13 BASC Hyperactivity 0.02 (-0.12, 0.15)   
14 BRIEF Emotional 
Control -0.04 (-0.19, 0.11) 
  
15 BASC Atypicality 0.06 (-0.06, 0.18)   
¥
These Bayesian beta coefficients and 95% credible intervals are from models that include both ∑DAP 
measures (∑DEPs and ∑DMPs), the molar sum of DEHP and the individual phthalate congeners of MEP, 
MIBP, MBP, MCPP, MBZP, as well as the individual phenol metabolites BPA, BP3, DCP25, and triclosan, 
and the pyrethroid metabolite 3PBA  
In Tables 10 and 11, scores have been scaled so that positive scores indicate more positive outcomes 
and negative scores indicate more adverse outcomes 
HOME scores, maternal IQ, maternal education at follow-up, maternal marital status at follow-up, 
maternal age, maternal race/ethnicity, maternal smoking during pregnancy, maternal alcohol consumption 
during pregnancy, maternal canned fish consumption during pregnancy, and alcohol were included in a 
DAG used to derive minimally sufficient sets for each factor 
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CHAPTER VI. CONCLUSIONS 
Summary of Findings 
Previous approaches to etiological studies of organophosphorus pesticides (OPs) and 
neurodevelopment have generally been performed under the assumptions that neurological 
traits are independent and that confounding by other xenobiotics is negligible. In this 
dissertation, we estimated associations between OPs and neurodevelopment while addressing 
both of these concerns. 
 Factor analysis is a dimension reduction method which uses underlying correlational 
structures to derive factors, and allows the user to rotate unique factors to be orthogonal. We 
applied this method to a set of composite scales and subscales originating from both parent-
report measures of behavior and executive functioning, and performance-based measures of 
intelligence. We determined there was a seven factor solution, including 1) Impulsivity & 
Externalizing, 2) Executive Functioning, 3) Internalizing, 4) Perceptual Reasoning, 5) 
Adaptability, 6) Processing Speed, and 7) Verbal Intelligence. Items from the parent-report 
measures of behavior and executive functioning tended to load together on factors, while items 
from the examiner-measured scales of intelligence loaded separately from the behavior and EF 
measures. The factors also generally aligned with the composite indices from the instruments. 
 To assess the utility of using factor scores over instrument-specific composite scores, 
we compared previously published well-characterized associations between smoking and 
neurodevelopment against estimates in our data using 1) instrument-specific composite scores, 
and 2) orthogonal varimax rotated factor scores. In prior literature, smoking has been 
consistently associated with impulsivity and externalizing behaviors, internalizing behaviors, and 
deficits in executive functioning, and less consistently associated with adaptive behaviors (Brion 
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et al., 2010; Daseking et al., 2015; Indredavik et al., 2007; Piper & Corbett, 2012; Stene-Larsen, 
Borge, & Vollrath, 2009; Williams et al., 1998). With the exception of internalizing behaviors, we 
replicated this data in our population with the instrument-specific composite scores. However, 
after adopting the orthogonal varimax rotation, which imposes orthogonality on the factors, only 
the association between smoking and Impulsivity/Externalizing remained. This suggests that the 
association between smoking and the other characteristics may, at least in part, be driven by 
associations between smoking and impulsivity/externalizing. We also reported associations 
between canned fish consumption, maternal education, preterm birth, and home environmental 
organization scores and neurodevelopment, all of which were consistent with the literature. 
 We also assessed associations between prenatal exposure to OPs and 
neurodevelopmental factor scores and the Working Memory Index, while controlling for the co-
exposures of phthalates, phenols, and pyrethroid pesticides in a Bayesian framework. We 
reported associations between ∑DMPs and worse Internalizing scores, but better Executive 
Functioning scores. We also reported associations between ∑DEPs and worse performance on 
the Working Memory Index. There is some prior support for the associations between OPs and 
internalizing behaviors and working memory (Beard et al., 2014; V. Rauh et al., 2011). However, 
prior research on associations between prenatal exposure to ∑DMPs and parent-reported 
executive functioning is limited to one other study that only used parent reports of attention or 
ADHD behaviors, and not other markers of executive functioning. In that study, ∑DMPs were 
associated with worse attention and parent-reported ADHD (Marks et al., 2010), which conflicts 
with our findings. However, the ∑DMP pesticide source in the Marks population, which was 
primarily agricultural workers, is likely different than the ∑DMP pesticide source in our 
population, which is composed of urban city-dwellers. Thus the exposures might not be 
comparable across the two studies. This possibility is one unfortunate drawback to working with 
the DAP biomarkers (discussed in more detail below).  
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 Finally, we initially hypothesized that OPs might be associated with ADHD, and that 
factor analysis might reveal an ADHD phenotype. However, no single factor seemed to capture 
the range of behaviors observed in ADHD. Rather, in our general population sample, we derived 
several factors that are implicated in ADHD, including Impulsivity and Externalizing, and  
Executive Functioning. OPs did not appear associated with Impulsivity and Externalizing, and 
DMPs were actually positively associated with the Executive Functioning factor, two hallmark 
deficits of ADHD, while DEPs were associated with worse Working Memory Index scores. As 
discussed previously, residual confounding may explain some of the association with executive 
functioning. Regardless, we did not observe the hypothesized association between OPs and an 
ADHD phenotype.  
Strengths and Limitations 
Strengths 
There were several strengths to this dissertation. We used a longitudinal, multiethnic 
cohort that included both mostly white mothers from a wealthy neighborhood in Manhattan, as 
well as mostly minority mothers from the low-income neighborhood of East Harlem. Although 
the two groups display widely divergent socioeconomic features and may have different sources 
of parent pesticide exposure for their OP metabolite measurements, there was minimal 
interaction by race in both studies, and the factor structure was consistent by race. Thus, our 
findings generally apply across the scope of socioeconomic strata represented in an urban 
population of New York City.  
We were able to adopt a novel framework for analyzing etiological associations with 
neurodevelopmental phenotypes that accounted for the complex correlational structure of 
neurobehavior. Dimension reduction enabled simultaneous examination of a wide range of 
neurobehavioral outcomes in an easily comparable format that collapsed over thirty separate 
outcomes into seven distinct factors. This method also allowed the assessment of etiological 
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associations with individual neurodevelopmental phenotypes that were independent of 
associations with other neurodevelopmental phenotypes. Phenotyping may also capture 
information over and above information captured in instrument-specific composite scores alone. 
Estimates of associations between OPs and factor scores appeared to be stronger and slightly 
more precise than the estimates between OPs and most of the individual items that loaded 
highly on the relevant factor. Additionally, as the factor loadings of items decreased, the 
associations between OPs and the items attenuated to the null. This highlights another 
advantage of using factor analysis; if we were to examine the individual items from an 
instrument, OPs might appear associated with some items but not others in a somewhat 
haphazard fashion. Performing a factor analysis, however, allows the user to order items 
according to the strength of their factor loading, which implements an interpretable structure on 
the items.  
Finally, we incorporated a mixture modeling approach to assess associations between 
OPs and neurodevelopment in a Bayesian framework, which stabilizes estimates from models 
with high numbers of variables and high collinearity among the covariates.  
Limitations 
 Primary limitations include loss to follow-up, lack of corroborating data on parent 
pesticide exposure, use of a spot-urine sample in pregnancy to assess DAPs, unmeasured 
covariates, reporting bias, and lack of multi-method measurements of behavior and executive 
functioning. 
 Approximately 60% of the sample from the original cohort did not return for at least one 
complete neurodevelopmental follow-up visit between the ages of 6-9. This is worrisome for two 
primary reasons: 1) this resulted in smaller sample sizes, and 2) this loss-to-follow up presents 
a possibility for bias. Although the limited sample size did not prevent us from generating a 
reliable factor structure or from observing associations between smoking or OPs and 
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neurodevelopment, there may have been repercussions for estimating interaction effects. In 
Chapter V, we only reported one interaction, between race and DMPs on Working Memory. 
Other interactions, particularly with PON1 or child sex, may have become apparent with a larger 
sample size and more participants per strata. Finally, the loss to follow-up may have resulted in 
biased estimates, if women who returned for follow-up were different than those who did not. 
Although the only measured characteristic that differed between the two groups was marital 
status, other unmeasured characteristics may confound relationships. This may have played a 
role particularly in estimating the relationship between DMPs and executive functioning: mothers 
with stronger executive functioning capacity may be more likely to eat a diet rich in fruits and 
vegetables during pregnancy (and thus have higher OP biomarkers while experiencing less 
toxicity), have children with better executive functioning, and be more likely to return for follow-
up. Such a concern might be alleviated by controlling for maternal measures of executive 
functioning, or improved dietary exposure ascertainment methods; however these assessments 
were unfortunately not collected in this study.  
Other measures of maternal psychiatric functioning or personality might have been 
important for other estimates. Controlling for maternal anxiety might increase precision of the 
DMP-Internalizing association, since maternal anxiety during pregnancy is associated with 
childhood anxiety (Van den Bergh, Mulder, Mennes, & Glover, 2005). Additionally, controlling for 
personality, addictive tendencies, and general psychiatric functioning of the mother might 
address concerns about possible confounding of the smoking-impulsivity/externalizing 
relationship, since women who are unable to quit smoking during pregnancy might struggle with 
higher levels of impulsivity or addiction than women who are able to quit, and such traits might 
be heritable in nature. Again, these measures were not collected in this study. 
Another limitation of this study is the reliance on self-reported cigarette use to assess 
smoking during pregnancy. Alternate measures, such as cotinine levels throughout pregnancy, 
may have reduced exposure misclassification by identifying mothers who smoked but did not 
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report smoking during pregnancy. We also did not include information on environmental tobacco 
smoke exposure during pregnancy or childhood. While most studies report on smoking during 
the prenatal window of exposure, children of mothers who smoke during pregnancy are most 
likely also exposed to tobacco smoke throughout infancy and childhood. The brain grows rapidly 
and undergoes dramatic neural differentiation and pruning during the first two years of life, thus 
the idea that early-life programming may take place after pregnancy is highly plausible.  
OP measurements during early childhood might have similarly provided interesting 
results. One cohort has observed associations between OP exposure during early childhood 
and neurodevelopment (Marks et al., 2010), but there is little supporting evidence for this in 
other cohorts due to the lack of biomarkers collected during childhood. Additionally, OP 
measurements throughout pregnancy could have helped describe a possible window of 
susceptibility, and possibly an effect for duration of exposure. Since the half-lives of most OPs 
range from hours to days, these measurements only reflect very recent exposure. Correlation 
coefficients of repeat measures of OPs in pregnancy range from 0.23 to 0.56, while the 
intraclass correlation coefficient of OPs is approximately 0.40 (Egeghy et al., 2011; Whyatt et 
al., 2009). While there are competing hypotheses regarding the “most susceptible” window of 
exposure, it is perhaps equally plausible that exposures at different time periods have different 
effects, since the brain is continually developing throughout pregnancy. Alternatively, consistent 
exposure throughout pregnancy might be substantially worse than a single high exposure during 
any given trimester. Unfortunately, the results from using a single spot urine sample in the third 
trimester preclude assessing any of these possibilities. 
 Use of DAP biomarkers in general have other limitations. Up to 86% of samples on fruits 
and vegetables may be pre-formed metabolites rather than parent compounds (Zhang et al., 
2008). Thus, exposure to direct parent compounds and exposure to preformed metabolites 
confer different toxicity levels that are not represented by DAP biomarkers. Although these 
concerns might be somewhat alleviated by measurements of maternal dietary intake during 
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pregnancy, such information would still not shed light on the amount of toxic oxons a participant 
was exposed to via diet. This information would only come from sampling the actual produce 
that was consumed. Another limitation of DAP biomarkers is the non-specificity of the 
metabolites – six OP metabolites represent ~ 30 registered pesticides (Wessels et al., 2003). 
These parent pesticides vary in their toxicities, and DAP biomarkers may represent different 
pesticides for different populations. These biomarkers may thus be more useful for populations 
experiencing a consistent exposure to a single OP pesticide, or to multiple OP pesticides with 
similar toxicities. Single spot urines of DAP biomarkers also do not capture differences in 
individual excretion patterns or DAP metabolism, which may be important variables in 
estimating the individual toxicity of OP exposures. Despite these limitations, DAP biomarkers 
remain one of the preferred measurements of OP exposure due to their high detection 
frequencies relative to OP pesticide-specific biomarkers, which typically have low detection 
rates.  
 Finally, our study is somewhat limited by the lack of performance-based measurements 
of executive functioning in Aim 1. Although parent-report measures of executive functioning are 
not correlated with performance-based measures in either our population or in several previous 
studies, it is unclear what the disparity between the two measurements represents. Researchers 
have speculated that the two methods measure different dimensions of neurobehavior, or at 
least different dimensions of executive functioning. We did incorporate the performance-based 
measure of the Working Memory Index in our second aim, and found somewhat comparable 
associations between DMPs and the Executive Functioning factor and between DMPs and the 
Working Memory Index, although the latter was relatively imprecise. However, we also found 
associations between DEPs and worse scores on the Working Memory Index, but not on the 
Executive Functioning factor. These results are in seeming conflict in multiple ways; first, that 
DMPs and DEPs seem to have an opposite effect on executive functioning, and second, that 
DMPs were at least suggestively associated with two measures of executive functioning while 
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DEPs were associated with just one. This conflicting pattern of associations might be easier to 
interpret if the meaning of the two measurements were clearer, and if more precise information 
was available regarding parent pesticide source and fruit and vegetable intake. 
Public Health Significance  
Organophosphorus pesticides have been banned from most residential uses (excluding 
roach bait stations and fire ant mound treatments) since 2001, although they are still used 
widely in agriculture. Earlier this year (2016), the EPA proposed to revoke all food residue 
tolerances for the OP insecticide chlorpyrifos, with an anticipated release of the final rule in 
December of 2016. This would essentially result in the elimination of exposure to chlorpyrifos 
(which devolves into DEPs) for the vast majority of the American public. However, this ruling 
would not ban chlorpyrifos from all use; golf courses, turf, green houses, and non-structural 
wood treatments such as utility poles and fence posts, would not be affected by the proposed 
rule. The findings of this dissertation are timely, as we report an association between prenatal 
exposure to DEPs, of which chlorpyrifos is one parent pesticide, and Working Memory deficits. 
Although we cannot definitively identify the parent pesticide of DEPs in our cohort as 
chlorpyrifos, this result does support findings from a different birth cohort that reported 
associations between a specific chlorpyrifos metabolite and deficits on the Working Memory 
Index. However, we also report associations that show a relationship between DMPs and more 
adverse internalizing behaviors, particularly anxiety. Such research may contribute to policy 
decisions regarding OPs other than just chlorpyrifos.  
Our findings of other modifiable characteristics that contribute to neurodevelopment may 
also be useful for advocating for healthy pregnancies. If the reported associations are causal, 
promoting higher education, encouraging mothers to eat low-mercury fish multiple times a week, 
preventing preterm birth, teaching mothers how to increase the predictability and organization of 
a child’s environment, and offering assistance to quit smoking during pregnancy may have 
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reverberating consequences on multiple dimensions of neurobehavior throughout childhood and 
possibly throughout life. The magnitude of the smoking and impulsivity and externalizing 
association was the highest of any of the modifiable risk factors and may result in the greatest 
gains, although this characteristic may simultaneously be the hardest to change due to the 
addictive nature of tobacco, and be the most subject to possible confounding by maternal traits. 
Of course, if the reported association between smoking and neurobehavior suffers from 
confounding by maternal traits, the magnitude of possible benefits will shrink. However, 
randomized trials of smoking cessation programs during pregnancy have resulted in both 
increasing the number of women who quit smoking relative to a control group, and reductions in 
preterm births and infants born with low birthweight (Chamberlain et al., 2013). These results 
already support the deployment of smoking cessation programs for pregnant women, and our 
results add another dimension to this argument. 
Nationwide, the economic costs of neurodevelopmental deficits have been quantified, 
particularly in regards to early childhood lead exposure. Even small deficits, such as the loss of 
0.67 IQ points on a population scale, translates to over $40 billion lost in economic productivity 
over the course of a generation (Landrigan, Schechter, Lipton, Fahs, & Schwartz, 2002). 0.67 
IQ points is roughly 0.05 standard deviations. Several of our estimated beta coefficients, which 
can be interpreted as changes in standard deviations, were substantially larger than this for the 
IQ factors. While the economic costs of behavioral problems have yet to be quantified in such a 
manner, anxiety disorders were estimated to cost the US more than $42 billion per year in the 
1990s (Greenberg et al., 1999). Even a small 10% reduction in anxiety disorders would translate 
to savings of $4 billion. Thus, preventing these costs by addressing modifiable environmental 
exposures, behaviors, and parenting techniques could have compound public health and 
economic benefits.     
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Directions for Future Research  
Future research of prenatal and early life determinants of childhood neurodevelopment 
would ideally incorporate parent/self, and teacher-reports of behavior and executive functioning, 
as well as performance-based measures of executive functioning. Such approaches may help to 
elucidate differences attributed to measurement method and reporter. 
Additionally, future research of OPs may be better served by incorporating non-
biomarker measurements of insecticide use, such as personal reports of fruit and vegetable 
consumption, personal pesticide use and pesticide exposure, or external reports such as state 
geographical records of pesticide applications. This information might enhance the accuracy of 
DAP biomarkers as a measurement of OP exposure.  
Some of the best support for findings in epidemiologic research involves the replication 
of findings in other populations. Only three U.S. birth cohorts have reported associations 
between prenatal exposure to OPs and adverse childhood outcomes. However, creating cohorts 
and measuring biomarkers is an expensive endeavor, particularly during an era of limited NIH 
funding. Alternative approaches to assessing prenatal exposure to pesticides and childhood 
neurodevelopment might be more fruitful; for example, linking pesticide use data with childhood 
academic achievement or medical records might be one inexpensive way of assessing at least 
some of these associations in other populations. 
Finally, findings of associations between prenatal exposure to OPs and neurological 
outcomes has thus far been limited to childhood neurodevelopment. Assessing associations 
with outcomes throughout the life-course might provide a better assessment of the true burden 
that OPs place on society.    
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Conclusions 
We reported several associations between prenatal and early life characteristics and 
neurodevelopment. Modifiable characteristics included maternal smoking during pregnancy, 
maternal canned fish consumption during pregnancy, organization of the home environment, 
and maternal education, while affected neurodevelopmental domains included measures of 
behavior, executive functioning, and IQ. We also reported associations between DMPs and 
worse Internalizing factor scores, between DMPs and better Executive Functioning factor 
scores, and between DEPs and more adverse Working Memory Index scores, after accounting 
for the complex correlational structure of several neurodevelopmental outcomes.
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APPENDIX 1 DSM V CRITERIA FOR ADHD 
Three types of ADHD may occur: If enough symptoms are present in both Inattention and Hyperactivity-
Impulsivity, this is Combined Presentation. If enough symptoms are present in Inattention but not 
Hyperactivity-Impulsivity, this is Predominantly Inattentive. If enough symptoms are present in 
Hyperactivity-Impulsivity, but not Inattention, this is Predominantly Hyperactive-Impulsive. 
Inattention  
Six or more symptoms of inattention for children up to age 16, five or more for adolescents 17 and 
older and adults, symptoms of inattention have been present for at least 6 months, and are 
inappropriate for developmental level 
  Often fails to give close attention to details or makes careless mistakes in schoolwork, at work, 
or with other activities. 
 Often has trouble holding attention on tasks or play activities. 
 Often does not seem to listen when spoken to directly. 
 Often does not follow through on instructions and fails to finish schoolwork, chores, or duties 
in the workplace (e.g., loses focus, side-tracked). 
 Often has trouble organizing tasks and activities. 
 Often avoids, dislikes, or is reluctant to do tasks that require mental effort over a long period of 
time (such as schoolwork or homework). 
 Often loses things necessary for tasks and activities (e.g. school materials, pencils, books, tools, 
wallets, keys, paperwork, eyeglasses, mobile telephones). 
 Is often easily distracted 
 Is often forgetful in daily activities. 
Hyperactivity and Impulsivity:  
Six or more symptoms of hyperactivity-impulsivity for children up to age 16, or five or more for 
adolescents 17 and older and adults; symptoms of hyperactivity-impulsivity have been present for at 
least 6 months to an extent that is disruptive and inappropriate for the person’s developmental level: 
  Often fidgets with or taps hands or feet, or squirms in seat. 
 Often leaves seat in situations when remaining seated is expected. 
 Often runs about or climbs in situations where it is not appropriate (adolescents or adults may 
be limited to feeling restless). 
 Often unable to play or take part in leisure activities quietly. 
 Is often "on the go" acting as if "driven by a motor". 
 Often talks excessively. 
 Often blurts out an answer before a question has been completed. 
 Often has trouble waiting his/her turn. 
 Often interrupts or intrudes on others (e.g., butts into conversations or games) 
 
In addition, the following conditions must be met 
  Several inattentive or hyperactive-impulsive symptoms were present before age 12 years. 
 Several symptoms are present in two or more setting, (e.g., at home, school or work; with 
friends or relatives; in other activities). 
 There is clear evidence that the symptoms interfere with, or reduce the quality of, social, 
school, or work functioning. 
 The symptoms do not happen only during the course of schizophrenia or another psychotic 
disorder. The symptoms are not better explained by another mental disorder (e.g. Mood 
Disorder, Anxiety Disorder, Dissociative Disorder, or a Personality Disorder). 
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APPENDIX 2 PROMAX ROTATED FACTOR PATTERN STRUCTURE AND ITEM LOADINGS 
OF CHILDHOOD NEURODEVELOPMENTAL SCALES (N=210) 
Factor 1 
 Impulsivity & 
Externalizing 
Factor 2 
 Executive Functioning 
Factor 3  
Internalizing 
Factor 4 
 Perceptual Reasoning 
Scale Loading Scale Loading Scale Loading Scale Loading 
Externalizing 
Problems 0.97 
Metacognition 
Index 0.96 
Internalizing 
Problems 0.89 
Perceptual 
Reasoning 
IQ 0.98 
Conduct 0.89 Planning 0.94 Anxiety 0.81 
Picture 
Concepts 0.78 
Aggression 0.85 
Working 
Memory 0.81 Withdrawal 0.77 
Matrix 
Reasoning 0.74 
Hyperactivity 0.75 Initiate 0.81 Somatization 0.69 
Block 
Design 0.71 
Inhibit 0.62 Monitor 0.80 Depression 0.59 Full Scale IQ 0.50 
Behavioral 
Regulation 
Index 0.61 
Global 
Executive 
Composite 0.75 Atypicality 0.54 
  
Adaptability -0.59 Organization 0.66 
Behavioral 
Symptoms 
Index 0.40 
  Behavioral 
Symptoms 
Index 0.58 Attention 0.49 Shift 0.38 
  Emotional 
Control 0.57 Inhibit 0.46 
Emotional 
Control 0.31 
  
Shift 0.40 
Behavioral 
Regulation 
Index 0.32 
    Depression 0.34 
      Attention 0.32 
          
Factor 
Structure        
% Variance 
accounted for  37.92  13.71  7.86  6.33 
Eigenvalue 14.03  5.07  2.91  2.34 
        
1BASC scales, 2BRIEF scales, 3WISC-IV or the WPPSI-III scales. Only items with loadings with absolute 
values >0.30 are shown here. Loadings are from a PCA with oblique promax rotation (factors are allowed 
to correlate)  
  103 
continued 
Factor 5  
Adaptability  
Factor 6  
Processing Speed 
Factor 7  
Verbal Intelligence 
Scale Loading Scale Loading Scale Loading 
Adaptive 
Skills Index 0.89 
Processing 
Speed 
Index
3
 0.96 Vocabulary
3
 0.85 
Leadership 0.85 Coding
3
 0.88 Verbal IQ
3
 0.83 
Social Skills 0.85 
Symbol 
Search
3
 0.71 
Full Scale 
IQ
3
 0.57 
Adaptability 0.56 
Full Scale 
IQ
3
 0.36 
Organization
2
 0.38 
    
Symbol 
Search
3
 0.31 
      
      
      
      
      
      
      
      
 5.10  4.25  3.05 
 1.89  1.57  1.13 
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APPENDIX 3 ASSOCIATIONS BETWEEN SMOKING AND NEURODEVELOPMENTAL 
OUTCOMES, BY OUTCOME MEASUREMENT METHOD 
Comparison of Prenatal Smoking and Neurodevelopment Associations by Analysis Method (n=162) 
 
Any smoking during 
pregnancy 
Smoking in First 
Trimester Only 
Smoking in Second or 
Third Trimesters 
    
Impulsivity & Externalizing factor, 
Varimax
2 
-0.51 (-0.92, -0.10) -0.29 (-0.80, 0.22) -0.82 (-1.42, -0.23) 
Impulsivity & Externalizing factor, 
Promax
1
 -0.51 (-0.92, -0.10) -0.27 (-0.79, 0.24) -0.84 (-1.45, -0.24) 
Externalizing Composite
3 
-0.60 (-1.00, -0.21) -0.36 (-0.84, 0.13) -0.97 (-1.55, -0.39) 
    
Executive Functioning factor, 
Varimax
2
 -0.32 (-0.75, 0.10) -0.32 (-0.85, 0.21) -0.32 (-0.94, 0.30) 
Executive Functioning factor, 
Promax
1
 -0.43 (-0.85, -0.02) -0.30 (-0.82, 0.22) -0.63 (-1.24, -0.02) 
Metacognition Index
3
 -0.47 (-0.86, -0.09) -0.23 (-0.71, 0.25) -0.55 (-1.12, 0.03) 
    
Internalizing factor, Varimax
2
 0.26 (-0.16, 0.68) 0.32 (-0.21, 0.84) 0.18 (-0.43, 0.80) 
Internalizing factor, Promax
1
 -0.03 (-0.45, 0.39) 0.11 (-0.41, 0.63) -0.24 (-0.85, 0.38) 
Internalizing Composite
3
 0.07 (-0.33, 0.47) 0.18 (-0.32, 0.68) -0.09 (-0.68, 0.50) 
    
Perceptual Reasoning factor, 
Varimax
2
 0.06 (-0.33, 0.45) 0.28 (-0.21, 0.77) -0.26 (-0.83, 0.31) 
Perceptual Reasoning factor, 
Promax
1
 0.06 (-0.31, 0.42) 0.25 (-0.21, 0.71) -0.22 (-0.76, 0.31) 
Perceptual Reasoning IQ
3
 0.14 (-0.25, 0.53) 0.37 (-0.11, 0.85) -0.19 (-0.76, 0.38) 
    
Adaptability factor, Varimax
2
 -0.08 (-0.48, 0.33) 0.06 (-0.45, 0.56) -0.27 (-0.85, 0.32) 
Adaptability factor, Promax
1
 -0.27 (-0.67, 0.14) -0.10 (-0.60, 0.41) -0.51 (-1.10, 0.08) 
Adaptive Skills Composite
3
 -0.33 (-0.71, 0.06) -0.10 (-0.58, 0.37) -0.66 (-1.23, -0.10) 
    
Processing Speed factor, Varimax
2
 -0.16 (-0.57, 0.26) -0.09 (-0.61, 0.43) -0.26 (-0.87, 0.36) 
Processing Speed factor, Promax
1
 -0.19 (-0.60, 0.23) -0.10 (-0.62, 0.42) -0.32 (-0.93, 0.29) 
Processing Speed IQ
3
 -0.22 (-0.66, 0.23) -0.11 (-0.69, 0.48) -0.46 (-1.07, 0.15) 
    
Verbal Intelligence, Varimax
2
 0.04 (-0.31, 0.40) -0.12 (-0.56, 0.32) 0.28 (-0.23, 0.79) 
Verbal Intelligence, Promax
1
 0.11 (-0.21, 0.42) 0.07 (-0.32, 0.46) 0.17 (-0.29, 0.63) 
Verbal IQ
3
 0.15 (-0.16, 0.46) 0.10 (-0.29, 0.49) 0.22 (-0.24, 0.68) 
All models adjusted for maternal race, maternal education at follow-up, alcohol consumption during pregnancy, 
and HOME scores  
1 
Promax (oblique) rotation allows factors to correlate 
2 
Varimax (orthogonal) rotation factors are statistically uncorrelated with each other.  
3 
The composite/index items are the highest loading composite item for each factor.    
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APPENDIX 4 BIVARIATE ASSOCIATIONS BETWEEN EARLY LIFE CHARACTERISTICS 
AND NEURODEVELOPMENTAL FACTORS1 IN THE MOUNT SINAI CHILDREN’S 
ENVIRONMENTAL HEALTH CENTER 
 
 
 
 
 
 
N Factor 1 
Impulsivity 
&Externalizing 
β (95% CI) 
Factor 2 
Executive 
Functioning 
β (95% CI) 
Factor 3 
Internalizing 
β (95% CI) 
Factor 4 
Perceptual 
Reasoning 
β (95% CI) 
Factor 5 
Adaptability 
β (95% CI) 
Factor 6 
Processing 
Speed 
β (95% CI) 
Factor 7 
Verbal 
Intelligence 
β (95% CI) 
Mothers Marital Status at Follow up       
 Married 61 referent referent referent referent referent referent referent 
 Living with 
Partner 
39 0.12 (-0.28, 
0.51) 
0.20 (-0.20, 
0.61) 
0.11 (-0.30, 
0.51) 
-0.29 (-0.69, 
0.10) 
-0.25 (-0.64, 
0.14) 
0.20 (-0.20, 
0.59) 
-0.48 (-0.87, -
0.08) 
 Single/Divorced/ 
Widowed 
99 -0.27 (-0.58, 
0.05) 
0.07 (-0.25, 
0.39) 
-0.02 (-0.34, 
0.30) 
-0.41 (-0.73, -
0.10) 
-0.46 (-0.76, -
0.15) 
0.09 (-0.23, 
0.40) 
-0.33 (-0.65, -
0.02) 
 Pr>chisq  0.07 0.61 0.80 0.04 0.02 0.62 0.04 
          
Maternal IQ        
 IQ < 100 91 referent referent referent referent referent referent referent 
 IQ ≥ 100 45 0.12 (-0.24, 
0.48) 
-0.49 (-0.85, -
0.13) 
-0.04 (-0.38, 
0.30) 
0.54 (0.19, 
0.89) 
0.18 (-0.18, 
0.53) 
0.06 (-0.28, 
0.39) 
0.80 (0.51, 
1.10) 
 Pr> chisq  0.50 0.01 0.82 <0.01 0.32 0.74 <0.01 
          
Maternal Education at Follow Up       
 High school or 
less 
84 referent referent referent referent referent referent referent 
 Some college 81 -0.06 (-0.36, 
0.24) 
-0.26 (-0.56, 
0.04) 
0.15 (-0.16, 
0.45) 
0.04 (-0.25, 
0.33) 
0.07 (-0.23, 
0.37) 
-0.15 (-0.46, 
0.15) 
0.55 (0.28, 
0.82) 
 Bachelor’s 
degree 
45 -0.16 (-0.52, 
0.21) 
-0.33 (-0.69, 
0.03) 
0.18 (-0.18, 
0.54) 
0.75 (0.40, 
1.09) 
0.46 (0.11, 
0.82) 
0.05 (-0.31, 
0.41) 
1.18 (0.85, 
1.50) 
 Pr> chisq  0.70 0.11 0.51 <0.01 0.03 0.47 <0.01 
          
Maternal Age at Delivery       
 <20 98 referent referent referent referent referent referent referent 
 20-25 55 -0.11 (-0.44, 
0.22) 
0.01 (-0.32, 
0.34) 
0.13 (-0.20, 
0.46) 
0.09 (-0.22, 
0.40) 
0.06 (-0.26, 
0.38) 
-0.22 (-054, 
0.11) 
0.28 (-0.04, 
0.59) 
 >25 57 -0.18 (-0.50, 
0.15) 
-0.31 (-0.63, 
0.02) 
-0.05 (-0.38, 
0.27) 
0.70 (0.39, 
1.01) 
0.50 (0.18, 
0.82) 
-0.16 (-0.48, 
0.17) 
0.74 (0.43, 
1.05) 
 Pr> chisq  0.54 0.13 0.61 <0.01 <0.01 0.38 <0.01 
          
Maternal Race       
 Black or other 
race 
57 referent referent referent referent referent referent referent 
 White 31 0.01 (-0.43, 
0.44) 
-0.33 (-0.76, 
0.10) 
0.07 (-0.37, 
0.50) 
1.14 (0.74, 
1.55) 
0.30 (-0.13, 
0.74) 
-0.01 (-0.45, 
0.43) 
1.05 (0.65, 
1.44) 
 Hispanic 122 0.22 (-0.09, 
0.53) 
-0.28 (-0.59, 
0.03) 
-0.04 (-0.35, 
0.28) 
0.14 (-0.15, 
0.43) 
-0.00 (-0.31, 
0.31) 
-0.00 (-0.31, 
0.31) 
-0.25 (-0.53, 
0.03) 
 Pr> chisq  0.29 0.16 0.87 <0.01 0.29 0.99 <0.01 
          
Maternal Smoking During Pregnancy       
 None 134 referent referent referent referent referent referent referent 
 Any 28 -0.53 (-0.91, -
0.15) 
-0.31 (-0.73, 
0.10) 
0.26 (-0.14, 
0.66) 
0.02 (-0.38, 
0.43) 
-0.18 (-0.59, 
0.23) 
-0.23 (-0.62, 
0.17) 
-0.06 (-0.44, 
0.33) 
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N Factor 1 
Impulsivity 
&Externalizing 
β (95% CI) 
Factor 2 
Executive 
Functioning 
β (95% CI) 
Factor 3 
Internalizing 
β (95% CI) 
Factor 4 
Perceptual 
Reasoning 
β (95% CI) 
Factor 5 
Adaptability 
β (95% CI) 
Factor 6 
Processing 
Speed 
β (95% CI) 
Factor 7 
Verbal 
Intelligence 
β (95% CI) 
 Pr> chisq  0.01 0.14 0.20 0.91 0.39 0.26 0.77 
          
Maternal Alcohol Use During 
Pregnancy 
      
 None 132 referent referent referent referent referent referent referent 
 Any 29 0.08 (-0.32, 
0.48) 
-0.07 (-0.50, 
0.35) 
0.11 (-0.30, 
0.52) 
0.68 (0.28, 
1.09) 
0.07 (-0.35, 
0.48) 
-0.01 (-0.41, 
0.39) 
0.74 (0.36, 
1.12) 
 Pr> chisq  
0.68 0.73 0.61 <0.01 0.74 0.96 <0.01 
          
Maternal Canned Fish Consumption During 
Pregnancy 
     
 < 1 times per 
week 
145 referent referent referent referent referent referent referent 
 1 or more times 
per week 
22 -0.16 (-0.59, 
0.27) 
-0.27 (-0.73, 
0.18) 
0.24 (-0.20, 
0.68) 
0.83 (0.40, 
1.26) 
0.36 (-0.09, 
0.80) 
-0.17 (-0.61, 
0.27) 
0.32 (-0.10, 
0.74) 
 Pr>Chisq  0.47 0.24 0.29 <0.01 0.12 0.45 0.14 
          
Child Sex        
 Male 100 referent referent referent referent referent referent referent 
 Female 105 0.35 (0.08, 
0.62) 
-0.11 (-0.39, 
0.16) 
-0.28 (-0.55, 
0.00) 
-0.27 (-0.54, 
0.00) 
0.42 (0.15, 
0.68) 
0.40 (0.13, 
0.67) 
-0.12 (-0.39, 
0.16) 
 Pr> chisq  0.01 0.41 0.05 0.05 <0.01 <0.01 0.40 
          
Gestational Age       
 Term Birth 150 referent referent referent referent referent referent referent 
 Preterm 60 0.28 (-0.02, 
0.57) 
-0.13 (-0.43, 
0.17) 
-0.34 (-0.64, -
0.05) 
-0.19 (-0.49, 
0.10) 
-0.13 (-0.43, 
0.17) 
-0.15 (-0.45, 
0.14) 
-0.46 (-0.75, -
0.16) 
 Pr> chisq  0.07 0.38 0.02 0.20 0.39 0.31 <0.01 
          
Head Circumference       
 Centimeters, 
continuous 
162 -0.04 (-0.14, 
0.06) 
-0.12 (-0.22, -
0.02) 
0.04 (-0.06, 
0.14) 
0.15 (0.05, 
0.24) 
0.00 (-0.10, 
0.10) 
0.07 (-0.03, 
0.17) 
0.06 (-0.03, 
0.16) 
 Pr> chisq  0.43 0.02 0.47 <0.01 0.99 0.17 0.19 
          
Birth weight       
 < median (< 
3270 g) 
76 referent referent referent referent referent referent referent 
 ≥Median (≥ 
3270 g) 
86 -0.25 (-0.55, 
0.04) 
-0.10 (-0.41, 
0.22) 
0.08 (-0.23, 
0.39) 
0.21 (-0.09, 
0.52) 
0.20 (-0.11, 
0.50) 
0.19 (-0.11, 
0.49) 
-0.12 (-0.41, 
0.17) 
 Pr> chisq  0.10 0.54 0.61 0.17 0.21 0.21 0.41 
          
Birth Length         
 <median (<51 
cm) 
75 referent referent referent referent referent referent referent 
 ≥median(≥51 
cm) 
85 -0.22 (-0.52, 
0.08) 
-0.17 (-0.49, 
0.14) 
0.33 (0.02, 
0.63) 
0.17 (-0.14, 
0.48) 
0.05 (-0.27, 
0.36) 
-0.02 (-0.32, 
0.29) 
-0.14 (-0.44, 
0.15) 
 Pr> chisq  0.15 0.29 0.03 0.29 0.77 0.90 0.34 
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N Factor 1 
Impulsivity 
&Externalizing 
β (95% CI) 
Factor 2 
Executive 
Functioning 
β (95% CI) 
Factor 3 
Internalizing 
β (95% CI) 
Factor 4 
Perceptual 
Reasoning 
β (95% CI) 
Factor 5 
Adaptability 
β (95% CI) 
Factor 6 
Processing 
Speed 
β (95% CI) 
Factor 7 
Verbal 
Intelligence 
β (95% CI) 
HOME Observation for Measurement of the Environment Scores     
 Overall Score 
Continuous  156 
0.00 (-0.02, 
0.03) 
0.01 (-0.01, 
0.04) 
0.01 (-0.02, 
0.04) 
0.01 (-0.02, 
0.04) 
0.04 (0.01, 
0.06) 
0.02 (0.00, 
0.05) 
0.01 (-0.01, 
0.04) 
 Pr> chisq  0.94 0.37 0.48 0.44 <0.01 0.07 0.33 
          
 Responsivity 
Ordinal 
categorical 156 
0.04 (-0.14, 
0.22) 
-0.01 (-0.20, 
0.18) 
0.12 (-0.07, 
0.30) 
0.05 (-0.14, 
0.23) 
0.13 (-0.05, 
0.31) 
0.01 (-0.17, 
0.19) 
0.15 (-0.03, 
0.32) 
 Pr> chisq  0.64 0.89 0.21 0.63 0.15 0.88 0.09 
          
 Involvement 
Ordinal 
categorical 156 
0.03 (-0.16, 
0.23) 
-0.04 (-0.25, 
0.16) 
0.04 (-0.16, 
0.24) 
0.22 (0.02, 
0.42) 
0.23 (0.04, 
0.42) 
0.09 (-0.10, 
0.29) 
0.13 (-0.06, 
0.32) 
 Pr> chisq  0.76 0.68 0.70 0.03 0.02 0.36 0.19 
  
        
 Organization 
Ordinal 
categorical 156 
-0.11 (-0.29, 
0.07) 
0.28 (0.09, 
0.47) 
0.21 (0.02, 
0.39) 
0.02 (-0.17, 
0.20) 
0.28 (0.10, 
0.46) 
-0.01 (-0.19, 
0.17) 
0.00 (-0.18, 
0.18) 
 Pr> chisq  0.24 <0.01 0.03 0.86 <0.01 0.94 0.99 
          
 Learning 
materials 
Ordinal 
categorical 156 
0.01 (-0.18, 
0.20) 
0.06 (-0.14, 
0.26) 
0.11 (-0.08, 
0.31) 
0.16 (-0.03, 
0.36) 
0.06 (-0.13, 
0.26) 
0.16 (-0.03, 
0.35) 
0.22 (0.04, 
0.41) 
 Pr> chisq  0.89 0.54 0.26 0.10 0.52 0.10 0.02 
          
 Acceptance 
Ordinal 
categorical 156 
0.07 (-0.13, 
0.26) 
-0.03 (-0.24, 
0.17) 
0.01 (-0.19, 
0.21) 
0.03 (-0.17, 
0.23) 
0.18 (-0.02, 
0.37) 
0.10 (-0.10, 
0.29) 
0.11 (-0.08, 
0.30) 
 Pr>chisq  0.51 0.77 0.95 0.79 0.08 0.32 0.25 
          
 Variety 
Ordinal 
categorical 156 
0.00 (-0.20, 
0.19) 
0.21 (0.00, 
0.42) 
0.16 (-0.04, 
0.36) 
0.13 (-0.08, 
0.33) 
0.22 (0.03, 
0.42) 
0.09 (-0.11, 
0.29) 
0.10 (-0.09, 
0.30) 
 Pr>chisq  0.97 0.05 0.12 0.22 0.03 0.37 0.31 
1
Higher factor scores indicate better outcomes (e.g., less impulsivity/internalizing, lower levels of anxiety/internalizing 
behaviors, higher verbal intelligence) 
Characteristics presented for all participants who were included in the factor analysis, where data is available
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APPENDIX 5 FREQUENTIST ASSOCIATIONS BETWEEN OPS AND 
NEURODEVELOPMENTAL FACTOR SCORES, WITH AND WITHOUT ADJUSTMENT FOR 
CO-EXPOSURES 
 ∑DMPs (, 95% CI) ∑DEPs (, 95% CI) 
 No co-exposure 
adjustment 
(n=157) 
Co-exposure 
adjustment
†
 
(n=141) 
No co-exposure 
adjustment (n=156) 
Co-exposure 
adjustment (n=141) 
Impulsivity & 
Externalizing 
0.03 (-0.11, 0.17) -0.02 (-0.18, 0.14) 0.07 (-0.10, 0.23) 0.11 (-0.08, 0.30) 
Executive Functioning 0.18 (0.03, 0.33) 0.18 (0.01, 0.36) -0.02 (-0.20, 0.15) -0.11 (-0.31, 0.10) 
Internalizing -0.16 (-0.30, -0.02) -0.16 (-0.31, 0.00) -0.08 (-0.23, 0.08) -0.02 (-0.20, 0.15) 
Perceptual Reasoning 0.05 (-0.09, 0.19) -0.01 (-0.17, 0.16) -0.01 (-0.17, 0.15) 0.00 (-0.19, 0.20) 
Adaptability -0.03 (-0.18, 0.12) -0.01 (-0.18, 0.15) -0.10 (-0.26, 0.07) -0.11 (-0.30, 0.08) 
Processing Speed -0.01 (-0.16, 0.13) 0.01 (-0.16, 0.18) 0.04 (-0.13, 0.21) -0.02 (-0.22, 0.18) 
Verbal Intelligence 0.06 (-0.06, 0.19) 0.07 (-0.07, 0.21) -0.04 (-0.18, 0.11) -0.04 (-0.21, 0.13) 
Working Memory Index 0.07 (-0.08, 0.23) 0.16 (0.00, 0.33) -0.16 (-0.33, 0.02) -0.23 (-0.42, -0.04) 
¥
The frequentist beta coefficients and 95% confidence intervals are from models that include one OP at a time (DEPs alone, 
DMPs alone – “no co-exposure adjustment”),  and also models that include both ∑DAP measures (∑DEPs and ∑DMPs), along 
with the molar sum of DEHP, the molar sum of low-molecular weight phthalates (MIBP, MEP, MBP) and the individual phthalate 
congeners of MCPP, MBZP, as well as the individual phenol metabolites BPA, BP3, DCP25, and triclosan, and the pyrethroid 
metabolite 3PBA (“co-exposure adjustment”). Factor scores have been scaled so that positive scores indicate more positive 
outcomes and negative scores indicate more adverse outcomes 
HOME scores, maternal IQ, maternal education at follow-up, maternal marital status at follow-up, maternal age, maternal 
race/ethnicity, maternal smoking during pregnancy, maternal alcohol consumption during pregnancy, maternal canned fish 
consumption during pregnancy, and alcohol were included in a DAG used to derive minimally sufficient sets for each facto
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APPENDIX 6 CODE USED IN DISSERTATION 
##SAS CODE FOR CREATING FACTORS 
**VARIMAX 
proc factor data=standardize nfactors=7 rotate=varimax  score outstat=pca_7 fuzz=0.3 simple msa ; 
var block_scale code_scale matreason_scale picconcep_scale vocab_scale symsearch_scale 
PIQ_PRI PSQ_PSI VIQ_VCI fsiq br_bri_mean br_emotional_mean br_inhibit_mean br_initiate_mean 
br_memory_mean br_mi_mean br_monitor_mean  
br_organization_mean br_plan_mean br_shift_mean br_gec_mean 
adp_t_mean0123 agg_t_mean0123 anx_t_mean0123 att_t_mean0123 hyp_t_mean0123 
wth_t_mean0123 intr_t_mean0123 ext_t_mean0123 bsi_t_mean0123 
dep_t_mean0123 som_t_mean0123 aty_t_mean0123 soc_t_mean0123 adpt_t_mean0123 
led_t_mean0123 con_t_mean0123; 
RUN; 
 
proc score data=standardize score=pca_7 out=pca_7scores; 
var block_scale code_scale matreason_scale picconcep_scale vocab_scale symsearch_scale 
PIQ_PRI PSQ_PSI VIQ_VCI fsiq br_bri_mean br_emotional_mean br_inhibit_mean br_initiate_mean 
br_memory_mean br_mi_mean br_monitor_mean  
br_organization_mean br_plan_mean br_shift_mean br_gec_mean 
adp_t_mean0123 agg_t_mean0123 anx_t_mean0123 att_t_mean0123 hyp_t_mean0123 
wth_t_mean0123 intr_t_mean0123 ext_t_mean0123 bsi_t_mean0123 
dep_t_mean0123 som_t_mean0123 aty_t_mean0123 soc_t_mean0123 adpt_t_mean0123 
led_t_mean0123 con_t_mean0123 ; 
run; 
************PROMAX ROTATED FACTORS; 
 
proc factor data=standardize nfactors=7 rotate=promax  score outstat=promax fuzz=0.3 simple msa ; 
var block_scale code_scale matreason_scale picconcep_scale vocab_scale symsearch_scale 
PIQ_PRI PSQ_PSI VIQ_VCI fsiq br_bri_mean br_emotional_mean br_inhibit_mean br_initiate_mean 
br_memory_mean br_mi_mean br_monitor_mean  
br_organization_mean br_plan_mean br_shift_mean br_gec_mean 
adp_t_mean0123 agg_t_mean0123 anx_t_mean0123 att_t_mean0123 hyp_t_mean0123 
wth_t_mean0123 intr_t_mean0123 ext_t_mean0123 bsi_t_mean0123 
dep_t_mean0123 som_t_mean0123 aty_t_mean0123 soc_t_mean0123 adpt_t_mean0123 
led_t_mean0123 con_t_mean0123; 
RUN; 
 
proc score data=standardize score=promax out=promax_scores type='pattern'; 
var block_scale code_scale matreason_scale picconcep_scale vocab_scale symsearch_scale 
PIQ_PRI PSQ_PSI VIQ_VCI fsiq br_bri_mean br_emotional_mean br_inhibit_mean br_initiate_mean 
br_memory_mean br_mi_mean br_monitor_mean  
br_organization_mean br_plan_mean br_shift_mean br_gec_mean 
adp_t_mean0123 agg_t_mean0123 anx_t_mean0123 att_t_mean0123 hyp_t_mean0123 
wth_t_mean0123 intr_t_mean0123 ext_t_mean0123 bsi_t_mean0123 
dep_t_mean0123 som_t_mean0123 aty_t_mean0123 soc_t_mean0123 adpt_t_mean0123 
led_t_mean0123 con_t_mean0123 ; 
run; 
 
##WINBUGS CODE, shrinking to mean of 0 and sd of 1 
 
dedp_nm_l_LN[i] ~ djl.dnorm.trunc(-2.5197724 , 0.37500623, -500, -0.79208) 
detp_nm_l_LN[i] ~ djl.dnorm.trunc(2.33299,  1.40313628, -500, -0.004885072) 
dep_nm_l_LN[i] ~ djl.dnorm.trunc(0.53881184,  0.1827317,-500, -0.085870945) 
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dmp_nm_l_LN[i] ~ djl.dnorm.trunc(2.61715, 0.42574248, -500, 0.115065123) 
dmtp_nm_l_LN[i]  ~ djl.dnorm.trunc(3.2244,  0.39832273,-500, -0.004885072) 
dmdp_nm_l_LN[i]  ~ djl.dnorm.trunc(0.71069863, 0.50155078, -500, -0.273969564) 
 
##calculating DAPS sum 
##ALL IN NANOMOLES 
 
dep_sum[i] <- log(exp(dedp_nm_l_LN[i])+exp(detp_nm_l_LN[i])+exp(dep_nm_l_LN[i])) 
dmp_sum[i] <- log(exp(dmdp_nm_l_LN[i])+exp(dmtp_nm_l_LN[i])+exp(dmp_nm_l_LN[i])) 
dap_sum[i] <- log(exp(dedp_nm_l_LN[i])+exp(detp_nm_l_LN[i])+exp(dep_nm_l_LN[i]) + 
exp(dmdp_nm_l_LN[i])+exp(dmtp_nm_l_LN[i])+exp(dmp_nm_l_LN[i])) 
 
dedp_out[i] <-dedp_nm_l_LN[i] 
detp_out[i] <-detp_nm_l_LN[i] 
dep_out[i] <-dep_nm_l_LN[i] 
dmdp_out[i] <-dmdp_nm_l_LN[i] 
dmtp_out[i] <-dmtp_nm_l_LN[i] 
dmp_out[i] <-dmp_nm_l_LN[i] 
 
dep_sum_out[i] <- dep_sum[i] 
dmp_sum_out[i] <-dmp_sum[i] 
 
 
#means,sds of daps -- exported the DAPS with the values below LOD imputed, incl metabolites 
# and summary measures, then merged with variables that had actual measured value, took means and 
got: 
#dep -5.0416379 , 1.7373222 
#detp -4.7876878, 1.0523500 
#dedp -7.0713732, 0.6675843 
#dmp -4.3240917, 1.4910056 
#dmdp -6.0450593, 1.2687206 
#dmtp -3.6438471, 1.5411503 
#depsum -3.8359428, 1.1403774 
#dmpsum -2.9558573, 1.3550287 
#dapsum -2.4316833, 1.1579961 
 
##calculate cratio 
# predict creatinine from variables 
 
lncreat[i] ~dnorm(mu.creat[i], tau.creat) 
mu.creat[i] <-  alpha.creat +  
     beta.creat[1]*MOMAGE[i] +  
     beta.creat[2]*mom_BMI[i] +  
     beta.creat[3]*baseline_hsorless[i] +  
     beta.creat[4]*white[i] +  
     beta.creat[5]*hispanic[i]  
 
 
#creatinine ratio 
cratio[i] <- (exp(lncreat[i])) / (exp(mu.creat[i])) 
 
#creatinine correct, log metabolites 
cratio_dep[i] <-  log(exp(dep_sum[i]) /cratio[i]) 
cratio_dmp[i] <- log(exp(dmp_sum[i]) /cratio[i]) 
cratio_dap[i] <-  log(exp(dap_sum[i]) /cratio[i]) 
 
  111 
cratio_dep_out[i] <- cratio_dep[i] 
cratio_dmp_out[i] <-cratio_dmp[i] 
cratio_dap_out[i] <- cratio_dap[i] 
 
 
#standardize cratios 
#cratio_dapz[i] <-  
cratio_depz[i] <- (cratio_dep[i] - 3.042524)/ 1.15099 
cratio_dmpz[i] <- (cratio_dmp[i] - 3.837248)/1.6048 
 
#standardize dmpsum 
dmp_sumz[i] <- (dmp_sum[i] - 3.3096552) / 1.267953 
dep_sumz[i] <- (dep_sum[i] - 2.49507)/1.144497 
 
 
Standard_scorez[i] <- (Standard_score[i] - 93.8 )/14.3 
###OTHER VALUES 
 
 
##PTHALATES  
 mbp_log[i] ~ djl.dnorm.trunc(3.58629, 0.788910677,-500,-0.3566749) 
 mbzp_log[i] ~ djl.dnorm.trunc(2.73489,0.48863088,-500,-0.5516476) 
 mcpp_log[i] ~ djl.dnorm.trunc(1.16315, 0.94624838,-500,-1.6094379) 
 mecpp_log[i] ~ djl.dnorm.trunc(3.55535,0.47212255,-500,0.0953102) 
 mehhp_log[i] ~ djl.dnorm.trunc(2.97041,0.33366341,-500,-0.9162907) 
 mehp_log[i] ~ djl.dnorm.trunc(1.79176,0.36260978,-500,-0.1053605) 
 meohp_log[i] ~ djl.dnorm.trunc(2.85647,0.36732536,-500, 0.0953102) 
 mep_log[i] ~ djl.dnorm.trunc(5.52228,0.43680145,-500,0.1151128) 
 mibp_log[i] ~ djl.dnorm.trunc(1.82455,0.96914124,-500,-1.2039728) 
#other xenobiotics: 
#no non detects for dcp25 or bp3 
bpa_ln[i] ~ djl.dnorm.trunc(0.26236, 0.97112055, -500, -0.9162907) 
trcs_ln[i] ~ djl.dnorm.trunc(2.37955, 0.22015845, -500, 0.80) 
 
#phenols and pyrethroids list: 
#bpa_ln dcp24_ln dcp25_ln bp3_ln trcs_ln tcp245_ln pba_bin dcca_bin 
 # Calculate dehp sum 
 dehp_log[i] <- log((exp(mehp_log[i])/278.34348)+(exp(mehhp_log[i])/294.34288) 
    +(exp(meohp_log[i])/292.327)+(exp(mecpp_log[i])/308.3264)) 
     
 lophth_log[i] <- log((exp(mbp_log[i])/222.24) + (exp(mibp_log[i])/ 222.26) +  
      exp(mep_log[i])/94.184) 
 
 # Standardize metabolites to mean and SD of observed distributions 
 
mbpz[i] <-(mbp_log[i] - 3.58629)/1.12572449 
mbzpz[i] <-(mbzp_log[i]- 2.73489 )/1.430571429 
mcppz[i] <-(mcpp_log[i]- 1.16315)/1.028010204 
mecppz[i] <-(mecpp_log[i]- 3.55535)/1.455367347 
mehhpz[i] <-(mehhp_log[i]- 2.97041)/1.731193878 
mehpz[i] <-(mehp_log[i]-  1.79176)/1.660658163 
meohpz[i] <-(meohp_log[i] -2.85647)/1.649964286 
mepz[i] <-(mep_log[i] - 5.52228)/1.513066327 
mibpz[i] <-(mibp_log[i]- 1.82455)/1.015795918 
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bpaz[i]<- (bpa_ln[i]- 0.26236)/1.014760204 
trcsz[i]<-(trcs_ln[i] - 2.37955)/2.131239796 
bp3z[i] <- (bp3_ln[i] - 2.4019948)/2.0856463 
dcp25z[i] <- (dcp25_ln[i] - 4.1312213)/1.5600545 
dehpz[i] <- (dehp_log[i] - 0.0106402)/0.9915109 
 
 
 
 
##actual model 
factor1reverse[i] ~dnorm (mu.f1[i], tau.f1) 
factor2reverse[i] ~ dnorm (mu.f2[i], tau.f2) 
factor3reverse[i] ~ dnorm (mu.f3[i], tau.f3) 
Factor4[i] ~ dnorm (mu.f4[i], tau.f4) 
Factor5[i] ~ dnorm (mu.f5[i], tau.f5) 
Factor6[i] ~dnorm (mu.f6[i], tau.f6) 
Factor7[i] ~dnorm(mu.f7[i], tau.f7) 
 
mu.f1[i] <- alpha.f1 + A.f1[i] + B.f1[i] + C.f1[i] 
mu.f2[i] <- alpha.f2 + A.f2[i] + B.f2[i] +  C.f2[i] 
mu.f3[i] <- alpha.f3 + A.f3[i] + B.f3[i] + C.f3[i] 
mu.f4[i] <- alpha.f4 + A.f4[i] + B.f4[i] +  C.f4[i]   
mu.f5[i] <- alpha.f5 + A.f5[i] + B.f5[i] +  C.f5[i]  
mu.f6[i] <- alpha.f6 + A.f6[i] + B.f6[i] +  C.f6[i] 
mu.f7[i] <- alpha.f7 + A.f7[i] + B.f7[i] + C.f7[i] 
 
#could shrink by classes to get more power  
#so beta phthalte is normal, alpha, sigma, put a prior on alpha, so you're shrinking towards a common 
mean 
# can drop the interactions too if theres nothing there 
# could try including DEP and just shrink everything 
 
#factor1 
#A for continous variables 
 A.f1[i]<-  
      beta.dm1*dmp_sumz[i] 
     + beta.de1*dep_sumz[i] 
     + beta.phth1[1]*dehpz[i] 
     + beta.phth1[2]*mbzpz[i]  
     + beta.phth1[3]*mcppz[i]  
     + beta.phth1[4]*mepz[i]  
     + beta.phth1[5]*mbpz[i]  
     + beta.phth1[6]*mibpz[i]  
   
 B.f1[i] <-    
      beta.phen1[1]*bpaz[i] 
     + beta.phen1[2]*bp3z[i] 
     + beta.phen1[3]*trcsz[i] 
     + beta.phen1[4]*dcp25z[i] 
     + beta.pyr1[1]*pba_bin[i] 
    # + beta.pyr1[2]*dcca_bin[i] 
 
 
 C.f1[i] <- 
        beta.f1[1]*lncreat[i] 
     +  beta.f1[2]*batch_ops[i] 
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     + beta.f1[3]*single_f[i] 
     +beta.f1[4]*SmokePreg[i] 
     +beta.f1[5]*Male[i] 
     +beta.f1[6]*home_yr1yr2[i] 
     +beta.f1[7]*spanish[i] 
     +beta.f1[8]*hispanic[i] 
     +beta.f1[9]*married_f[i] 
          
 
 
#factor2 
 
 A.f2[i]<-  
      beta.dm2*dmp_sumz[i]   
     +beta.de2*dep_sumz[i]   
     + beta.phth2[1]*dehpz[i] 
     + beta.phth2[2]*mbzpz[i]  
     + beta.phth2[3]*mcppz[i]  
     + beta.phth2[4]*mepz[i]  
     + beta.phth2[5]*mbpz[i]  
     + beta.phth2[6]*mibpz[i]  
   
 B.f2[i] <-    
      beta.phen2[1]*bpaz[i] 
     + beta.phen2[2]*bp3z[i] 
     + beta.phen2[3]*trcsz[i] 
     + beta.phen2[4]*dcp25z[i] 
     + beta.pyr2[1]*pba_bin[i] 
    # + beta.pyr2[2]*dcca_bin[i] 
 C.f2[i] <- 
        beta.f2[1]*lncreat[i] 
     +  beta.f2[2]*batch_ops[i] 
     + beta.f2[3]*organization_yr1yr2_3[i] 
     +beta.f2[4]*involvement_yr1yr2_3[i] 
     +beta.f2[5]*MOMAGE[i] 
     +beta.f2[6]*Standard_scorez[i] 
     +beta.f2[7]*carer_bach[i] 
     +beta.f2[8]*white[i] 
     +beta.f2[9]*hispanic[i] 
     +beta.f2[10]*SmokePreg[i] 
     +beta.f2[11]*Male[i] 
     +beta.f2[12]*carer_hs[i] 
 
 
 
#factor3 
 A.f3[i]<-  
      beta.dm3*dmp_sumz[i]   
      + beta.de3*dep_sumz[i] 
     + beta.phth3[1]*dehpz[i] 
     + beta.phth3[2]*mbzpz[i]  
     + beta.phth3[3]*mcppz[i]  
     + beta.phth3[4]*mepz[i]  
     + beta.phth3[5]*mbpz[i]  
     + beta.phth3[6]*mibpz[i]  
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 B.f3[i] <-    
      beta.phen3[1]*bpaz[i] 
     + beta.phen3[2]*bp3z[i] 
     + beta.phen3[3]*trcsz[i] 
     + beta.phen3[4]*dcp25z[i] 
     + beta.pyr3[1]*pba_bin[i] 
     + beta.pyr3[2]*dcca_bin[i] 
 C.f3[i] <- 
        beta.f3[1]*lncreat[i] 
     +  beta.f3[2]*batch_ops[i] 
     + beta.f3[3]*organization_yr1yr2_3[i] 
     +beta.f3[4]*carer_hs[i] 
      
#factor4 
 A.f4[i]<-  
      beta.dm4*dmp_sumz[i]  
     + beta.de4*dep_sumz[i] 
     + beta.phth4[1]*dehpz[i] 
     + beta.phth4[2]*mbzpz[i]  
     + beta.phth4[3]*mcppz[i]  
     + beta.phth4[4]*mepz[i]  
     + beta.phth4[5]*mbpz[i]  
     + beta.phth4[6]*mibpz[i]  
   
 B.f4[i] <-    
      beta.phen4[1]*bpaz[i] 
     + beta.phen4[2]*bp3z[i] 
     + beta.phen4[3]*trcsz[i] 
     + beta.phen4[4]*dcp25z[i] 
     + beta.pyr4[1]*pba_bin[i] 
    # + beta.pyr4[2]*dcca_bin[i] 
 C.f4[i] <- 
        beta.f4[1]*lncreat[i] 
     + beta.f4[2]*batch_ops[i] 
     +beta.f4[3]*white[i] 
     +beta.f4[4]*single_f[i] 
     +beta.f4[5]*MOMAGE[i] 
     +beta.f4[6]*Standard_scorez[i] 
     +beta.f4[7]*organization_yr1yr2_3[i] 
     +beta.f4[8]*carer_bach[i] 
     +beta.f4[9]*involvement_yr1yr2_3[i] 
     +beta.f4[10]*alcohol_cat1 [i] 
     +beta.f4[11]*spanish[i] 
     +beta.f4[12]*examiner2[i] 
     +beta.f4[13]*examiner3[i] 
     +beta.f4[14]*examiner4[i] 
     +beta.f4[15]*examiner5[i]  
     +beta.f4[16]*canfish1xweek[i] 
         
 
#factor5 
 A.f5[i]<-  
      beta.dm5*dmp_sumz[i]  
     + beta.de5*dep_sumz[i] 
     + beta.phth5[1]*dehpz[i] 
     + beta.phth5[2]*mbzpz[i]  
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     + beta.phth5[3]*mcppz[i]  
     + beta.phth5[4]*mepz[i]  
     + beta.phth5[5]*mbpz[i]  
     + beta.phth5[6]*mibpz[i]  
   
 B.f5[i] <-    
      beta.phen5[1]*bpaz[i] 
     + beta.phen5[2]*bp3z[i] 
     + beta.phen5[3]*trcsz[i] 
     + beta.phen5[4]*dcp25z[i] 
     + beta.pyr5[1]*pba_bin[i] 
    # + beta.pyr5[2]*dcca_bin[i] 
 C.f5[i] <- 
        beta.f5[1]*lncreat[i] 
     +  beta.f5[2]*batch_ops[i] 
     +beta.f5[3]*MOMAGE[i] 
     + beta.f5[4]*Male[i] 
     +beta.f5[5]*organization_yr1yr2_3[i]  
     +beta.f5[6]*learning_mat_yr1yr2_3[i] 
     +beta.f5[7]*single_f [i] 
     +beta.f5[8]*married_f[i] 
     +beta.f5[9]*carer_bach[i] 
     +beta.f5[10]*canfish1xweek[i] 
      
     
     
#factor6 
 A.f6[i]<-  
      beta.dm6*dmp_sumz[i]  
      +beta.de6*dep_sumz[i] 
     + beta.phth6[1]*dehpz[i] 
     + beta.phth6[2]*mbzpz[i]  
     + beta.phth6[3]*mcppz[i]  
     + beta.phth6[4]*mepz[i]  
     + beta.phth6[5]*mbpz[i]  
     + beta.phth6[6]*mibpz[i]  
   
 B.f6[i] <-    
      beta.phen6[1]*bpaz[i] 
     + beta.phen6[2]*bp3z[i] 
     + beta.phen6[3]*trcsz[i] 
     + beta.phen6[4]*dcp25z[i] 
     + beta.pyr6[1]*pba_bin[i] 
    # + beta.pyr6[2]*dcca_bin[i] 
 C.f6[i] <- 
        beta.f6[1]*lncreat[i] 
     +  beta.f6[2]*batch_ops[i] 
     + beta.f6[3]*home_yr1yr2[i]  
     + beta.f6[4]*responsivity_yr1yr2_3[i] 
     +beta.f6[5]*Male[i] 
     +beta.f6[6]*spanish[i] 
     +beta.f6[7]*examiner2[i] 
     +beta.f6[8]*examiner3[i] 
     +beta.f6[9]*examiner4[i] 
     +beta.f6[10]*examiner5[i] 
     +beta.f7[11]*carer_bach[i] 
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 #factor7 
 A.f7[i]<-  
      beta.dm7*dmp_sumz[i]   
      + beta.de7*dep_sumz[i] 
     + beta.phth7[1]*dehpz[i] 
     + beta.phth7[2]*mbzpz[i]  
     + beta.phth7[3]*mcppz[i]  
     + beta.phth7[4]*mepz[i]  
     + beta.phth7[5]*mbpz[i]  
     + beta.phth7[6]*mibpz[i]  
   
 B.f7[i] <-    
      beta.phen7[1]*bpaz[i] 
     + beta.phen7[2]*bp3z[i] 
     + beta.phen7[3]*trcsz[i] 
     + beta.phen7[4]*dcp25z[i] 
     + beta.pyr7[1]*pba_bin[i] 
   #  + beta.pyr7[2]*dcca_bin[i] 
 C.f7[i] <- 
        beta.f7[1]*lncreat[i] 
     +  beta.f7[2]*batch_ops[i] 
     + beta.f7[3]*MOMAGE[i]  
     +beta.f7[4]*single_f[i] 
     +beta.f7[5]*learning_mat_yr1yr2_3[i] 
     +beta.f7[6]*carer_hs[i] 
     + beta.f7[7]*Standard_score[i] 
     +beta.f7[8]*married_f[i] 
     +beta.f7[9]*carer_bach[i] 
     +beta.f7[10]*spanish[i] 
     +beta.f7[11]*white[i] 
     +beta.f7[12]*examiner4[i] 
     + beta.f7[13]*alcohol_cat1[i] 
     +beta.f7[14]*canfish1xweek[i] 
     +beta.f7[15]*examiner5[i] 
     +beta.f7[16]*examiner2[i] 
     +beta.f7[17]*examiner3[i] 
  
     
# missing variables: home scores, alcohol_cat1, stnadard_score  
 
 
home_yr1yr2[i] ~ dnorm (homemu[i], tau.home) 
homemu[i] <- alpha.home + A.home[i] +B.home[i]  
  
A.home[i]<- beta.home[1]*canfish1xweek[i] + 
   beta.home[2]*white[i] + 
   beta.home[3]*carer_bach[i] + 
   beta.home[4]*factor1reverse[i]+ 
   beta.home[5]*factor2reverse[i]+ 
   beta.home[6]*factor3reverse[i]  
B.home[i] <-  
    beta.home[7]*Male[i] + 
    beta.home[8]*SmokePreg[i] + 
    beta.home[9]*Standard_scorez[i] + 
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    beta.home[10]*Factor4[i]+ 
    beta.home[11]*Factor5[i]+ 
    beta.home[12]*Factor6[i] + 
    beta.home[13]*Factor7[i] + 
    beta.home[14]*married_f[i] + 
    beta.home[15]*hispanic[i] + 
    beta.home[16]*MOMAGE[i] 
 
organization_yr1yr2_3[i] ~ dnorm (orgmu[i], tau.org) 
orgmu[i] <- alpha.org + A.org[i] +B.org[i]  
  
A.org[i]<- beta.org[1]*canfish1xweek[i] + 
   beta.org[2]*white[i] + 
   beta.org[3]*carer_bach[i] + 
   beta.org[4]*factor1reverse[i]+ 
   beta.org[5]*factor2reverse[i]+ 
   beta.org[6]*factor3reverse[i]  
B.org[i] <-  
    beta.org[7]*Male[i] + 
    beta.org[8]*SmokePreg[i] + 
    beta.org[9]*Standard_scorez[i] + 
    beta.org[10]*Factor4[i]+ 
    beta.org[11]*Factor5[i]+ 
    beta.org[12]*Factor6[i] + 
    beta.org[13]*Factor7[i] + 
    beta.org[14]*married_f[i] + 
    beta.org[15]*hispanic[i] + 
    beta.org[16]*MOMAGE[i] 
    
learning_mat_yr1yr2_3[i] ~ dnorm (lmmu[i], tau.lm) 
lmmu[i] <- alpha.lm + A.lm[i] +B.lm[i]  
A.lm[i]<- beta.lm[1]*canfish1xweek[i] + 
   beta.lm[2]*white[i] + 
   beta.lm[3]*carer_bach[i] + 
   beta.lm[4]*factor1reverse[i]+ 
   beta.lm[5]*factor2reverse[i]+ 
   beta.lm[6]*factor3reverse[i]  
B.lm[i] <-  
    beta.lm[7]*Male[i] + 
    beta.lm[8]*SmokePreg[i] + 
    beta.lm[9]*Standard_scorez[i] + 
    beta.lm[10]*Factor4[i]+ 
    beta.lm[11]*Factor5[i]+ 
    beta.lm[12]*Factor6[i] + 
    beta.lm[13]*Factor7[i] + 
    beta.lm[14]*married_f[i] + 
    beta.lm[15]*hispanic[i] + 
    beta.lm[16]*MOMAGE[i]   
    
variety_yr1yr2_3[i] ~ dnorm (vmu[i], tau.v) 
vmu[i] <- alpha.v + A.v[i] +B.v [i]  
A.v [i]<- beta.v [1]*canfish1xweek[i] + 
   beta.v [2]*white[i] + 
   beta.v [3]*carer_bach[i] + 
   beta.v [4]*factor1reverse[i]+ 
   beta.v [5]*factor2reverse[i]+ 
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   beta.v [6]*factor3reverse[i]  
B.v [i] <-  
    beta.v [7]*Male[i] + 
    beta.v [8]*SmokePreg[i] + 
    beta.v [9]*Standard_scorez[i] + 
    beta.v [10]*Factor4[i]+ 
    beta.v [11]*Factor5[i]+ 
    beta.v [12]*Factor6[i] + 
    beta.v [13]*Factor7[i] + 
    beta.v [14]*married_f[i] + 
    beta.v [15]*hispanic[i] + 
    beta.v [16]*MOMAGE[i]   
 
responsivity_yr1yr2_3[i] ~ dnorm (rmu[i], tau.r) 
rmu[i] <- alpha.r + A.r[i] +B.r [i]  
A.r [i]<- beta.r[1]*canfish1xweek[i] + 
   beta.r [2]*white[i] + 
   beta.r [3]*carer_bach[i] + 
   beta.r [4]*factor1reverse[i]+ 
   beta.r [5]*factor2reverse[i]+ 
   beta.r [6]*factor3reverse[i]  
B.r [i] <-  
    beta.r [7]*Male[i] + 
    beta.r [8]*SmokePreg[i] + 
    beta.r [9]*Standard_scorez[i] + 
    beta.r [10]*Factor4[i]+ 
    beta.r [11]*Factor5[i]+ 
    beta.r [12]*Factor6[i] + 
    beta.r [13]*Factor7[i] + 
    beta.r [14]*married_f[i] + 
    beta.r [15]*hispanic[i] + 
    beta.r [16]*MOMAGE[i]  
     
 involvement_yr1yr2_3[i] ~ dnorm (invmu[i], tau.inv) 
invmu[i] <- alpha.inv + A.inv[i] +B.inv [i]  
A.inv[i]<- beta.inv[1]*canfish1xweek[i] + 
   beta.inv [2]*white[i] + 
   beta.inv [3]*carer_bach[i] + 
   beta.inv [4]*factor1reverse[i]+ 
   beta.inv [5]*factor2reverse[i]+ 
   beta.inv[6]*factor3reverse[i]  
B.inv [i] <-  
    beta.inv [7]*Male[i] + 
    beta.inv [8]*SmokePreg[i] + 
    beta.inv [9]*Standard_scorez[i] + 
    beta.inv [10]*Factor4[i]+ 
    beta.inv [11]*Factor5[i]+ 
    beta.inv [12]*Factor6[i] + 
    beta.inv [13]*Factor7[i] + 
    beta.inv [14]*married_f[i] + 
    beta.inv [15]*hispanic[i] + 
    beta.inv [16]*MOMAGE[i]  
     
 
alcohol_cat1[i] ~ dbern(p.alc[i]) 
logit(p.alc[i] )<- alpha.alc + A.alc[i] + B.alc[i]  
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A.alc[i]<- beta.alc[1]*canfish1xweek[i] + 
   beta.alc[2]*white[i] + 
   beta.alc[3]*carer_bach[i] + 
   beta.alc[4]*factor1reverse[i]+ 
   beta.alc[5]*factor2reverse[i]+ 
   beta.alc[6]*factor3reverse[i]  
B.alc[i] <-  
    beta.alc[7]*Male[i] + 
    beta.alc[8]*SmokePreg[i] + 
    beta.alc[9]*home_yr1yr2[i] + 
    beta.alc[10]*Factor4[i]+ 
    beta.alc[11]*Factor5[i]+ 
    beta.alc[12]*Factor6[i] + 
    beta.alc[13]*Factor7[i] + 
    beta.alc[14]*married_f[i]+ 
    beta.alc[15]*organization_yr1yr2_3[i] 
       
Standard_score[i] ~ dnorm (iqmu[i], tau.iq) 
iqmu[i] <- alpha.iq + A.iq[i] +B.iq [i]  
A.iq [i]<- beta.iq[1]*canfish1xweek[i] + 
   beta.iq [2]*white[i] + 
   beta.iq [3]*carer_bach[i] + 
   beta.iq [4]*factor1reverse[i]+ 
   beta.iq [5]*factor2reverse[i]+ 
   beta.iq [6]*factor3reverse[i]  
B.iq [i] <-  
    beta.iq [7]*Male[i] + 
    beta.iq [8]*SmokePreg[i] + 
    beta.iq [9]*Factor4[i]+ 
    beta.iq [10]*Factor5[i]+ 
    beta.iq [11]*Factor6[i] + 
    beta.iq [12]*Factor7[i] + 
    beta.iq [13]*married_f[i] + 
    beta.iq [14]*hispanic[i] + 
    beta.iq [15]*MOMAGE[i] + 
    beta.iq[16]*home_yr1yr2[i]+ 
    beta.iq[17]*responsivity_yr1yr2_3[i]+ 
    beta.iq[18]*organization_yr1yr2_3[i]+ 
    beta.iq[19]*learning_mat_yr1yr2_3[i]+ 
    beta.iq[20]*variety_yr1yr2_3[i]      
  
 
  
mom_BMI[i] ~ dnorm (bmimu[i], tau.bmi) 
bmimu[i] <- alpha.bmi + A.bmi[i] +B.bmi [i]  
A.bmi [i]<- beta.bmi[1]*canfish1xweek[i] + 
   beta.bmi [2]*white[i] + 
   beta.bmi [3]*carer_bach[i] + 
   beta.bmi [4]*factor1reverse[i]+ 
   beta.bmi [5]*factor2reverse[i]+ 
   beta.bmi [6]*factor3reverse[i]  
B.bmi[i] <-  
    beta.bmi [7]*Male[i] + 
    beta.bmi [8]*SmokePreg[i] + 
    beta.bmi [9]*Factor4[i]+ 
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    beta.bmi [10]*Factor5[i]+ 
    beta.bmi [11]*Factor6[i] + 
    beta.bmi [12]*Factor7[i] + 
    beta.bmi [13]*married_f[i] + 
    beta.bmi [14]*hispanic[i] + 
    beta.bmi [15]*MOMAGE[i] + 
    beta.bmi[16]*home_yr1yr2[i]+ 
    beta.bmi[17]*responsivity_yr1yr2_3[i]+ 
    beta.bmi[18]*organization_yr1yr2_3[i]+ 
    beta.bmi[19]*learning_mat_yr1yr2_3[i]+ 
    beta.bmi[20]*variety_yr1yr2_3[i]    
 
baseline_hsorless[i] ~dbern( p.bh[i]) 
logit(p.bh[i] )<- alpha.alc + carer_bach[i] + carer_hs[i] 
} 
 
        #Priors 
alpha.f1~ dnorm(0,1) 
alpha.f2~ dnorm(0,1) 
alpha.f3~ dnorm(0,1) 
alpha.f4~ dnorm(0,1)      
alpha.f5~ dnorm(0,1) 
alpha.f6~ dnorm(0,1) 
alpha.f7~dnorm(0,1) 
alpha.wmi~dnorm(0,1) 
alpha.creat~dnorm(0,1) 
 
alpha.alc~dnorm(0,1) 
alpha.org~dnorm(0,1) 
alpha.home~dnorm(0,1) 
alpha.iq~dnorm(0,1) 
alpha.r~dnorm(0,1) 
alpha.v~dnorm(0,1) 
alpha.lm~dnorm(0,1) 
alpha.inv~dnorm(0,1) 
alpha.bmi~dnorm(0,1) 
 
## trying a DPP  
 
#just give it initial values for imputing single 
# for imputing all variables, have to heirarchically specify the models, do y|x1, x2, then x2|x1, then x1 ~ 
bernoulli   
 
 
sigma.f1 ~dunif(0,2) 
tau.f1 <- 1/(sigma.f1*sigma.f1) 
 
sigma.f2 ~dunif(0,2) 
tau.f2 <- 1/(sigma.f2*sigma.f2) 
 
sigma.f3 ~dunif(0,2) 
tau.f3 <- 1/(sigma.f3*sigma.f3) 
 
sigma.f4 ~dunif(0,2) 
tau.f4 <- 1/(sigma.f4*sigma.f4) 
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sigma.f5 ~dunif(0,2) 
tau.f5 <- 1/(sigma.f5*sigma.f5) 
 
sigma.f6 ~dunif(0,2) 
tau.f6 <- 1/(sigma.f6*sigma.f6) 
 
sigma.f7~dunif(0,2) 
tau.f7<-1/(sigma.f7*sigma.f7) 
 
sigma.wmi~dunif(0,2) 
tau.wmi<-1/(sigma.wmi*sigma.wmi) 
 
sigma.home ~ dunif(0,2) 
tau.home <-1/(sigma.home*sigma.home) 
 
sigma.lm~dunif(0,2) 
tau.lm <- 1/(sigma.lm*sigma.lm) 
 
sigma.org~dunif(0,2) 
tau.org <- 1/(sigma.org*sigma.org) 
 
sigma.r~dunif(0,2) 
tau.r <- 1/(sigma.r*sigma.r) 
 
sigma.v~dunif(0,2) 
tau.v <- 1/(sigma.v*sigma.v) 
 
sigma.inv~dunif(0,2) 
tau.inv <- 1/(sigma.inv*sigma.inv) 
 
sigma.iq~dunif(0,2) 
tau.iq <- 1/(sigma.iq*sigma.iq) 
 
sigma.bmi~dunif(0,2) 
tau.bmi <- 1/(sigma.bmi*sigma.bmi) 
 
sigma.creat~dunif(0,2) 
tau.creat <- 1/(sigma.creat*sigma.creat) 
 
# need priors for beta.dm1 beta.phth1[1-4] beta.phen1[1-6] beta.pyr1[1-2]  beta. phthi1[1-4) 
beta.pheni1[1-6] # #beta.pyri1[1-2] beta.f1[1-10]  
 
for (a in 1:9) { beta.f1[a] ~ dnorm (0, 1)} 
for (b in 1:6) {beta.phth1[b] ~dnorm(0, 1)} 
for (c in 1:4){beta.phen1[c] ~dnorm(0, 1)} 
#phth1.tau)} 
#phen1.tau)} 
beta.dm1~dnorm(0, 1) 
beta.de1~dnorm(0, 1) 
dap1.sigma~dunif(0.001, 5) 
dap1.tau<-1/(pow(dap1.sigma, 2)) 
beta.pyr1[1]~dnorm(0, 1) 
beta.pyr1[2]~dnorm(0,1) 
 
 
phth1.sigma ~ dunif (0.001, 5) 
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phth1.tau<-1/(pow(phth1.sigma, 2)) 
phen1.sigma~dunif(0.001, 5) 
phen1.tau<-1/(pow(phen1.sigma,2)) 
 
 
for (f in 1:12) { beta.f2[f] ~ dnorm (0, 1)} 
for (g in 1:6) {beta.phth2[g] ~dnorm(0, 1)} 
#phth2.tau)} 
for (i in 1:4){beta.phen2[i] ~dnorm(0, 1)} 
#phen2.tau)} 
beta.dm2~dnorm(0, 1) 
beta.de2~dnorm(0, 1) 
dap2.sigma~dunif(0.001, 5) 
dap2.tau<-1/(pow(dap2.sigma, 2)) 
beta.pyr2[1]~dnorm(0,1) 
beta.pyr2[2]~dnorm(0,1) 
 
 
phth2.sigma ~ dunif (0.001, 5) 
phth2.tau<-1/(pow(phth2.sigma, 2)) 
phen2.sigma~dunif(0.001, 5) 
phen2.tau<-1/(pow(phen2.sigma,2)) 
 
 
 
for (k in 1:4) { beta.f3[k] ~ dnorm (0, 1)} 
for (l in 1:6) {beta.phth3[l] ~dnorm(0, 1)} 
for (n in 1:4){beta.phen3[n] ~dnorm(0, 1)} 
beta.dm3~dnorm(0, 1) 
beta.de3~dnorm(0,1) 
beta.pyr3[1]~dnorm(0,1) 
beta.pyr3[2]~dnorm(0,1) 
 
dap3.sigma ~dunif(0.001, 5) 
dap3.tau<-1/(pow(dap3.sigma,2)) 
phth3.sigma ~ dunif (0.001, 5) 
phth3.tau<-1/(pow(phth3.sigma, 2)) 
phen3.sigma~dunif(0.001, 5) 
phen3.tau<-1/(pow(phen3.sigma,2)) 
 
for (p in 1:16) { beta.f4[p] ~ dnorm (0, 1)} 
for (q in 1:6) {beta.phth4[q] ~dnorm(0, 1)} 
#phth4.tau)} 
for (s in 1:4){beta.phen4[s] ~dnorm(0,1)} 
# phen4.tau)} 
beta.dm4~dnorm(0, 1) 
beta.de4~dnorm(0, 1) 
beta.pyr4[1]~dnorm(0,1) 
beta.pyr4[2]~dnorm(0,1) 
dap4.sigma ~dunif(0.001, 5) 
dap4.tau<-1/(pow(dap4.sigma,2)) 
 
phth4.sigma ~ dunif (0.001, 5) 
phth4.tau<-1/(pow(phth4.sigma, 2)) 
phen4.sigma~dunif(0.001, 5) 
phen4.tau<-1/(pow(phen4.sigma,2)) 
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for (u in 1:10) { beta.f5[u] ~ dnorm (0, 1)} 
for (v in 1:6) {beta.phth5[v] ~dnorm(0, 1)} 
#phth5.tau)} 
for (x in 1:4){beta.phen5[x] ~dnorm(0, 1)} 
#phen5.tau)} 
beta.dm5~dnorm(0,1) 
beta.de5~dnorm(0, 1) 
beta.pyr5[1]~dnorm(0,1) 
beta.pyr5[2]~dnorm(0,1) 
 
dap5.sigma ~dunif(0.001, 5) 
dap5.tau<-1/(pow(dap5.sigma,2)) 
phth5.sigma ~ dunif (0.001, 5) 
phth5.tau<-1/(pow(phth5.sigma, 2)) 
phen5.sigma~dunif(0.001, 5) 
phen5.tau<-1/(pow(phen5.sigma,2)) 
 
for (aa in 1:11) { beta.f6[aa] ~ dnorm (0, 1)} 
for (bb in 1:6) {beta.phth6[bb] ~dnorm(0, 1)}  
#phth6.tau)} 
for (dd in 1:4){beta.phen6[dd] ~dnorm(0,  1)} 
#phen6.tau)} 
beta.dm6~dnorm(0,  1) 
beta.de6~dnorm(0,1) 
beta.pyr6[1]~dnorm(0, 1) 
beta.pyr6[2]~dnorm(0,1) 
dap6.sigma ~dunif(0.001, 5) 
dap6.tau<-1/(pow(dap6.sigma,2)) 
 
phth6.sigma ~ dunif (0.001, 5) 
phth6.tau<-1/(pow(phth6.sigma, 2)) 
phen6.sigma~dunif(0.001, 5) 
phen6.tau<-1/(pow(phen6.sigma,2)) 
 
 
for (ee in 1:17) { beta.f7[ee] ~ dnorm (0, 1)} 
for (ff in 1:6) {beta.phth7[ff] ~dnorm(0,  1)}  
# phth7.tau)} 
for (gg in 1:4){beta.phen7[gg] ~dnorm(0,  1)}  
#phen7.tau)} 
beta.dm7~dnorm(0, 1) 
beta.de7~dnorm(0,1) 
beta.pyr7[1]~dnorm(0,1) 
beta.pyr7[2]~dnorm(0,1) 
dap7.sigma ~dunif(0.001, 5) 
dap7.tau<-1/(pow(dap7.sigma,2)) 
phth7.sigma ~ dunif (0.001, 5) 
phth7.tau<-1/(pow(phth7.sigma, 2)) 
phen7.sigma~dunif(0.001, 5) 
phen7.tau<-1/(pow(phen7.sigma,2)) 
 
 
 
for (hh in 1:16) {beta.org[hh] ~ dnorm (0, 1)} 
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for (jj in 1:15) {beta.alc[jj] ~ dnorm (0, 1)} 
for (kk in 1:16) {beta.lm[kk] ~ dnorm (0, 1)} 
for (mm in 1:16) {beta.v[mm] ~ dnorm (0, 1)} 
for (nn in 1:16) {beta.r[nn] ~ dnorm (0, 1)} 
for (oo in 1:16) {beta.home[oo] ~ dnorm (0, 1)} 
for (pp in 1:16) {beta.inv[pp] ~ dnorm (0, 1)} 
for (ii in 1:20) {beta.iq[ii] ~ dnorm (0, 1)} 
 
 
for (uu in 1:5) {beta.creat[uu]~dnorm(0,1)} 
for (vv in 1:20) {beta.bmi[vv] ~ dnorm (0, 1)} 
} 
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